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In the seven decades since the first atomic-level structures of biomolecules were determined, the 
development and application of novel research methods has led to an advanced understanding of 
biological functions at the molecular level. In addition to experimental methods, key advances 
have been spurred by computer simulations, which provide an in silico representation of 
accumulated prior knowledge of biomolecular structure and dynamics. These models can be used 
both (i) as a complement to experimental results, filling in the gaps where experimental 
information is not accessible, and (ii) as complete representations, directing future research. 
Critically, the validity of either application depends on the accuracy of the models used. In this 
work, I aspired to combine computational and experimental methods to characterize the structure 
and dynamics of the flexibly linked two-domain protein MoCVNH3. In Chapter 1 I describe my 
motivation, and the suspected simulation artifacts observed in our preliminary simulations, which 
led me to investigate how accurately simulation models represent salt bridge interactions. Chapter 
2 details my comparison of current models (“force fields”), for which significant variation but 
consistent overstabilization of salt bridges was discovered. This work motivated the development 
of a new force field, AMBER ff15ipq, which corrects, to some degree, the overstabilization and 
introduces extensive improvements, described in Chapter 3. Finally, in Chapter 4, I applied this 
new force field in simulations of MoCVNH3, for which I collected extensive experimental data 
leading to the determination of a structural ensemble. I validated the simulations against the 
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experimental data set, and identified further directions for improvement. Overall, the work 
presented here demonstrates the power of integrating experimental and computational methods. 
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1.0  MOLECULAR BIOPHYSICS OF FLEXIBLY LINKED MULTI-DOMAIN 
PROTEINS 
1.1 INTRODUCTION 
Multi-domain proteins in which the connected domains each fold and function independently are 
prevalent in nature.1,2 Such proteins, through spatial and temporal coordination of their varied 
functional units, are capable of executing specific and tailored activities in catalysis, signaling, 
regulation of gene expression, and other cellular processes.3 The individual domains are connected 
by inter-domain linkers whose length and composition enable them to adopt orientations that have 
evolved for specific biological activities and functions.4,5 In many cases, the linkers are highly 
flexible, allowing the domains to adopt numerous inter-domain orientations, from which the 
selection of functional competent conformations may occur.6 While most multi-domain proteins 
are linked linearly in sequence, roughly one tenth possess domain insertions where a ‘guest’ 
domain is implanted into a loop of a ‘host’ domain, such that the two domains are connected by a 
pair of inter-domain linkers.7 
Characterization of the relative domain orientations within multi-domain proteins has been 
challenging by traditional structural biology techniques, such as X-ray crystallography, due to the 
inherent flexibility of inter-domain linkers, lack of density for certain segments of the polypeptide 
chain, and influence of crystal packing on the positioning of domains. On the other hand, multi-
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domain proteins represent intriguing targets for integrative structural biology approaches, which 
combine results from experiments and computer simulations5,8 by either (i) computationally 
generating a large ensemble of potential structural models and subsequently filtering the models 
based on agreement between computational and experimental data, or (ii) explicitly biasing the 
generation of structural models in accord with the experimental data. Such approaches have been 
particularly useful for studying flexibly linked multi-domain proteins and protein complexes,9–15 
often integrating data from NMR, SAXS, X-ray crystallography, and other experimental 
techniques into a single structural model. Critically, the validity of any approaches aimed at 
bridging the gaps between experimentally accessible and computationally generated data depends 
on the accuracy of the biomolecular force fields used in the computations, which dictate sampling 
of the conformational space for the entire system. 
1.2 THE MOCVNH3 PROTEIN 
An ideal test system among flexibly linked multi-domain proteins is the relatively small, two-
domain protein MoCVNH3 that has been structurally characterized by our group using both NMR 
spectroscopy and X-ray crystallography.16,17 MoCVNH3 is a domain-insertion protein in which a 
‘guest’ LysM domain is inserted into a surface loop of a ‘host’ Cyanovirin-N Homology (CVNH) 
domain, positioning the LysM domain between the two pseudo-symmetric halves of two-lobed 
CVNH domain (Figure 1.1).18 This protein is found in Magnaporte oryzae, an ascomycete fungus 
that causes rice blast disease, the most devastating infection of cultivated rice, which destroys 
crops in unprecedented amounts worldwide.19 Functionally, both CVNH and LysM are 
carbohydrate-binding domains; CVNH binds to mannose sugars, while LysM interacts with 
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GlcNAc-containing carbohydrates such as peptidoglycan and chitin.20,21 The binding of 
carbohydrates by each domain in MoCVNH3 is independent of the other, with no communication 
between the domains.22 While the wild-type protein could not be crystallized, complete removal 
of the inter-domain linkers yielded a construct that crystallized and maintained the ability to bind 
both carbohydrate ligands. A comparison of the resulting crystal structure with the NMR structure 
of wild-type MoCVNH3 revealed that the absence of the linkers has no effect on the structures of 
the individual domains.17 However, although the domain structures of wild-type MoCVNH3 were 
solved to high resolution by NMR, no fixed relative domain orientations were compatible with the 
solution data, due to the lack of inter-domain restraints.22 
 
Figure 1.1. Lowest energy structure of the solution NMR ensemble of the two-domain protein MoCVNH3.22 The 
CVNH domain is shown in red, the LysM domain in blue, and the inter-domain linkers in green. Other structures 
within the ensemble have different inter-domain orientations. 
LysM
CVNH
Linkers
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1.3 SIMULATION AND SUSPECTED ARTIFACTS 
Since the details of the inter-domain orientations sampled by MoCVNH3 were inaccessible to our 
NMR data, we instead turned to all-atom molecular dynamics (MD) simulation in explicit solvent. 
MD simulation can, in principle, provide a view of biophysical processes with atomic spatial 
resolution and femtosecond temporal resolution. However, the accuracy of MD simulation is 
limited by (i) the simulation duration, restricting the accessible biological processes and the 
quantitative precision of the results, and (ii) the force field, restricting the results’ accuracy and the 
qualitative confidence that may be placed in them. Over the last two decades improvements and 
hardware and algorithms have increased the maximum achievable duration of MD simulations 
from one microsecond23 to over one millisecond.24 A key advance was the development of Anton, 
a supercomputer designed solely and specifically for running MD simulations, whose 
optimizations enable it to simulate roughly 3 orders of magnitude faster than the conventional 
resources available at the time of its development.25 We were granted an allocation on Anton to 
simulate MoCVNH3, making it feasible to seek the multi-microsecond duration we anticipated 
would be needed to characterize the distribution of inter-domain orientations. 
Increases in accessible simulation duration drive advancements in the accuracy of force 
fields, as longer simulations reveal artifacts not immediately apparent in shorter ones. In order to 
optimally make use of our Anton allocation, we used conventional resources to run a series of 1-
μs tests using several force fields and water models, eventually selecting the AMBER ff99SB-
ILDN force field and TIP4P-Ew water model for our production simulation.26,27 At the time, 
AMBER ff99SB-ILDN represented the latest generation of the AMBER force field lineage, 
including improvements to backbone and side-chain torsion parameters,26,28 while TIP4P-Ew 
offered accurate reproduction of the properties of water alongside improved reproduction of NMR 
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observables.27,29 Based on our NMR results,22 our expectation was that the two domains would 
sample a variety of inter-domain orientations over the course of our simulation. In our 1-μs test, 
this was what we observed. 
 
Figure 1.2. Fixed inter-domain orientation of MoCVNH3 observed in a 1-μs MD simulation of MoCVNH3 using the 
AMBER ff99SB-ILDN force field and TIP4P-Ew water model. Residues involved in salt bridge interactions present 
at the inter-domain interface are labeled and shown in licorice. 
 
However, when we ran our simulation of MoCVNH3 on Anton, we found that after ~30 ns 
the two domains of MoCVNH3 adopted a conformation in which the LysM domain latched onto 
the CVNH domain, and remained in this orientation for the remainder of the 1-μs simulation. This 
extensive sampling of a stable, fixed inter-domain orientation contrasted with our expectations 
based on our NMR data. We examined the inter-domain interactions between the two domains, 
finding that a series of salt bridges, or pairs of amino acids whose oppositely charged side-chains 
are within hydrogen-bonding distance,30 were a key part of the complex (Figure 1.2). Subsequent 
reexamination of our test simulation showed that similar contacts were made between the two 
domains at the end of that simulation. The two domains did not come into close contact for the 
first 850 ns of the simulation, but once they did, similar salt bridge interactions were formed for 
the remaining 150 ns. While our 1-μs simulations were insufficient to conclude that the simulation 
model contradicts experiment, it led us to suspect that the result might be an artifact of the chosen 
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force field and water model. We therefore set out to test the accuracy of salt bridge interactions in 
AMBER ff99SB-ILDN/TIP4P-Ew and other force field/water model combinations, as described 
in the next chapter. 
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2.0  THE ACCURACY OF SALT BRIDGE INTERACTIONS IN BIOMOLECULAR 
FORCE FIELDS 
This chapter is based on a research article previously published as: Debiec, K. T.; Gronenborn, A. 
M.; Chong L. T. Evaluating the strength of salt bridges: A comparison of current biomolecular 
force fields. Journal of Physical Chemistry B, 2014, 118, 6561-6569. 
2.1 INTRODUCTION 
Recent advances in computer hardware and software have greatly extended the time scales that 
can be covered by biomolecular simulations. These longer time scales (beyond nanoseconds) are 
essential for the rigorous evaluation of current biomolecular force fields. One important 
characteristic of these force fields is the ability to accurately model the formation of salt bridges, 
or pairs of amino acids whose oppositely charged side-chains are within hydrogen-bonding 
distance in proteins.30 However, it has long been suspected that the forces between oppositely 
charged amino acids are overly attractive in molecular dynamics (MD) simulations with current 
biomolecular force fields, and there have been a number of efforts to reduce this artifact in the 
improvement of various force fields.31–33 Previous theoretical studies have analyzed the 
contribution of salt bridges to protein or protein-protein complex stability using both implicit34–38 
and explicit modeling of solvation.39,40 Others have studied salt bridges using amino acid 
analogues,41–49 often using biasing techniques in the simulations.42–44 More recently, a 
comprehensive comparison of force field/water model combinations was conducted for salt bridge 
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interactions between the amino and carboxyl groups of zwitterionic amino acids using extensive 
simulations in explicit solvent on the microsecond (μs) time scale.50  
Here, we evaluated six biomolecular force fields for their ability to accurately model the 
strengths of salt bridges between the side chains of oppositely charged amino acids by unbiased, 
microsecond-scale MD simulations in explicit solvent. In particular, we directly compared current 
AMBER, CHARMM, and OPLS force fields in simulations of association between the side-chain 
analogues of three different pairs of amino acids, Arg/Asp, Lys/Asp, and His(+)/Asp. We further 
tested one of the pairs, Arg/Asp, by simulating association of blocked amino acid dipeptides. In 
addition, we evaluated the influence of the solvent model on the strengths of the salt bridges by 
simulating the side-chain analogue pairs using a selection of different force field/water model 
combinations. To our knowledge, our microsecond-scale simulations provide the most extensive 
sampling of salt bridge formation to date, yielding thousands of association/dissociation events, 
permitting quantitative comparisons, both between the force fields and with experiment. Our 
results reveal considerable variability among the current force fields in terms of the resulting 
strengths of salt bridge interactions as well as differences from experimental data. 
2.2 METHODS 
2.2.1 Preparation of starting models 
We modeled the formation of salt bridges between the following pairs of oppositely charged amino 
acids using side-chain analogues: Arg/Asp (guanidinium cation/acetate anion), Lys/Asp 
(butylammonium cation/acetate anion), and His(+)/Asp (imidazolium cation/acetate anion). Our 
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systems were constructed to be consistent with the experimental conditions under which the 
equilibrium association constants (KA) of guanidinium acetate and butylammonium acetate have 
been measured,51 i.e. using the same concentrations (0.9 M guanidinium and 0.02 M acetate, which 
corresponds to 100 molecules of guanidinium and two molecules of acetate in the presence of 
~18,000 explicit water molecules). To ensure a net charge of zero, we included 98 chloride ions 
(the same counterion that is present in the experiments). The same concentrations of the cation, 
anion, and chloride ions were also used for the model systems consisting of 
butylammonium/acetate and imidazolium/acetate. Starting models for these simulations were 
constructed using the Packmol software package,52 immersing the appropriate number of side-
chain analogues in periodic, cubic boxes of explicit solvent. For the Arg/Asp salt bridge, we also 
used blocked amino acid dipeptides (acetyl—arginine—N-methylamide and acetyl—aspartate—
N-methylamide) to model salt bridge formation. Only a single copy of each blocked dipeptide was 
included, corresponding to a concentration of 0.012 M for each salt-bridging partner, with a 
distance of 10 Å between the amino acids. All force field parameters of the side-chain analogues 
were based on those of the complete amino acids. For the chloride ions, parameters derived 
specifically for the water model were used when available; otherwise, parameters derived for a 
similar water model were used.53–55 Nonbonded parameters of the side-chain analogues, along with 
those used to model chloride ions and blocked amino acid dipeptides are provided in the associated 
publication.56 
To alleviate any unfavorable interactions, each model was subjected to energy 
minimization followed by a two-stage equilibration with harmonic position restraints on all heavy 
atoms of the side-chain analogues (force constant of 10 kcal mol-1 Å-2) using the Desmond 3.0.1.0 
software package.57 In the first stage, the energy-minimized system was equilibrated for 20 ps at 
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constant temperature (25 oC) using a weak Langevin thermostat58 (frictional constant of 1 ps-1). 
During the second stage, the system was equilibrated for 1 ns at constant temperature (25 oC) and 
pressure (1 atm) using the Martyna-Tobias-Klein thermostat and barostat59 (coupling time 
constants of 1.0 ps and 2.0 ps, respectively). To enable a 2-fs time step, bonds to hydrogen were 
constrained to their equilibrium values using the M-SHAKE algorithm.60 A short-range nonbonded 
cutoff of 10.0 Å was used, and long-range electrostatics were calculated using the particle mesh 
Ewald (PME) method.61 The frame from the second half of the NPT equilibration with volume 
closest to the average was used to start the production simulation. 
2.2.2 Simulation details 
To obtain extensive sampling of salt bridge association (and dissociation) events, 1-µs MD 
simulations were performed for each side-chain analogue system; 10-µs simulations were 
performed for the blocked arginine and aspartate dipeptide systems. All simulations were carried 
out in the NVT ensemble using a 64-node Anton special-purpose supercomputer, which is able to 
run MD simulations roughly two orders of magnitude faster than conventional hardware25 
(altogether, the simulations required a total of 40 machine-days). The temperature was maintained 
at 25 oC using the Nosé-Hoover thermostat62 with a weak coupling constant of 0.5 ps. Van der 
Waals and short-range electrostatic interactions were truncated at 10.0 Å; long-range electrostatic 
interactions were calculated using the Gaussian split Ewald method.63 To enable a 2.5-fs time step, 
bonds to hydrogen were constrained to their equilibrium lengths using the M-SHAKE algorithm.60 
Conformations were saved every picosecond for analysis. 
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2.2.3 Calculation of equilibrium association constants 
Equilibrium association constants (KA) were calculated from the populations of the bound and 
unbound states of the oppositely charged side-chain analogues. For example, the KA for association 
between guanidinium and acetate was calculated using the following: 
𝐾𝐴 =
[𝑏𝑜𝑢𝑛𝑑 𝑠𝑡𝑎𝑡𝑒]
[𝑢𝑛𝑏𝑜𝑢𝑛𝑑 𝑠𝑡𝑎𝑡𝑒][𝑢𝑛𝑏𝑜𝑢𝑛𝑑 𝑔𝑢𝑎𝑛𝑖𝑑𝑖𝑛𝑖𝑢𝑚]
= (
𝑃𝑏𝑜𝑢𝑛𝑑
𝑃𝑢𝑛𝑏𝑜𝑢𝑛𝑑 𝑎𝑐𝑒𝑡𝑎𝑡𝑒𝑃𝑢𝑛𝑏𝑜𝑢𝑛𝑑 𝑔𝑢𝑎𝑛𝑖𝑑𝑖𝑛𝑖𝑢𝑚
) (
1
𝐶0
) (2.1) 
where Pbound is the population of the bound state; Punbound guanidinium and Punbound acetate are the 
populations of unbound guanidinium and acetate, respectively; and C0 is the reference 
concentration of guanidinium (i.e., 0.9 M). In addition to species in which a single acetate molecule 
is bound to a single cation molecule, forming a 1:1 complex (e.g., the guanidinium/acetate 
complex), species in which acetate is bound to two cation molecules, forming a 1:2 complex (e.g., 
the diguanidinium/acetate complex) were observed. KA values for the latter are included in Table 
2.3; the results discussed below focus on formation of the major complex, which is the 1:1 
complex. Standard errors in the KA values were calculated using a block averaging method.
64 
For each side-chain analogue system, the unbound and bound states were defined using the 
potential of mean force (PMF) as a function of the minimum distance between the nitrogen and 
oxygen atoms of the positively and negatively charged analogues, respectively (minimum N-O 
distance; see Figure 2.1). In particular, the point of inflection between the bound state free energy 
minimum (~2.5-3 Å) and the desolvation barrier (~3-3.5 Å) was used as the bound state cutoff, 
while 4.5 Å was used as the unbound state cutoff. If the minimum N-O distance between an 
analogue pair dropped below the bound state cutoff they were classified as bound until they crossed 
the unbound state cutoff, and vice versa. For simulations of the blocked arginine and aspartate 
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dipeptides, the same definitions of the unbound and bound states were used as for the 
guanidinium/acetate system. 
 
 
Figure 2.1. Potentials of mean force (PMF) between three different pairs of oppositely charged side-chain analogues 
using six biomolecular force fields with the TIP4P-Ew explicit water model. 
2.2.4 Calculation of the solvent dielectric constant 
The dielectric constant of water in each simulation, εwater, was calculated using the following 
equation: 
𝜀 = 1 +
〈𝑀𝑤𝑎𝑡𝑒𝑟
2 〉 − 〈𝑀𝑤𝑎𝑡𝑒𝑟〉
2
3𝜀0𝑉𝑤𝑎𝑡𝑒𝑟𝑘𝐵𝑇
(2.2) 
where Mwater is the net dipole moment of water, Vwater is the volume occupied by water, T is the 
temperature of the system, kB is the Boltzmann constant, and ε0 is the permittivity of free space. 
The net dipole moment of water was calculated using the following: 
𝑀𝑤𝑎𝑡𝑒𝑟 = ∑ 𝑞𝑖𝑟𝑖
𝑁
𝑖=1
(2.3) 
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where q is the atomic charge of each water site and r is its position vector.65,66 The dielectric 
constant of water, rather than that of the complete system, was used since it is impossible to 
calculate the contributions of molecules with a net charge to the system dipole moment from 
simulations with periodic boundary conditions.66 The appropriate volume was thus the volume of 
the water molecules present in the system. For each water model used, a pure water system of the 
same total volume as that of the amino acid analogue systems was equilibrated using the same 
protocol and the molecular volume of water calculated. For each analogue system, the number of 
water molecules present was multiplied by the molecular volume to calculate the approximate 
volume of water present in the system. Standard errors in the εwater values were calculated using a 
block averaging method.64 
2.3 RESULTS AND DISCUSSION 
We compared the following six current biomolecular force fields in terms of their ability to model 
salt bridge interactions: AMBER ff99SB-ILDN,28 AMBER ff03,31 AMBER ff13α,33 
CHARMM27,67 CHARMM22*,32 and OPLS_2005.68 In particular, we simulated association (and 
dissociation) of salt bridges between the following three pairs of oppositely charged amino acids: 
Arg/Asp, Lys/Asp, and His(+)/Asp. We focused primarily on simulating side-chain analogues (i.e., 
guanidinium, butylammonium, and imidazolium cations for arginine, lysine, and histidine, 
respectively, and acetate anion for aspartate) since these analogues are the minimal systems for 
studying the formation of salt bridges. In addition, equilibrium association constant (KA) values 
for such systems have been experimentally measured,51,69 providing an excellent opportunity to 
validate the simulations. While blocked amino acid dipeptides (i.e., acetyl—amino acid—N-
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methylamide) might be regarded as being more representative of the protein environment, no 
experimental KA values for the association of oppositely charged amino acid dipeptides are 
available. Nonetheless, we evaluated the force fields in simulating such systems, focusing on just 
one of the three salt bridges, Arg/Asp. Finally, in addition to the above simulations, in which each 
biomolecular force field was paired with the TIP4P-Ew explicit water model, which reproduces 
the liquid properties of water at the temperatures and pressures relevant to biology,27 we also 
evaluated the influence of the water model on the strength of the salt bridges by testing a selection 
of force field/water model combinations for all three pairs of side-chain analogues. For each force 
field a selection of water models drawn from TIP3P,70 mTIP3P,71 TIP4P,70 TIP4P/2005,72 and 
SPC/E73 were tested, including the water model with which each force field was originally derived. 
2.3.1 Association constants of side-chain analogues 
To validate our simulations of association between oppositely charged side-chain analogues, we 
computed KA values and compared these to those measured by experiments. Experimental KA 
values have been measured for guanidinium/acetate and butylammonium/acetate association by 
monitoring changes in the pKa of acetate in the presence or absence of either the guanidinium or 
butylammonium cation.51 Our microsecond-long simulations yielded thousands of independent 
binding events, permitting the extraction of extremely precise KA values, with the mean lifetimes 
of the bound state ranging from ~10-300 ps and the mean lifetimes of the unbound state ranging 
from ~20-120 ps (Table 2.3). 
In general, the KA values computed from our side-chain analogue simulations are 
overestimated in comparison to experimentally measured values, with the AMBER ff03 force field 
overestimating the strengths of the salt bridges to the least extent and the OPLS_2005 force field 
   15 
to the greatest extent, when using the same water model (Table 2.1). The computed KA values vary 
considerably among the force fields. For example, when using the TIP4P-Ew water model, the 
computed KA values for the three types of salt bridges vary by as much as ~4-fold, ~3-fold, and 
~4-fold for the associations of guanidinium, butylammonium, and imidazolium with acetate, 
respectively, which amounts to ~1.4-fold, ~1.8-fold, and ~1.9-fold differences in the probabilities 
of binding (Pbound) (see Figure 2.2). We note that our definition of the bound state is very 
conservative and that the use of less conservative definitions (e.g., use of the desolvation barrier 
as a cutoff) yields even stronger association constants, without affecting our overall conclusions. 
 
 
Figure 2.2. Probabilities of binding (Pbound) between acetate and one or more molecules of three cationic side-chain 
analogues using six biomolecular force fields with the TIP4P-Ew explicit water model. The Pbound values that 
correspond to the experimentally determined KA values of guanidinium acetate and butylammonium acetate are 
depicted as horizontal gray bars;51 no experimentally measured KA is available for the imidazolium acetate system. 
Error bars represent 95% confidence intervals calculated using a block averaging method.64  
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Table 2.1. Association constants (KA) and probabilities of binding (Pbound) for three different pairs of oppositely 
charged side-chain analogues using six biomolecular force fields and six explicit water models. Results are from 1-μs 
simulations and standard errors were calculated using a block averaging method.64 
Force Field  
Water 
Model 
Guanidinium/Acetate Butylammonium/Acetate Imidazolium/Acetate 
Pbound
a
  KA (M
-1) Pbound
a
  KA (M
-1) Pbound
a
  KA (M
-1) 
AMBER ff99SB-ILDN TIP4P-Ew   0.57 2.23 ± 0.03   0.32 0.53 ± 0.01   0.36 0.65 ± 0.01 
AMBER ff03 TIP4P-Ew   0.45 1.12 ± 0.01   0.28 0.45 ± 0.00   0.32 0.54 ± 0.00 
AMBER ff13ALPHA TIP4P-Ew   0.54 2.28 ± 0.03   0.48 1.20 ± 0.01   0.40 0.79 ± 0.01 
CHARMM27 TIP4P-Ew   0.61 4.06 ± 0.10   0.45 0.98 ± 0.01   0.35 0.63 ± 0.01 
CHARMM22* TIP4P-Ew   0.48 1.31 ± 0.02   0.39 0.75 ± 0.01   0.29 0.47 ± 0.00 
OPLS-AA TIP4P-Ew   0.63 5.03 ± 0.25   0.53 1.43 ± 0.03   0.57 2.25 ± 0.06 
OPLS_2005 TIP4P-Ew   0.63 4.92 ± 0.17   0.50 1.27 ± 0.02   0.55 1.96 ± 0.04 
AMBER ff99SB-ILDN TIP3P   0.57 4.52 ± 0.09   0.39 0.78 ± 0.01   0.45 1.04 ± 0.01 
AMBER ff03 TIP3P   0.49 1.53 ± 0.01   0.33 0.58 ± 0.00   0.36 0.65 ± 0.00 
CHARMM27 TIP3P   0.53 9.03 ± 0.34   0.52 1.65 ± 0.03   0.44 1.00 ± 0.01 
CHARMM22* TIP3P   0.52 1.88 ± 0.02   0.44 1.03 ± 0.01   0.34 0.59 ± 0.00 
OPLS-AA TIP3P   0.56 13.57 ± 0.73   0.55 2.42 ± 0.05   0.55 3.85 ± 0.12 
OPLS_2005 TIP3P   0.59 11.65 ± 0.59   0.54 2.22 ± 0.04   0.55 3.37 ± 0.10 
CHARMM27 mTIP3P   0.58 6.34 ± 0.20   0.47 1.20 ± 0.02   0.39 0.77 ± 0.01 
CHARMM22* mTIP3P   0.49 1.41 ± 0.01   0.50 0.76 ± 0.01   0.29 0.48 ± 0.00 
CHARMM22* mTIP3P   0.49 1.38 ± 0.01     
OPLS_2005 TIP4P   0.60 8.18 ± 0.30     0.57 3.07 ± 0.07 
AMBER ff03 TIP4P/2005   0.42 0.94 ± 0.01     0.29 0.46 ± 0.00 
AMBER ff99SB-ILDN SPC/E   0.60 2.98 ± 0.05     0.42 0.84 ± 0.01 
CHARMM27 SPC/E   0.64 5.62 ± 0.17   0.49 1.23 ± 0.02   0.40 0.78 ± 0.01 
CHARMM22* SPC/E   0.51 1.54 ± 0.02     0.31 0.52 ± 0.00 
OPLS_2005 SPC/E   0.66 5.26 ± 0.19     0.58 2.13 ± 0.04 
Experiment51,69,
b
 ~0.25 ± 0.03 ~0.37 ± 0.05 ~0.22 ± 0.03 ~0.31 ± 0.05 
  
  
                                               
a Standard errors of Pbound were uniformly ≤0.01. 
b Experimental KA values of guanidinium and butylammonium acetate permit only a qualitative estimate of the 
associated error. Taking two experimentally measured KA values of guanidinium acetate using different protocols into 
account,51,69 we estimate an error of ±0.05, although the true uncertainty is not known. Using this estimate, we have 
back-calculated the range of simulated Pbound values that would be expected in our simulation, based on the 
experimental KA. 
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One potential factor that could influence the degree of salt bridge formation in our 
simulations is the choice of force field parameters for the chloride ions. To verify that these 
parameters are not the cause for overestimating salt bridge strength, we carried out simulations of 
a single guanidinium/acetate pair (corresponding to concentrations of 0.1 M) with no chloride ions 
present. The resulting KA values are even higher than those measured in the presence of chloride 
ions, indicating that the chloride ion parameters do not cause disproportionate salt bridge stability 
(Table 2.4). 
Two obvious features of a force field that influence the strength of the salt bridges are the 
atomic charges and radii. As expected, the CHARMM22* force field yields KA values that are 
closer to experiment than those from the parent CHARMM27 force field since the atomic charges 
for the arginine, aspartate, and glutamate residues were parametrized specifically to reproduce the 
experimental association of guanidinium acetate.32 However, the CHARMM22* force field does 
not produce as close agreement with experiment as the AMBER ff03 force field, which shows 
good agreement for butylammonium acetate. Given these results, it appears that the general 
strategy used to derive atomic charges for the AMBER ff03 force field is reasonably effective for 
modeling electrostatic interactions. This strategy involved the derivation of atomic charges in the 
presence of a continuum solvent model with a dielectric constant of 4 to mimic an organic solvent 
(protein-like) environment. The resulting atomic charges in the AMBER ff03 force field are 
notably less polarized than those in the AMBER ff9X family (including the AMBER ff99SB-
ILDN force field tested here), which were derived in vacuum and share the same set of atomic 
radii. The AMBER ff03 atomic charges are also less polarized than those in the AMBER ff13 
force field, with atomic charges possessing increased polarity relative to previous AMBER charge 
models.33 In the AMBER ff13 charge model, nonpolarizable point charges have been fit to 
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implicitly account for solvent polarization, using iterative cycles of classical MD simulations with 
explicit water (i.e., TIP4P-Ew) to estimate the water charge density around the solute, followed by 
quantum mechanical calculations to determine updated solute charges. 
Interestingly, although certain critical atomic radii (e.g., the nitrogen in butylammonium 
and the oxygen in acetate) in the AMBER ff13 force field were adjusted from their original values 
in the AMBER ff99 force field to reproduce experimental hydration free energies of the relevant 
amino acid analogues,33 the resulting strengths of the salt bridges are more overestimated, relative 
to the other tested AMBER force fields. Notably, the AMBER ff13 force field results in a free 
energy landscape for salt bridge formation that is significantly different from those of the other 
force fields. In particular, as shown by the PMFs as a function of the minimum N-O distance 
between the oppositely charged analogues for the three types of salt bridges (Figure 2.1), the free 
energy minima for the bound states are consistently shifted to the right in the AMBER ff13α force 
field relative to the other force fields. When we substituted the atomic radii in the AMBER ff13 
force field with the original radii from the AMBER ff99 force field, the free energy minima for 
the bound states shifted back towards those of the other force fields and yielded significantly 
deeper minima as well as more pronounced desolvation barriers, particularly for the 
guanidinium/acetate and imidazolium/acetate systems (Figure 2.7). 
Since the atomic charges of the OPLS_2005 force field are not significantly different from 
those of the other force fields, the most likely reason for the fact that this force field overestimates 
the KA values to the greatest extent is that the atomic radii of the nitrogen-attached hydrogen atoms 
are smaller than those used by the other force fields, potentially allowing the pairs to associate 
more closely and increasing their electrostatic attraction. Consistent with this notion, simulations 
using the OPLS-AA force field, which differs from the OPLS_2005 force field only in that it omits 
   19 
atomic radii for these hydrogen atoms, resulted in slightly more strongly associated salt bridges 
(Table 2.3). We note that the ranking of the strengths of the three types of side-chain salt bridges 
in our study by the AMBER ff99SB-ILDN, CHARMM27, and OPLS-AA force fields is consistent 
with that observed for their oppositely charged termini in a recent study by others.50 
2.3.2 Association constants of amino acid dipeptides 
As mentioned above, we additionally tested salt bridge formation of the Arg/Asp pair by 
simulating association/dissociation of blocked amino acid dipeptides, testing six different force 
fields in conjunction with the TIP4P-Ew explicit water model. As shown in Table 2.2, the relative 
ranking of the force fields in terms of the KA is generally consistent with our results from the 
corresponding side-chain analogue system (guanidinium/acetate). The only exception is the 
AMBER ff13α force field, which yields the weakest KA for the association of the amino acid 
dipeptides, as opposed to an intermediate KA value for the association of guanidinium/acetate. As 
indicated by the PMF between the arginine and aspartate dipeptides (Figure 2.3), the bound state 
free energy minimum of the AMBER ff13α force field is the most shallow among the tested force 
fields, corresponding to the lowest frequency of salt bridge formation. The inclusion of the 
backbone groups, therefore, appears to alter its propensity for salt bridge formation, likely through 
the competition of side-chain/backbone interactions with the side-chain/side-chain interactions 
between the two amino acids. This result emphasizes the benefit of using unbiased simulations; 
had the relative orientations of the amino acids been fixed as in previous studies,14 any effects of 
significant side-chain/backbone interactions on the frequency of salt bridge formation would not 
have been apparent. 
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Table 2.2. Association constants (KA) and probabilities of side-chain/side-chain (PSC/SC bound) and side-chain/backbone 
association (PSC/BB bound), respectively, for blocked arginine and aspartate dipeptides using six biomolecular force fields 
with the TIP4P-Ew water model. Results are from 10-μs simulations and standard errors were calculated using a block 
averaging method.64 
Force Field Water Model 
Arginine/Aspartate 
 
PSC/SC bound KA (M
-1) PSC/BB bound PSC/SC bound / PSC/BB bound 
AMBER ff99SB-ILDN TIP4P-Ew 0.041 ± 0.003 3.51 ± 0.94 0.010 ± 0.001 4.1 ± 0.4 
AMBER ff03 TIP4P-Ew 0.033 ± 0.002 3.24 ± 0.67 0.017 ± 0.001 1.9 ± 0.2 
AMBER ff13α TIP4P-Ew 0.023 ± 0.002 1.83 ± 0.43 0.018 ± 0.001 1.3 ± 0.1 
CHARMM27 TIP4P-Ew 0.113 ± 0.012 7.53 ± 3.60 0.007 ± 0.001 16.4 ± 2.0 
CHARMM22* TIP4P-Ew 0.038 ± 0.003 3.11 ± 0.65 0.007 ± 0.001 5.5 ± 0.5 
OPLS_2005 TIP4P-Ew 0.153 ± 0.016 19.07 ± 8.58 0.013 ± 0.001 11.8 ± 1.6 
 
 
 
Figure 2.3. Potentials of mean force (PMF) between blocked arginine and aspartate dipeptides using six biomolecular 
force fields with the TIP4P-Ew water model. The larger noise level compared to the data presented in Figure 2.1 is 
caused by simulating a single pair of binding partners, rather than a concentrated solution. 
 
To monitor side-chain/backbone association, we used the same minimum N-O distance 
coordinate and bound and unbound state definitions as used for the side-chain/side-chain 
interactions. A comparison of the relative probabilities of side-chain/side-chain versus side-
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chain/backbone association (Figure 2.4) reveals that the force fields generally prefer side-
chain/side-chain association by a factor of ~2x or more over side-chain/backbone association. The 
exception is AMBER ff13α, which shows a lower preference for side-chain/side-chain association 
of ~1.3x. This slight preference over side-chain/backbone association is likely due to the 
substantially more polarized backbone amide and carbonyl groups of the AMBER ff13 force 
field relative to previous AMBER force fields (including the AMBER ff99SB-ILDN and AMBER 
ff03 force fields).33 Thus, as a result of the delicate balance of side-chain/side-chain and side-
chain/backbone interactions, the strength of the Arg/Asp salt bridge appears to be most accurately 
modeled (least overstabilized) by the AMBER ff13 force field in a model system that is 
representative of a protein environment. 
 
Figure 2.4. Probability of side-chain/side-chain association (𝐏𝐛𝐨𝐮𝐧𝐝
𝐒𝐂/𝐒𝐂 ) over the probability of side-chain/backbone 
association (𝐏𝐛𝐨𝐮𝐧𝐝
𝐒𝐂/𝐁𝐁) between blocked arginine and aspartate dipeptides using six biomolecular force fields with the 
TIP4P-Ew water model. Error bars represent 95% confidence intervals calculated using a block averaging method.64 
2.3.3 Influence of the water model 
In addition to the force field, the choice of water model can affect the strength of salt bridges. To evaluate the 
influence of the water model, we tested the above three side-chain analogue systems with a selection of force 
field/water model combinations in addition to the force field/TIP4P-Ew combinations. Regardless of the water 
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model, the relative ranking of the force fields is unchanged in terms of the KA values, with Pbound varying by 5-
10% between the water models (Table 2.1). We also evaluated the dependence of salt bridge interactions on the 
dielectric constant of the employed water model (εwater). Interestingly, despite the fact that the SPC/E water 
model yields a computed dielectric constant (εwater = 70;  
Table 2.5) that is closest to the experimental value (εwater = 78.4)74 among all of the tested water models, the use 
of the SPC/E water model results in stronger salt bridge interactions than seen with the TIP4P-Ew water model, 
in which the εwater value is underestimated (εwater= 56;  
Table 2.5). In fact, as shown in Figure 2.5, there appears to be no clear correlation between εwater 
of the water model and the strength of the salt bridges. As an aside, the CHARMM27 and 
CHARMM22* force fields were tested with both the standard TIP3P and the CHARMM-modified 
TIP3P (mTIP3P) water model with which they were developed. The mTIP3P water model includes 
atomic radii on hydrogen as well as oxygen atoms,71 whereas standard TIP3P includes only the 
oxygen atom. Using the mTIP3P water model consistently results in lower KA values, in better 
agreement with experiment. This suggests that it may be advisable to use of the CHARMM-
modified TIP3P, rather than the standard TIP3P water model with any CHARMM force field. 
 
Figure 2.5. Relationship between the probability of binding (Pbound) and the dielectric constant of the water model 
(εwater) for three different pairs of oppositely charged side-chain analogues simulated using six biomolecular force 
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fields and six explicit water models. The Pbound values that correspond to the experimental association constants (KA) 
for the guanidinium acetate and butylammonium acetate systems are depicted as horizontal gray bars;51,69 no 
experimentally measured KA is available for the imidazolium acetate system. The εwater values were calculated from 
the first 100 ns of each simulation. For each model, the presence of the solutes lowers the εwater for each system by 
10−15 relative to that of pure water ( 
Table 2.5). Note that the error bars are not visible, because 95% confidence intervals for both Pbound and εwater lie 
within the symbols’ area in the graph. 
2.4 CONCLUSIONS 
We compared the modeling of salt bridge interactions using six current biomolecular force fields. 
Three different salt bridges (Arg/Asp, Lys/Asp, and His(+)/Asp) were simulated and considerable 
differences in their strengths were noted, both between the force fields and with experiment. Given 
the availability of experimentally measured KA values for the association of oppositely charged 
side-chain analogues, we have focused primarily on modeling salt bridge formation using these 
systems. We also tested the applicability of our results to amino acids by simulating blocked amino 
acid dipeptides for one of the salt bridges, Arg/Asp. 
Our side-chain analogue simulations reveal that the computed KA values are generally 
overestimated, relative to experimental values, with the AMBER ff03 force field overestimating 
the strengths of the salt bridges to the least extent and the OPLS_2005 force field to the greatest 
extent when using the same water model (TIP4P-Ew). For the blocked arginine and aspartate 
dipeptides, we observed general agreement in the relative ranking of the force fields with that 
obtained from simulations with the corresponding side-chain analogues. The only exception is the 
AMBER ff13α force field, which resulted in the lowest probability of salt bridge formation, likely 
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due to the presence of competing side-chain/backbone interactions. Thus, while the AMBER ff03 
force field overestimates the strength of salt bridges to the least extent for the side-chain analogue 
systems, the AMBER ff13 force field results in an even lower frequency of salt bridge formation 
than the AMBER ff03 force field for the complete amino acids. Finally, we examined the influence 
of the water model on the strengths of the salt bridges. Irrespective of the water model, the relative 
ranking of the force fields remained unchanged, with no clear correlation between the probability 
of binding (salt bridge formation) and the dielectric constant of the solvent (εwater). 
In conclusion, when running MD simulations in which salt bridge formation may be of 
interest, careful attention should be paid to the specific force field and water model in MD 
simulations of protein systems. Several current force fields yield considerably higher KA values 
than those experimentally determined, a discrepancy that may lead to erroneous conclusions. Our 
encouraging results with the AMBER ff13 force field suggest that charge derivation strategies 
which implicitly incorporate solvent polarization from explicit water may significantly extend the 
lifetime of fixed-charge force fields, which include all of the force fields tested in this study. 
Nonetheless, departures from these simple point charge models may also be necessary. For 
example, using polarizable force fields that permit varying the charge distribution within a 
molecule based on both its conformation and environment may alleviate such shortcomings. In the 
past, the solvation of ions75,76 and charged small molecules,77 have been modeled using polarizable 
force fields, resulting in improved agreement with experiment, compared to CHARMM27 and 
AMBER ff99 force fields (equivalent to the AMBER ff99SB-ILDN force field used here). Future 
work will determine whether or not this also holds for protein salt bridges 
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2.6 SUPPORTING INFORMATION 
2.6.1 Supporting figures 
 
Figure 2.6. Structures and atom names for side-chain analogues and blocked amino acid dipeptides. 
 
Figure 2.7. Potentials of mean force (PMF) between three different pairs of oppositely charged amino acid analogues 
using the AMBER ff13α force field with its modified atomic radii or with those of the AMBER ff99 force field. The 
former simulation was 1 µs in duration while the latter was 100 ns in duration. 
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2.6.2 Supporting tables 
Table 2.3. Association constants (KA), probabilities of binding (Pbound), and mean lifetimes of the bound and unbound 
states for three different pairs of oppositely charged side-chain analogues using six biomolecular force fields and six 
explicit water models. In addition, the OPLS-AA force field, which differs from the OPLS_2005 force field only in 
the omission of atomic radii on nitrogen-attached hydrogens, was tested. Results are from 1-μs simulations (with the 
exception of those run with the OPLS-AA force field and TIP4P-Ew water model, which were 500-ns in duration) 
and standard errors were calculated using a block averaging method.64 
Guanidinium (G) / Acetate (A) 
Force Field 
Water 
Model 
G + A ⇌ GA G + GA ⇌ G2A Mean Lifetime 
of Bound State 
(ps)
c
 
Mean Lifetime of 
Unbound State 
(ps)
c
 
Pbound
c
 KA (M
-1) Pbound
c
 KA (M
-1)
c
 
AMBER ff99SB-ILDN TIP4P-Ew   0.57 2.23 ± 0.03 0.14 0.28 46 34 
AMBER ff03 TIP4P-Ew   0.45 1.12 ± 0.01 0.09 0.22 22 25 
AMBER ff13α TIP4P-Ew   0.54 2.28 ± 0.03 0.18 0.37 30 22 
CHARMM27 TIP4P-Ew   0.61 4.06 ± 0.10 0.21 0.39 82 45 
CHARMM22* TIP4P-Ew   0.48 1.31 ± 0.02 0.10 0.24 31 33 
OPLS-AA TIP4P-Ew
d
   0.63 5.03 ± 0.25 0.22 0.40 169 75 
OPLS_2005 TIP4P-Ew   0.63 4.92 ± 0.17 0.21 0.38 161 76 
AMBER ff99SB-ILDN TIP3P   0.57 4.52 ± 0.09 0.26 0.52 53 28 
AMBER ff03 TIP3P   0.49 1.53 ± 0.01 0.14 0.31 24 22 
CHARMM27 TIP3P   0.53 9.03 ± 0.34 0.36 0.75 98 43 
CHARMM22* TIP3P   0.52 1.88 ± 0.02 0.16 0.34 35 29 
OPLS-AA TIP3P
d
   0.56 13.57 ± 0.73 0.36 0.71 232 75 
OPLS_2005 TIP3P   0.59 11.65 ± 0.59 0.32 0.61 214 75 
CHARMM27 mTIP3P   0.58 6.34 ± 0.20 0.29 0.56 95 48 
CHARMM22* mTIP3P   0.49 1.41 ± 0.01 0.12 0.27 32 33 
CHARMM22* mTIP3P   0.49 1.38 ± 0.01 0.11 0.25 32 33 
OPLS_2005 TIP4P   0.60 8.18 ± 0.30 0.29 0.54 144 49 
AMBER ff03 TIP4P/2005   0.42 0.94 ± 0.01 0.07 0.19 21 27 
AMBER ff99SB-ILDN SPC/E   0.60 2.98 ± 0.05 0.16 0.30 54 35 
CHARMM27 SPC/E   0.64 5.62 ± 0.17 0.22 0.38 96 46 
CHARMM22* SPC/E   0.51 1.54 ± 0.02 0.11 0.24 36 34 
OPLS_2005 SPC/E   0.66 5.26 ± 0.19 0.19 0.33 192 89 
Experiment51,69,
e
 ~0.25 ± 0.03 ~0.37 ± 0.05 
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Butylammonium (B) / Acetate (A) 
Force Field 
Water 
Model 
B + A ⇌ BA B + BA ⇌ B2A Mean Lifetime 
of Bound State 
(ps)
c
 
Mean Lifetime of 
Unbound State 
(ps)
c
 
Pbound
c
 KA (M
-1) Pbound
c
 KA (M
-1)
c
 
AMBER ff99SB-ILDN TIP4P-Ew   0.32 0.53 ± 0.01   0.02 0.07 27 58 
AMBER ff03 TIP4P-Ew   0.28 0.45 ± 0.00   0.02 0.07 16 30 
AMBER ff13α TIP4P-Ew   0.48 1.20 ± 0.01   0.07 0.16 53 53 
CHARMM27 TIP4P-Ew   0.45 0.98 ± 0.01   0.04 0.10 78 91 
CHARMM22* TIP4P-Ew   0.39 0.75 ± 0.01   0.04 0.11 48 74 
OPLS-AA TIP4P-Ew
d
   0.53 1.43 ± 0.03   0.07 0.15 103 86 
OPLS_2005 TIP4P-Ew   0.50 1.27 ± 0.02   0.06 0.14 99 91 
AMBER ff99SB-ILDN TIP3P   0.39 0.78 ± 0.01   0.05 0.13 34 50 
AMBER ff03 TIP3P   0.33 0.58 ± 0.00   0.03 0.12 17 33 
CHARMM27 TIP3P   0.52 1.65 ± 0.03   0.12 0.26 127 89 
CHARMM22* TIP3P   0.44 1.03 ± 0.01   0.08 0.20 68 74 
OPLS-AA TIP3P
d
   0.55 2.42 ± 0.05   0.18 0.37 172 85 
OPLS_2005 TIP3P   0.54 2.22 ± 0.04   0.18 0.37 164 86 
CHARMM27 mTIP3P   0.47 1.20 ± 0.02   0.09 0.20 112 105 
CHARMM22* mTIP3P   0.50 0.76 ± 0.01   0.06 0.14 57 87 
CHARMM27 SPC/E   0.49 1.23 ± 0.02   0.06 0.14 107 102 
Experiment51,69,
e
 ~0.22 ± 0.03 ~0.31 ± 0.05 
    
        
 
        
Imidazolium (I) / Acetate (A) 
Force Field 
Water 
Model 
I + A ⇌ IA I + IA ⇌ I2A Mean Lifetime 
of Bound State 
(ps)
c
 
Mean Lifetime of 
Unbound State 
(ps)
c
 
Pbound
c
 KA (M
-1) Pbound
c
 KA (M
-1)
c
 
AMBER ff99SB-ILDN TIP4P-Ew   0.36 0.65 ± 0.01   0.03 0.10 23 43 
AMBER ff03 TIP4P-Ew   0.32 0.54 ± 0.00   0.03 0.10 13 27 
AMBER ff13α TIP4P-Ew   0.40 0.79 ± 0.01   0.04 0.12 18 28 
CHARMM27 TIP4P-Ew   0.35 0.63 ± 0.01   0.03 0.10 37 67 
CHARMM22* TIP4P-Ew   0.29 0.47 ± 0.00   0.02 0.09 23 55 
OPLS-AA TIP4P-Ew
d
   0.57 2.25 ± 0.06   0.14 0.27 163 95 
OPLS_2005 TIP4P-Ew   0.55 1.96 ± 0.04   0.14 0.28 150 97 
AMBER ff99SB-ILDN TIP3P   0.45 1.04 ± 0.01   0.06 0.16 28 34 
AMBER ff03 TIP3P   0.36 0.65 ± 0.00   0.04 0.12 13 24 
CHARMM27 TIP3P   0.44 1.00 ± 0.01   0.07 0.18 53 63 
CHARMM22* TIP3P   0.34 0.59 ± 0.00   0.04 0.13 28 55 
OPLS-AA TIP3P
d
   0.55 3.85 ± 0.12   0.27 0.55 278 105 
OPLS_2005 TIP3P   0.55 3.37 ± 0.10   0.26 0.52 255 105 
CHARMM27 mTIP3P   0.39 0.77 ± 0.01   0.05 0.14 49 74 
CHARMM22* mTIP3P   0.29 0.48 ± 0.00   0.03 0.11 26 62 
OPLS_2005 TIP4P   0.57 3.07 ± 0.07   0.21 0.42 145 63 
AMBER ff03 TIP4P/2005   0.29 0.46 ± 0.00   0.02 0.08 12 31 
AMBER ff99SB-ILDN SPC/E   0.42 0.84 ± 0.01   0.04 0.10 28 41 
CHARMM27 SPC/E   0.40 0.78 ± 0.01   0.04 0.11 46 69 
CHARMM22* SPC/E   0.31 0.52 ± 0.00   0.02 0.09 27 59 
OPLS_2005 SPC/E   0.58 2.13 ± 0.04   0.11 0.22 196 120 
 
                                               
c Standard errors of Pbound for the 1:1 and 1:2 complex and KA for the 1:2 complex were uniformly ≤ 0.01, while those 
of the mean lifetimes of the bound and unbound states were ≤ 3 ps. 
d Simulations were run with the Desmond dynamics engine rather than the Anton dynamics engine, using the particle 
mesh Ewald method61 rather than the Gaussian split Ewald method63 for treatment of long-range electrostatics. The 
two dynamics engines and simulation protocols yield the same results, as verified by simulations of guanidinium 
acetate with the CHARMM22* force field and mTIP3P water model, which yield both KA and Pbound values that agree 
to within the computed standard error. 
e Experimental KA values of guanidinium and butylammonium acetate permit only a qualitative estimate of the 
associated error. Taking two experimentally measured KA values of guanidinium acetate using different protocols into 
account,51,69 we estimate an error of ± 0.05, although the true uncertainty is not known. Using this estimate, we have 
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Table 2.4. Association constants (KA) and probabilities of binding (Pbound) for guanidinium acetate from simulations 
involving a single molecule of guanidinium and acetate (0.1 M concentrations) without any chloride ions, using six 
biomolecular force fields with the TIP4P-Ew explicit water model. Also shown are the KA and Pbound values computed 
from simulations containing 0.02 M acetate, 0.9 M guanidinium, and 0.9 M chloride ion. Results are from 1-μs 
simulations and standard errors were calculated using a block averaging method.64 
Force Field Water Model 
0.1 M Guanidinium 
0.1 M Acetate 
No Chloride Ions
f
 
0.9 M Guanidinium 
0.02 M Acetate 
0.9 M Chloride Ion 
Pbound
g
 KA (M
-1) Pbound
g
 KA (M
-1) 
AMBER ff99SB-ILDN TIP4P-Ew   0.20 2.91 ± 0.12   0.57 2.23 ± 0.03 
AMBER ff03 TIP4P-Ew   0.11 1.26 ± 0.04   0.45 1.12 ± 0.01 
AMBER ff13α TIP4P-Ew   0.19 2.74 ± 0.10   0.54 2.28 ± 0.03 
CHARMM27 TIP4P-Ew   0.31 6.01 ± 0.32   0.61 4.06 ± 0.10 
CHARMM22* TIP4P-Ew   0.14 1.69 ± 0.06   0.48 1.31 ± 0.02 
OPLS_2005 TIP4P-Ew   0.34 ± 0.02 7.23 ± 0.50   0.63 4.92 ± 0.17 
Experiment51,69,
h
 ~0.04 ± 0.01 ~0.37 ± 0.05 ~0.25 ± 0.03 ~0.37 ± 0.05 
 
Table 2.5. Dielectric constants (εwater) of pure water solutions simulated using the same protocol as for the amino acid 
analogue systems. Simulations were 100-ns in duration. Standard errors were calculated using a block averaging 
method.64
Water Model εwater 
TIP4P-Ew 56.1 ± 0.4 
TIP3P 102.1 ± 0.6 
mTIP3P 109.4 ± 0.7 
TIP4P 52.2 ± 0.3 
TIP4P/2005 67.0 ± 0.5 
SPC/E 69.7 ± 0.5 
Experiment74 78.4 ± 0.1 
                                               
back-calculated the range of simulated Pbound values that would be expected in our simulation, based on the 
experimental KA. 
f Simulations were run with the Desmond dynamics engine rather than the Anton dynamics engine, using the particle 
mesh Ewald method61 rather than the Gaussian split Ewald method63 for treatment of long-range electrostatics. 
g Standard errors of Pbound were uniformly ≤ 0.01, unless otherwise noted. 
h Experimental KA values of guanidinium and butylammonium acetate permit only a qualitative estimate of the 
associated error. Taking two experimentally measured KA values of guanidinium acetate using different protocols into 
account,51,69 we estimate an error of ± 0.05, although the true uncertainty is not known. Using this estimate, we have 
back-calculated the range of simulated Pbound values that would be expected in our simulation, based on the 
experimental KA.  
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2.7 SUBSEQUENT DEVELOPMENTS 
Based on the promising results I obtained with the CHARMM22* and AMBER ff13α force fields, 
I decided to focus my production simulation of MoCVNH3 on these two force fields. Since ff13α 
was still a work in progress at the time, I reached out to the force field’s developers about the 
availability of the final version, called ff14ipq. Upon receipt of the final force field, I first tested 
where or not our conclusions about ff13α applied to ff14ipq by simulating association of the three 
oppositely charged side-chain analogue pairs, as well as the Arg and Asp dipeptides. I discovered, 
as described in the next chapter, that changes made late in the development of ff14ipq led to severe 
overstabilization of salt bridge interactions. The developers asked us to collaborate on the 
development of an updated version, eventually named ff15ipq, leading to the work described 
below. 
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3.0  THE AMBER FF15IPQ FORCE FIELD FOR PEPTIDES AND PROTEINS 
This chapter is based on a research article previously published as: Debiec, K. T.; Cerutti, D.S.; 
Baker, L. R.; Gronenborn, A. M.; Case, D. A.; Chong, L. T. Further along the road less traveled: 
AMBER ff15ipq, an original protein force field built on a self-consistent physical model. Journal 
of Chemical Theory and Computation, 2016, 12, 3926-3947. 
3.1 INTRODUCTION 
Akin to developments spurred by the rapid expansion of computer power around 2000, the 
burgeoning capacity provided by programmable graphics processing units (GPUs) has extended 
the utility of molecular simulations as a practical tool for assessing biophysical processes.78,79 
Notably, GPU-accelerated computing has enabled routine simulations on the microsecond (μs) 
time scale, a critical regime on which biological processes including protein recognition, ligand 
binding, and protein conformational changes occur.80 Access to these longer time scales may 
reveal flaws in the simulation models that were not previously apparent, driving refinements and 
leading toward improved predictive power of these models. 
Historically, efforts in force field development have been largely focused on selecting only 
a subset of the parameters in a complex model for reoptimization, e.g., reoptimizing certain torsion 
parameters while keeping the set of atomic charges fixed to improve the accuracy in modeling 
particular behaviors, while retaining what is already successful. However, such efforts are limited 
by the accuracy of the unoptimized parameters. Many recent force field updates have focused on 
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refinements of torsion parameters.28,32,81–89 However, these refinements may be compensating for 
deficiencies in the modeling of electrostatic and nonbonded interactions that limit the maximum 
attainable accuracy of the model. In addition, contemporary force fields have a tendency to borrow 
from a similar set of values for bond lengths, angles, and atomic radii that were fit many years ago, 
leading to interdependencies that may be difficult to untangle when optimizing only a portion of 
the parameters. 
More recently, semiautomated schemes have been developed to simultaneously optimize 
hundreds of parameters thereby enabling the rapid development of new force fields. In particular, 
the Force Balance90 and Implicitly Polarized Charge (IPolQ) methods33,91 have yielded the 
AMBER ff15fb92 and ff14ipq force fields,91 respectively. These methods rely largely on automated 
tools for parameter optimization, but still require some amount of manual intervention in the form 
of fitting set composition or user-specified settings of the fitting algorithm. The engine behind the 
IPolQ workflow is the mdgx module of the AMBER software package.93 This module combines 
its molecular dynamics (MD) facility with linear algebra routines for solving least-squares 
problems, manages extensive bookkeeping to organize parameters, provides user control over the 
fitting process, and interprets statistics to aid in further refinements. The mdgx module contains 
charge and torsion fitting routines that were built throughout the development of AMBER ff14ipq, 
the first complete protein force field based on the IPolQ scheme.91 
Here, we have developed the new AMBER ff15ipq force field using the IPolQ workflow. 
The original motivation for the development of ff15ipq was to tackle concerns that its predecessor, 
ff14ipq, overestimates the stability of salt bridge interactions – a limitation shared with many other 
contemporary force fields.56 However, in contrast to recently developed variants of force fields 
that address such concerns,32,94,95 ff15ipq is far from a limited adjustment of its predecessor. 
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Rather, ff15ipq is a complete rederivation, comprising new atomic charges, a greatly expanded 
torsion parameter set with several new atom types to decouple distinct amino acids, and new 
backbone angle bending terms. In addition, whereas ff14ipq employed the TIP4P-Ew model for 
the solvent in the IPolQ scheme,27 ff15ipq uses SPC/Eb, a recently developed three-point water 
model that yields more accurate rotational diffusion for proteins in solution.96 The use of a three-
point water model instead of a four-point water model, leaving out a virtual site, affords a modest 
improvement in the speed of CPU-based simulations and a larger acceleration in computing under 
the AMBER GPU engine.97 In addition, the more-accurate rotational diffusion afforded by SPC/Eb 
opens new avenues for validating ff15ipq through direct calculation of NMR relaxation 
parameters. With the aid of GPUs and the AMBER GPU engine, we have extensively validated 
the force field by running MD simulations of peptide and protein systems on the μs time scale, 
yielding over 200 μs of aggregate simulation time.  
We expect ff15ipq, or a close relative, to be valuable for a long time, even as we explore 
more expensive alternatives by adding virtual sites to both the protein and the standard water 
model. In addition, we are working to apply the mdgx workflow to other classes of biopolymers 
such as carbohydrates and nucleic acids, and to small organic molecules. We hope that the 
sweeping reoptimization made possible by mdgx and tools similar to it will inspire initiatives with 
other force fields and create complete chemical representations with predictive power in 
biomolecular simulations. Of future interest will be comparisons to contemporary force fields that 
have been developed in the traditional manner such as AMBER ff14SB,81 OPLS-AA/M,88 and 
CHARMM36,87 as well as those developed using alternative sweeping reoptimization schemes, 
such as AMBER ff15fb.92 
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3.2 THEORY 
3.2.1 The IPolQ method of force field parametrization 
The Implicitly-Polarized Charge (IPolQ) method is a protocol for parametrizing fixed-charge force 
fields for solution-phase simulations that is comprised of two main components, implemented in 
the mdgx program of AmberTools.93 The first component is a protocol for deriving nonpolarizable 
atomic charges that implicitly represent the energy of polarization by the presence of a solvent 
such as water.33 The IPolQ charge derivation draws on approximations of dipole interactions in an 
external electrostatic field to arrive at the optimal nonpolarizable representation of a solute’s 
atomic charges in the presence of a solvent such as water: precisely halfway between the charges 
that would reproduce the solute’s electrostatic field in the gas phase and those that would reproduce 
the solute’s electrostatic field after solvent-induced polarization.98 This averaging comes about 
from the fact that the energy of a set of polarizable dipoles in an external field is identical to the 
energy of a set of fixed dipoles whose polarizations are halfway between the field-polarized dipoles 
and their gas-phase counterparts. IPolQ fits such fixed charges by applying the Restrained 
Electrostatic Potential (REsP) method,99 using a pair of representations of the solute’s electrostatic 
field corresponding to the vacuum and solution phases. While the former representation is 
straightforward to obtain from QM calculations, the latter is computationally unfeasible using a 
pure QM representation. Instead, the IPolQ method represents the polarizing Solvent Reaction 
Field Potential (SRFP) in its QM calculation using a field of point charges, derived from an MD 
simulation in which water, represented by the model with which the solute will ultimately be 
simulated, moves in equilibrium around the fixed solute.33 Atomic charges are subsequently fit to 
reproduce the QM electrostatic potential at a set of grid points surrounding the molecule. As 
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described previously,33 grid points are selected within the first and second solvation shells, with 
the inner boundary defined by excluding points for which the energy of the Lennard-Jones 
interaction between the solute and a probe representing the water model exceeds a selected 
maximum cutoff. While, in this work, we have applied equal weights to all of the selected grid 
points, others have found that more consistent charges may be obtained by applying a weighting 
function to de-emphasize points close to or distant from the solute.100 Such improvements will be 
investigated as the IPolQ method is applied to other classes of molecules beyond peptides and 
proteins. 
The second component of the IPolQ method is an extension for the fitting of bonded 
parameters that accounts for the discrepancy between the desired solution-phase conformational 
preferences and vacuum-phase QM calculations. This is accomplished by fitting a pair of solute 
charge sets: one appropriate for the vacuum phase (Qvac), and the other for the solution phase 
(Qsolv). In the presence of the Qvac charge set, the force field’s bonded parameters are fit to 
reproduce the relative vacuum-phase QM energies of a diverse set of solute conformations. In 
subsequent simulations in the solution-phase, these same bonded parameters are paired with the 
polarized Qsolv charge set with the intention that the difference in the charge sets would account 
for the difference in solute conformational preferences between the vacuum and solution phases.91 
3.2.2 Choice of water model for rederivation of IPolQ atomic charges 
In contrast to the standard REsP method of fitting atomic charges for AMBER force fields,99 the 
IPolQ method explicitly considers the influence of the water model on the solute’s charge 
distribution.33 While the atomic charges of the ff14ipq force field were fit using the TIP4P-Ew 
water model,27 we have elected to fit the charges of ff15ipq using the SPC/Eb water model.
96 This 
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recently developed water model offers two advantages: in addition to the reduction in 
computational cost that is obtained by switching from a four-point to a three-point water model, 
this water model has been parametrized to yield accurate rotational diffusion of solvated proteins.  
A key advantage to carrying out simulations with accurate rotational diffusion is the ability 
to directly calculate the NMR relaxation parameters 15N R1 and R2 and 
15N-1H heteronuclear NOE. 
These parameters provide information about fast dynamics (picosecond(ps), or nanosecond (ns) 
scale) of individual backbone N-H bond vectors within a protein, potentially offering a powerful 
means with which to validate MD simulations.101 In principle, these NMR relaxation parameters 
may be calculated directly from an MD trajectory from the autocorrelation functions of the 
backbone N-H vectors. In practice, however, the poor reproduction of protein rotational diffusion 
in MD simulations using popular water models such as TIP3P limits the utility of such 
calculations.29,96 This limitation has historically been addressed using approaches such as model-
free analysis that attempt to separate the global rotational diffusion of the protein from its residue-
specific internal dynamics, comparing only the internal dynamics between experiment and 
simulation. However, these approaches require extensive fitting of models to the experimental 
data, and further require that the global and local dynamics occur on separable time scales, limiting 
their applicability to highly flexible systems such as disordered peptides and proteins. Therefore, 
it would be preferable for MD simulations to yield accurate rotational diffusion, such that the 
simulated and experimental relaxation parameters can be compared directly. 
Our decision to fit the charges of ff15ipq to the SPC/Eb water model was based on 
preliminary tests in which we ran a series of 24 simulations of the proteins GB3, ubiquitin, and 
binase using two different force fields (AMBER ff99SB-ILDN and CHARMM22*)28,32 paired 
with four different water models (TIP3P, TIP4P-Ew, TIP4P-D, and SPC/Eb)
27,70,96,102 (Figure 
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3.13). Consistent with prior published work,29,96 TIP3P and TIP4P-Ew yielded rotational diffusion 
significantly faster than experiment, and SPC/Eb yielded the most accurate result. 
3.2.3 Extensions supporting restrained angle fitting 
Earlier versions of mdgx were capable of fitting angle stiffnesses alongside torsions, but recent 
advances proposed by Vanommeslaeghe et al. permit the calculation of both the optimal stiffness 
constant and equilibrium value from the same linear least-squares problem.103 The strategy 
generalizes work by Hopkins and Roitberg,104 representing the parabolic angle as the sum of two 
parabolic basis functions and solving for both scaling coefficients to interpolate the optimal 
parameters. Basis functions were chosen such that their minima lay at 0.2 radians from the 
equilibria of the original angles, which had been inherited from the AMBER ff94 force field.105 
As explained by Vanommeslaeghe et al., the optimized angle's stiffness is given by the sum of 
coefficients solved for each basis function, and its equilibrium is given by the average of the two 
basis functions' minima weighted by their coefficients. Restraints on the optimized angle 
parameters follow from these definitions: a restraint equation setting the sum of the two 
coefficients Ci,1 and Ci,2 to a target value Ki, such as the stiffness of the original angle in the input 
force field, will harmonically penalize solutions which depart from the original stiffness value: 
𝛼𝑠𝑐𝑙𝑁𝑖𝛼𝑐𝑝𝑙[𝐶𝑖,1 + 𝐶𝑖,2] = 𝛼𝑠𝑐𝑙𝑁𝑖𝛼𝑐𝑝𝑙𝐾𝑖 (3.1) 
A similar restraint on the ratio of the two coefficients can be used to penalize solutions which 
depart from the original equilibrium value Ti, if the minima of the basis functions scaled by Ci,1 
and Ci,2 are Bi,1 and Bi,2, respectively: 
𝛼𝑠𝑐𝑙𝑁𝑖[𝐶𝑖,1(𝑇𝑖 − 𝐵𝑖,1) + 𝐶𝑖,2(𝑇𝑖 − 𝐵𝑖,2)] = 0.0 (3.2) 
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As explained in the previous study,91 these restraint equations will have a more pronounced effect 
if the data set contains only 10 rather than 1000 data points. Therefore, both sides of each restraint 
equation were scaled by a user-defined constant (αscl) times the number of instances in which each 
optimizable angle appeared in the data set Ni, analogous to the scaling constant applied to torsion 
restraints. The scaling constants may appear to have no effect on the solution to the equations when 
either these constants are present on both sides of the equation or one side of the equation is zero. 
However, since the least squares fit finds an approximate solution to each equation, the scaling 
constants do, in fact, influence the relative importance of each restraint. In addition, due to the fact 
that these restraints penalize numerical deviations from the target values but angle stiffnesses and 
equilibria are expressed in different units by numbers of different scale, a separate scaling factor 
(αcpl) was introduced to control the way in which restraints on the equilibria scale relative to 
restraints on the stiffness. For example, an αcpl of ~57 applied to restraints on equilibria would 
penalize 1° deviations from the original value by the same amount as a 1 kcal/(mol rad2) deviation 
from the original stiffness constant. After some experimentation, however, we found that, in our 
very large and heterogeneous data sets, much smaller values of αcpl (0.5 to 1.0) result in the best 
fits to the data while partitioning the changes between equilibria and stiffness constants. 
3.2.4 Addition of new atom types 
Alongside the fitting of torsions and angles, several new atom types were added to ff15ipq in order 
to more accurately capture residue-specific conformational preferences. Most protein force fields 
use Gly and Ala as templates to develop backbone torsion parameters that are then inherited by 
other residues. The AMBER IPolQ force fields adopt an unconventional, concerted approach in 
which Φ, Ψ, Φ᾽, Ψ᾽, and all other torsions are simultaneously fit to the conformational preferences 
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of all residues in which they appear. While the resulting backbone torsions therefore consider the 
conformational preferences of residues other than Gly and Ala, their overall accuracy may 
decrease as different residues pull the parameters in different directions. Within the context of the 
IPolQ fitting method, a set of backbone torsion parameters that more accurately capture the 
conformational preferences of different residues may be obtained by introducing new atom types, 
creating decoupled classes of backbone torsions, which are applied to subsets of residues. 
During the development of ff14ipq, three such classes were introduced: one for Gly, one 
for Pro, and one for all other residues. In order to decouple the Φ and Ψ torsions of Gly, which 
lacks Cβ and therefore has no Φ᾽ and Ψ᾽ torsions, a unique Cα atom type was assigned.91 Similarly, 
the backbone torsions of Pro were decoupled by assigning a unique atom type for the backbone N. 
This additional atom type not only created unique Φ, Ψ, and Ψ’ terms for Pro, but also a set of 
separate Ψ and Ψ’ torsions for residues preceding Pro, thereby enabling the force field to capture 
the unique conformational preferences of these contexts.106 The remaining residues were further 
divided into three subclasses based on their Cβ types, which determine the applied Φ᾽ and Ψ᾽ 
torsions. The Cβ types of ff14ipq yielded four subclasses: (i) flexible positively charged residues 
(Arg, Lys), (ii) residues whose Cβ atoms are bonded to two heavy atoms and whose side-chains 
are not aromatic (Asn, Asp, Cys, Gln, Glu, Leu, Met, Ser), (iii) residues whose Cβ atoms are 
bonded to three heavy atoms (Ile, Thr, Val), and (iv) all other residues (Ala, His, Phe, Trp, Tyr). 
Notably, this last subclass yielded Φ᾽ and Ψ᾽ torsions shared between Ala and the bulky aromatic 
residues. This unusual coupling was a consequence of the force field’s lineage from ff12SB, where 
refitting of Χ1 torsions alongside fixed Φ, Ψ, Φ᾽, and Ψ᾽ did not require a unique Cβ type for the 
aromatic residues, which already have unique Cγ types that yield unique Χ1.81 
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In order to further improve the accuracy of residue-specific conformational preferences in 
ff15ipq, several new atom types were added to further decouple the backbone torsion parameters 
of different residues, leading to a total of five backbone classes. In order to restrict each class of 
backbone torsions to a single set of scaled 1-4 electrostatic terms, negatively-charged (Asp, Glu) 
and positively-charged (Arg, Lys) residues have been given unique Cα types, decoupling their Φ, 
Ψ, Φ’, and Ψ’ from those of the neutral residues. While the backbone N of Pro was decoupled in 
ff14ipq, it retained a shared Ψ’ torsion; to break this dependency, Pro has now been assigned a 
new Cα atom type. Finally, the coupling between Ala and the bulky aromatic residues has been 
removed by assigning His, Phe, Trp, and Tyr a unique Cβ type, decoupling their Φ’ and Ψ’ terms 
from Ala. This decoupling divides the neutral residues into four subclasses: (i) Ala (ii) residues 
whose Cβ atoms are bonded to two heavy atoms (Asn, Cys, Gln, Leu, Met, Ser), (iii) residues 
whose Cβ atoms are bonded to three heavy atoms (Ile, Thr, Val), and (iv) bulky aromatic residues 
(His, Phe, Trp, Tyr). The backbone torsion classes of the 28 residue forms supported by ff15ipq 
are listed in Table 3.4. 
3.3 METHODS 
3.3.1 Calculation of the probability of binding (Pbound) for salt bridges 
To compare the accuracy of ff15ipq in modeling the stability of protein salt bridges to its 
predecessor ff14ipq and contemporary force fields, we simulated the association of three pairs of 
oppositely charged amino acid side-chain analogues: guanidinium cation/acetate anion (Arg/Asp), 
butylammonium cation/acetate anion (Lys/Asp), and imidazolium cation/acetate anion 
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(His(+)/Asp). For comparison, such simulations were carried out using the polarizable force fields 
CHARMM Drude-2013 and AMOEBA,107,108 in addition to other fixed-charge force fields that we 
had previously tested using these three model systems, as described in  Chapter 2.56 
Simulations with ff15ipq, ff14ipq, and AMOEBA were carried out using the AMBER 15 
software package,93 while those with CHARMM Drude-2013 were run with NAMD 2.10.0,109,110 
following a protocol analogous to that used for the previously evaluated fixed-charge force fields 
(full details are provided in Section 3.7.1).56 Systems were constructed to be consistent with the 
experimental conditions under which the association constants (KA) of guanidinium acetate and 
butylammonium acetate have been measured,51 i.e., each system consisted of 100 molecules of 
cation (guanidinium, butylammonium, or imidazolium), 2 molecules of acetate, and 98 chloride 
counterions solvated by ~18,000 water molecules. For the fixed-charge force fields, parameters of 
the side-chain analogues were based on those of the complete amino acids. For the CHARMM 
Drude-2013 polarizable force field, parameters of guanidinium, imidazolium, and acetate were 
those distributed alongside the force field.107 Since methylammonium rather than butylammonium 
was used as the analogue of Lys during the development of Drude-2013,107 the butylammonium 
acetate system was not tested with this force field. For the AMOEBA force field, parameters of 
guanidinium, imidazolium, and acetate were generated using the Poltype derivation protocol 
(details are provided in section 3.7.1).111 As it was with CHARMM Drude-2013, the 
butylammonium acetate system was not tested with AMOEBA. 
For all of the simulations mentioned above, the probability that an acetate molecule was 
bound to one or more cation molecules was calculated by assigning each pair to either the bound 
or the unbound state. For each force field and pair of side-chain analogues, definitions of the 
unbound and bound states were based on the potential of mean force (PMF) as a function of the 
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minimum distance between nitrogen atom(s) of the cation and the oxygen atoms of acetate. In 
particular, the cutoff between the bound and unbound states was defined as the point of inflection 
between the free energy minimum of the bound state (∼2.5−3 Å) and the free energy maximum, 
which corresponds to the desolvation barrier (∼3−3.5 Å). Pairs whose minimum N-O distances 
were below this cutoff were assigned to the bound state, while those beyond were assigned to the 
unbound state. In addition to species in which a single acetate molecule was bound to a single 
cation molecule, forming a 1:1 complex (e.g., the guanidinium/acetate complex), species in which 
acetate was bound to two or more cation molecules (e.g., the 2:1 diguanidinium/acetate complex) 
were observed and counted separately. Standard errors were calculated using a block averaging 
method.64 
3.3.2 Rederivation of IPolQ atomic charges with the SPC/Eb water model 
The atomic charges of ff15ipq were fit using the IPolQ module of mdgx as described previously 
for ff14ipq.91 During charge fitting, each amino acid was represented by a blocked dipeptide 
including acetyl (Ace) and N-methylamide (Nme) caps; terminal forms were represented by 
omitting one of the blocking groups, while the disulphide form of cysteine (Cyx) was represented 
by a pair of dipeptides linked by a disulfide bond. To expand on the set of amino acids and 
protonation states that were supported by ff15ipq, atomic charges were also derived for the 
following: the N- and C-terminal forms of protonated aspartate (Ash) and glutamate (Glh), the C-
terminal form of neutral lysine (Lyn), the terminal and nonterminal forms of deprotonated cysteine 
(Cym), and the noncanonical amino acid norleucine (Nle). 
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Each solute of interest was solvated in a cubic box of SPC/Eb water with a clearance of 10 
Å between the solute and the edge of the box, and subjected to a high-temperature MD simulation 
at 450 K, from which were collected a set of 20 conformations. Each conformation was 
subsequently re-equilibrated at 298 K before being input to the IPolQ module of mdgx. This 
module was used to run an MD simulation with the solute fixed, during which the coordinates of 
surrounding solvent molecules were collected and used to generate a collection of point charges 
representing the solvent reaction field potential. This collection consists of an inner cloud of point 
charges taken directly from the coordinates of solvent molecules within 5 Å of the solute, and three 
outer shells of point charges fit to reproduce contributions to the solvent reaction field potential 
from the infinite periodic system beyond 5 Å. 
A pair of QM calculations for the solute were then run at the MP2/cc-pVTZ level of 
theory:112–115 one in vacuum and the other including the solvent reaction field potential as modeled 
by the collection of point charges. These calculations were run using the ORCA 3.0.3 software 
package for each conformation of each residue,116 requiring over 3,000 density calculations. The 
resulting densities were then input to mdgx’s FitQ module, yielding a pair of charge sets, one valid 
for simulation in vacuum (Qvac) and the other for simulation in solution (Qsolv). 
3.3.3 Generation and extension of the angle and torsion fitting dataset 
The bonded parameters of ff15ipq were fit to reproduce the relative vacuum-phase QM MP2/cc-
pVTZ potential energies of a set of diverse conformations of short peptides using an iterative cycle 
of refinement, similar to that used for its predecessor, ff14ipq.91 This cycle involved the following 
steps: (i) MD simulations were carried out to generate a set of peptide conformations, (ii) these 
conformations were subjected to energy minimization in vacuum using the molecular mechanics 
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(MM) energy function with Qvac and the current generation of bonded parameters, (iii) QM 
energies of the energy-minimized conformations were calculated, (iv) the conformations and 
energies were used to fit an improved set of bonded parameters, and (v) steps (i) through (iv) were 
repeated to fit the next generation of bonded parameters. In this way, subsequent generations of 
the force field “learned” from the biases of their ancestors, provided those biases were captured in 
the QM energies of the additional conformations that resulted from step (i) of the iterative cycle.  
During the development of ff14ipq, selected conformations from an initial fitting set of 
~28,000 were subjected to energy minimization with each new generation of bonded parameters 
to yield new conformations, accumulating a total of 65,000 structures and single-point energies.91 
The first generation of ff15ipq fitting data was created by pairing ff14ipq with generalized Born 
implicit solvent MD simulations117 of amino-acid dipeptides at 450 K, followed by vacuum energy 
minimization of many snapshots from each simulation. While we have not tested how well ff14ipq 
behaves with implicit solvent, the purpose was to capture any spurious conformational preferences 
that might remain in the original force field. Additionally, we included ~1,400 conformations of 
the Ace-Ala-Pro-Ala-Nme tetrapeptide, while the second generation added numerous tripeptides 
containing Gly, and conformations of the disulfide-bridged Cys•Cys system (among the largest of 
all the systems used in QM single point energy calculations). These refinements added ~15,000 
new conformations to the ff15ipq fitting set. 
The next three generations of refinement were designed to cover sampling of the multiple 
classes of backbone parameters applied to different residues, as described in Section 3.2.4. In order 
to ensure sampling of diverse backbone conformations, conformations were generated by 
progressively restraining Φ and Ψ at 20° intervals using a 16 kcal/mol·rad2 harmonic restraint over 
the course of the MD simulation, yielding 324 conformations of each. Since the unique backbone 
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nitrogen type of Pro creates unique Ψ and Ψ’ terms for preceding residues, the third generation of 
conformations consisted of 51 Pro-containing tripeptides for which the non-Pro residue’s Φ and Ψ 
were restrained. At this point in development, it was decided to branch the positively and 
negatively charged residues into unique backbone classes, and as such the fourth and fifth 
generations of refinement consisted of 57 tripeptides containing the charged residues Asp, Glu, 
Cym (deprotonated Cys), Arg, Lys, and Hip (doubly-protonated His), in which Φ and Ψ of the 
charged residues were restrained. In order to cover the unique backbone parameters applied to the 
terminal forms of each residue, additional conformations were added for a set of 78 terminal NXaa-
Nme and Ace-CXaa monopeptides. For these terminal systems, scans of either the unique Ψ of the 
N-terminal forms or the unique Φ of the C-terminal forms were performed at 2° intervals, yielding 
180 conformations of each. Since the unique backbone nitrogen types of the N-termini and Pro in 
tandem yield an additional set of Ψ terms for NXaa-Pro, scans of Ψ were run for an additional set 
of NXaa-Pro-Nme dipeptides. Finally, in order to cover the unique backbone Ψ and Ψ’ terms of 
the amide blocking group (Nhe), scans of Φ and Ψ were run for 17 Ace-Xaa-Nhe dipeptides, 
yielding 324 conformations of each. During these three generations of refinement, ~60,0000 
conformations were added to the ff15ipq fitting set. 
After the fifth generation of refinement, support for the fitting of angle equilibria and force 
constants alongside torsions was implemented in mdgx, and subsequent generations emphasized 
comprehensive sampling of backbone angles. The sixth, seventh, and eighth generations of 
refinement consisted of perturbations of the angles around N, Cα, and C. Starting from an initial 
conformation, a selected angle of interest was subjected to a random perturbation within a range 
of ±20° of its original equilibrium value (as inherited from the ff94 force field and retained in 
contemporaries such as ff14SB). Target values for the other angles around the same central atom 
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were then chosen by taking their initial values and adjusting them such that the total sum of angles 
around the central atom was appropriate for the known geometry; target sums of 360° for planar 
geometry around N and C and 660° for tetrahedral geometry around Cα were used. During 
subsequent MM minimization, the target values for these angles were restrained using 256 
kcal/mol•rad2 harmonic restraints. During the eighth and final generation of refinement, angle 
perturbations were resampled in the context of new scans of Φ and Ψ backbone torsions at 10° 
intervals for each Ace-Xaa-Nme dipeptide, yielding 1296 conformations of each, alongside 
additional sampling of terminal monopeptides. During these three generations, ~125,000 
conformations were added, yielding a final fitting set of ff15ipq consisting of >250,000 single-
point QM energies, which is over four times larger than that used for ff14ipq. 
3.3.4 Fitting of torsion and angle terms 
As done previously for ff14ipq, the torsion parameters of ff15ipq were fit using a linear least-
squares fit implemented in the Param module of mdgx;91 extensions to the module for angle fitting 
are described in Section 3.2.3. This module selects a set of torsional barrier heights, angle 
equilibria, and angle stiffnesses that best reproduce the relative conformational energies of the 
systems included in the fitting set. During the fitting process, the Fourier series lengths and phase 
angles of the torsional terms were not optimized, and phase angles were set to either 0° or 180° to 
enable the development of parameters that are transferable to alternative chiralities. All backbone 
Φ, Ψ, Φ’, Ψ’, and side-chain Χ torsions of nonterminal forms of the amino acid residues were 
allocated four terms in their Fourier series. Torsions unique to the terminal forms of residues and 
residues preceding Pro were restricted to only three terms since these terms were less exhaustively 
sampled in the fitting set. This restriction was applied to limit the risk of overfitting. While all 
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torsion parameters of residues in the fitting set were fit, only angles in which the central atom was 
the N, Cα, or C of a nonterminal residue were fit. For Pro, only the angles around Cα were fit since 
the unique backbone N type of Pro introduces a large number of parameters that depend on the 
preceding residue. In order to avoid overfitting torsional barrier heights, torsions were restrained 
towards 0° with a force constant of 2x10-4 kcal/mol. Similarly, angles were restrained to their 
original values, inherited from ff94, with the equilibria and stiffness force constants set to 5x10-5 
kcal/mol and 2x10-4 kcal/mol, respectively. 
3.3.5 Umbrella sampling of tetrapeptides 
To characterize the backbone conformational preferences of ff15ipq in explicit SPC/Eb water, we 
carried out umbrella sampling simulations of blocked tetrapeptides Ace-Ala-Xaa-Ala-Nme, 
calculating the potential of mean force as a function of the backbone Φ and Ψ torsions of the central 
residue Xaa. In order to identify differences in the conformational preferences between ff15ipq, 
its predecessor ff14ipq, and contemporary force fields, simulations of Ace-Ala-Ala-Ala-Nme were 
carried out using the AMBER force fields ff15ipq, ff14ipq,91 and ff14SB;81 the OPLS force field 
OPLS-AA/M;88 and the CHARMM force fields CHARMM36 and Drude-2013.87,107 Analogous 
simulations were carried out to compare the conformational preferences of other central amino 
acid residues using the AMBER ff15ipq, ff14ipq, ff14SB, and CHARMM36 force fields. The 
backbone Φ and Ψ torsions of the central residue were restrained in a series of 1296 windows 
spaced at 10° intervals, using a harmonic penalty function with a force constant of 8 kcal/mol·rad2. 
Each window was seeded from a continuous, incrementally restrained simulation, and sampled for 
2.0 ns following a 0.2-ns equilibration. From each set of 1296 windows were reconstructed the 
unbiased potentials of mean force using the weighted histogram analysis method (WHAM).118,119 
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3.3.6 Simulations of benchmark systems 
To validate ff15ipq as a general force field for peptides and proteins, extensive MD simulations 
on the μs time scale were carried out for a variety of benchmark systems consisting of both 
structured and disordered peptides and proteins. For each system, the amino-acid sequence or PDB 
code, sources of initial coordinates, and temperatures maintained throughout the simulations are 
listed in Table 3.1. Further details of the benchmark systems are provided below. 
 
Table 3.1. Peptide and protein validation systems. 
System Sequence/PDB Residues Temperature (K) Duration (μs) 
Ala5 +AAAAAØ 5 298 6 
K19 Ace-GGG-(KAAAA)3-K-Nhe120 19 275, 285, …, 315, 325 4 
(AAQAA)3 Ace-(AAQAA)3-Nhe121 15 280, 290, …, 320, 330 4 
GB1 Hairpin +GEWTYDDATKTFTVTE-122 16 275, 285, …, 315, 325 4 
Chignolin +GYDPETGTWG-, 1UAO123 10 298 4 
Cln025 +YYDPETGTWY-, 2RVD124 10 280, 290, …, 360, 370 4 
Trp-cage 1L2Y125 20 275, 285, …, 315, 325 4 
Binase 1BUJ126 109 298 10 
BPTI 5PTI127 58 298 10 
GB3 1P7E128 56 298 10 
Lysozyme 4LZT129 129 300 2 
Ubiquitin 1UBQ130 76 298 10 
Villin Headpiece
i
 2F4K
131 35 303 10 
P53
j
 1YCR
132 13 298 10 
P53/MDM2
b
 1YCR
132 13/85 298 10 
S-peptide
k
 1RNU
133 22 298 10 
S-peptide/S-protein
c
 1RNU
133 22/104 298 10 
                                               
i HP35 double-norleucine mutant mutant (Lys24Nle, Asn27His, and Lys29Nle) 
j The p53 peptide used contained residues 17-29 of the full-length protein and included an N-terminal acetyl (Ace) 
and C-terminal amide (Nhe) blocking group. MDM2 included residues 25-109 of the full-length protein, omitting a 
mobile N-terminal region unresolved in the crystal structure. The N- and C-termini of MDM2 were blocked with 
acetyl (Ace) and N-methylamide (Nme) blocking groups, respectively. 
k In order to accurately match the amino acid sequences used in NMR experiments,215,216 residues not resolved in the 
crystal structure were built using Avogadro.217 Residues STSAA were appended to the C-terminus of the S-peptide, 
and SSS to the N-terminus of the S-protein. Additionally, residues GA were appended to the N-terminus of the S-
peptide, representing a cloning artifact present in the NMR experiments. These residues were not restrained during 
equilibration of the system. The NMR experiments on the S-peptide/S-protein complex were conducted at pH 3.7, 
making the appropriate protonation state of Asp and Glu, whose pKas average ~3.7 and ~4.1, uncertain within the 
confines of our model which does not capture proton exchange. We therefore elected to run our simulations with Asp 
deprotonated and Glu deprotonated; His was protonated in all simulations. 
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3.3.6.1 Structured peptides and proteins 
As done for ff14ipq,91 we validated ff15ipq by simulating penta-alanine (Ala5), the α-helical K19 
peptide, the GB1 β-hairpin from the C-terminal fragment of Protein G, the designed β-hairpin 
chignolin, Trp-cage, GB3, and lysozyme. We also carried out simulations of the α-helical 
(AAQAA)3 peptide, the Cln025 mutant of the chignolin β-hairpin, the double-norleucine variant 
of the villin headpeice subdomain, bovine pancreatic trypsin inhibitor (BPTI), ubiquitin, and 
binase. 
3.3.6.2 Disordered peptides 
In order to evaluate the ability of ff15ipq to model disordered proteins, we simulated two classic 
systems for studying the binding processes of disordered peptides that fold only upon binding their 
partner proteins: (a) the N-terminal p53 peptide and MDM2 oncoprotein, and (b) the S-peptide and 
S-protein cleavage products of the RNAse A protein. Both of these peptides fold into α-helical 
conformations only upon binding their partner proteins. Simulations were performed with these 
peptides both in isolation and in complex with their protein binding partners. 
3.3.6.3 Simulation configuration and analysis 
Simulations of benchmark systems were carried out using the GPU implementation of the pmemd 
module in the AMBER 15 software package.97,134 Each system was solvated in a truncated 
octahedral box of SPC/Eb explicit water with a 12 Å buffer for the disordered peptide/protein 
systems and 10 Å buffer for all other systems. Prior to production simulation, each system was 
subjected to energy minimization followed by a three-stage equilibration. In the first stage, a 20-
ps simulation of the energy-minimized system was carried out at constant temperature while 
restraining the solute heavy atoms to their initial positions using a harmonic potential with a force 
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constant of 1 kcal/(mol Å2). In the second stage, a 1 ns simulation was carried out at constant 
pressure with the same harmonic position restraints. Finally, an additional 1 ns unrestrained 
simulation was carried out at constant temperature and pressure. Temperatures were maintained at 
selected values (between 270 and 370 K) using a Langevin thermostat (frictional constant of 1 
ps−1) while pressure was maintained at 1 atm using a Monte Carlo barostat (200 fs between 
attempts to change the system volume).58 Van der Waals and short-range electrostatic interactions 
were truncated at 10 Å; long-range electrostatic interactions were calculated using the particle 
mesh Ewald method.61 To enable at least a 2 fs time step, bonds to hydrogen were constrained to 
their equilibrium values using the SHAKE and SETTLE algorithms.135,136 For the K19, 
(AAQAA)3, GB1 hairpin, chignolin, and Cln025 systems, hydrogen mass repartitioning was used 
to enable the use of longer time steps.137 In particular, the masses of solute hydrogen atoms were 
increased by a factor of three, and that of their attached heavy atoms decreased by a corresponding 
amount such that the total mass remained constant; the masses of water molecules were not 
repartitioned. This mass repartitioning scheme enables a 4 fs time step for simulations at 300 K; 
for simulations at >300 K, shorter time steps were used and set to be equal to 1200 K fs divided 
by the set temperature. Conformations were saved every ps for analysis by the AmberTools cpptraj 
program.138 Diagnostics included DSSP,139 rotational diffusion,29 and NMR relaxation calculated 
by the iRED method.140 
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3.4 RESULTS 
3.4.1 Strengths of protein salt bridges 
To evaluate the accuracy of ff15ipq in modeling the strengths of protein salt bridges, we simulated 
the association of three pairs of oppositely charged amino acid side-chain analogues: guanidinium 
cation/acetate anion (Arg/Asp), butylammonium cation/acetate anion (Lys/Asp), and imidazolium 
cation/acetate anion (His(+)/Asp). For each salt bridge, the resulting probability of an anion 
binding to one or more cation molecules (Pbound) was compared to experiment (if available) as well 
as those of six other fixed-charge force fields, including ff14ipq, ff14SB, ff03, CHARMM22*, 
CHARMM36, and OPLS_2005, and two polarizable force fields, CHARMM Drude-2013 and 
AMOEBA. 
The original motivation for the development of ff15ipq was to correct for the 
overstabilization of protein salt bridges by its predecessor, ff14ipq. During the development of 
ff14ipq, the Lennard-Jones radii of several polar heavy atoms were refit to reproduce the 
experimental solvation free energies of side-chain analogues.33 Although the resulting set of radii 
were initially intended to be applied globally, several of the larger radii resulted in increased 1-4 
repulsion during torsion fitting, which made the torsion parameters more difficult to fit. To 
overcome this difficulty, mixed Lennard-Jones combining rules (called LJEDIT within AMBER 
software or NBFIX within CHARMM) were applied to these polar groups, assigning different 
radii for their solute-solvent interactions from those used for their solute-solute interactions. For 
example, for the carboxylate oxygen atoms of the side-chains of Asp and Glu larger Lennard-Jones 
radii for interactions with water were used than for interactions with solute atoms.91 An undesirable 
effect of this strategy, however, was the overstabilization of salt bridges – to the point that in our 
   52 
simulations each acetate molecule was bound to three or more cation molecules (e.g., guanidinium) 
for most of the simulation (Figure 3.1 and Figure 3.14). Essentially, the larger radii used for solute-
solvent interactions forced the carboxylate group out of solution and into interactions with 
available solute atoms. 
For ff15ipq, we addressed the problem of overstabilized salt bridges by discarding the 
mixed Lennard-Jones radii of ff14ipq and instead applied empirical corrections to the radii of polar 
hydrogen atoms bonded to nitrogen (atom type ‘H’) in both the protein backbone and side-chains 
(note that the original σ of 1.07 Å for this atom type may equivalently be expressed as an R* of 
0.6000, and the details of its fitting appear to have been lost to history).105,141 These corrections 
were determined from simulations of the three oppositely-charged side-chain analogue systems 
with H σ ranging from the ff94 value of 1.07 Å up to 1.5 Å, calculating the probability of salt 
bridge formation (Pbound), and comparing this probability to that from experiments. Based on the 
results (Figure 3.14) we selected a σ of 1.3 Å for nitrogen-attached hydrogens in both the protein 
backbone and side-chains. For guanidinium acetate, we found that a further increase in σ to 1.5 Å 
for the side chain of Arg was necessary to achieve satisfactory agreement with the experimental 
value of this system. All other Lennard-Jones radii retained their original ff94 values. 
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Figure 3.1. Probability of binding (Pbound) between acetate and one or more molecules of three cationic side-chain 
analogues using seven fixed-charge and two polarizable biomolecular force fields, each paired with either the water 
model with which it was derived or that with which it is most-commonly used. The Pbound values corresponding to the 
experimentally determined KA values of guanidinium acetate and butylammonium acetate are depicted as horizontal 
gray bars;51,69 no experimental value is available for the imidazolium acetate system. Error bars represent 95% 
confidence intervals calculated using a block averaging method.64 Results for the CHARMM36, CHARMM22*, 
OPLS_2005, AMBER ff14SB, and AMBER ff03 force fields are from previous simulation studies described in 
Chapter 2.56 
 
As shown in Figure 3.1, ff15ipq yields Pbound values that are among the most reasonable, 
relative to the other fixed-charge force fields that were tested (ff03, ff14SB, ff14ipq, OPLS_2005, 
CHARMM22*, and CHARMM36). For guanidinium acetate, our results with ff15ipq are roughly 
consistent with CHARMM22* and ff03, which we had previously found to provide the most 
accurate modeling of this system.56 For butylammonium acetate, ff15ipq yields a Pbound that is 
slightly higher than that of AMBER ff03, but similar to those of CHARMM22* and ff14SB. For 
imidazolium acetate, ff15ipq yields a Pbound that is higher than those of CHARMM22* and ff03, 
but similar to that of ff14SB. Of particular note is that CHARMM22* was also parametrized to 
reproduce the experimental association of guanidinium acetate, but via adjustments to the atomic 
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charges of only the side-chains of Arg, Asp, and Glu;32 as a result, these adjusted parameters are 
inconsistent with the rest of the force field, whose charges had been fit years earlier using a 
different method.142 Along the same lines, a recently developed variant of the AMBER ff99SB-
ILDN force field has involved the application of mixed Lennard-Jones combining rules 
exclusively to interactions between the side chains of Arg, Asp, and Glu.94,95 In contrast to the post 
hoc adjustments of these two other force fields, our approach involves first adjusting the Lennard-
Jones radii followed by refitting of atomic charges and bonded parameters. This approach – which 
has been an onerous one in the past – has been significantly streamlined by the mdgx software. 
We note that all of the fixed-charge force fields are outperformed by the more expensive, 
polarizable CHARMM Drude-2013 and AMOEBA force fields. While it is likely that much of 
their superior performance results from the more complex charge model for the solutes, it is also 
possible that the solute-solvent interactions – which compete with solute-solute interactions – are 
more accurately represented by the use of polarizable water models. In particular, fixed-charge 
water models similar to the SPC/Eb model used here have recently been found to underestimate 
the strength of solute-solvent interactions in general,102 and it is possible that this limitation of the 
water models restricts the accuracy with which the solute models may represent salt bridges. 
3.4.2 Optimization of torsion and angle parameters 
A key metric for assessing the accuracy of the torsion and angle parameters of ff15ipq was the 
ability to reproduce the target QM potential energy surface. Figure 3.2 shows the distribution and 
root mean square error (RMSE) of ff15ipq energies with respect to their target QM potential 
energies for the 20 canonical amino acids. The RMSE values for all neutral residues are <1.3 
kcal/mol, while those of the negatively charged residues Asp and Glu are <1.9 kcal/mol, and those 
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of the positively charged residues Arg and Lys are <2.4 kcal/mol. As shown in Figure 3.15, the 
neutral forms Asp, Gln, and Lys (Ash, Glh, and Lyn, respectively) have RMSE values that are 
consistent with the other neutral residues, suggesting that the increased RMSE values of Lys and 
Arg, relative to uncharged residues, are related to their net charge, rather than to their additional 
flexible Χ torsions. Optimization of the backbone angle parameters introduced a 5-15% 
improvement in RMSE and enabled expansion of the fitting set by more than four-fold without 
sacrificing the ability to reproduce those parts of the QM potential energy surface represented in 
the original data set. 
 
 
Figure 3.2. Distributions of residuals of relative molecular mechanical potential energies with respect to their quantum 
mechanical target potential energies for 18 Ace-Xaa-Nme dipeptides and the Ace-Ala-Ala-Ala-Nme and Ace-Gly-
Gly-Gly-Nme tetrapeptides. 25th, 50th, and 75th percentiles are represented by horizontal lines, and means are 
represented by white circles. Each dataset is colored by its corresponding backbone torsion class (see Table 3.4). 
 
3.4.3 Conformational preferences of individual residues and very short peptides 
To assess the accuracy of ff15ipq in modeling the backbone conformational preferences of proteins 
within computationally tractable systems, we carried out a series of simulations of short peptides 
which may be affordably simulated to convergence. Initially, we focused on simulations of the 
   56 
Ace-Ala-Ala-Ala-Nme tetrapeptide, for which we calculated the PMF as a function of the 
backbone Φ and Ψ torsions of the central residue. Figure 3.3 shows the results for ff15ipq, its 
predecessor ff14ipq, and several contemporary force fields. Relative to ff14ipq, ff15ipq has larger 
free energy barriers (by ~1 kcal/mol) between the α well (Φ ≈ -70°, Ψ ≈ -20°) and γ’ well (Φ ≈ -
80°, Ψ ≈ 60°) and between the β well (Φ ≈ -150°, Ψ ≈ 150°) and PPII well (Φ ≈ -70°, Ψ ≈ 140°). 
In addition, ff15ipq has a more clearly defined ξ well (Φ ≈ -140°, Ψ ≈ 50°). On the left half of the 
Ramachandran plot, the depth of the Lα well (Φ ≈ 60°, Ψ ≈ 40°) has decreased slightly, and that 
of the γ well (Φ ≈ 70°, Ψ ≈ -40°) has decreased by ~1 kcal/mol, while the PII’ well (Φ ≈ 60°, Ψ ≈ 
-130°) has been retained. Relative to the ff14SB and CHARMM36 force fields, ff15ipq shows 
similar α and PPII well depths, though ff14SB and CHARMM36 do not exhibit γ᾽ or ξ wells and 
the precise positions of the various wells differ between the force fields. Larger differences are 
observed relative to the OPLS-AA/M and polarizable CHARMM Drude-2013 force fields, which 
have shallower and deeper β wells, respectively. 
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Figure 3.3. Potentials of mean force for the central residue of blocked alanine tetrapeptides as a function of backbone 
Φ and Ψ torsions of the central residue using five fixed-charge force fields and one polarizable force field. Each force 
field was paired with either the water model with which it was derived or that with which it is most-commonly used. 
 
Next, we extended our validation of ff15ipq by examining residue-specific backbone 
conformational preferences. In particular, we carried out simulations of Ace-Ala-Xaa-Ala-Nme 
tetrapeptides containing each of the 20 canonical residues at the central position, including the 25 
protonation states of these residues that are supported by the force field. For comparison, 
analogous simulations were carried out using the ff14ipq, ff14SB, and CHARMM36 force fields. 
The resulting Φ/Ψ backbone torsional preferences of the central residues were then compared to 
those of Ala-Xaa-Ala obtained from the Neighbor-Dependent Ramachandran Distribution 
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(NDRD) dataset, derived from conformations observed in the loops regions of proteins (non-α-
helix/β-sheet secondary structures).143 The NDRD dataset is drawn from a collection of ~3,000 
high-resolution crystal structures in the Protein Data Bank,144 and accounts for the influence of 
preceding and following residues on the Φ/Ψ backbone torsional preferences of the central residue. 
Given the considerable differences in the contexts of our simulations and the NDRD experimental 
dataset, i.e., solution vs crystal environment, we focused solely on qualitative differences between 
the simulated and experimental conformational preferences of each peptide. In particular, we 
compared the conformational preferences of peptides containing a nonalanine central residue 
relative to that of the reference Ace-Ala-Ala-Ala-Nme peptide. 
Generally, both ff15ipq and ff14ipq show greater variation between amino acids than 
ff14SB and CHARMM36, which apply the same backbone torsions to all residues (Figure 3.16). 
Several differences between ff15ipq and ff14ipq are apparent. For the neutral residues whose Cβ 
atoms are bound to two heavy atoms, the clearest difference is the decreased favorability of the -
180° < Ψ < -90° region for Asn, Gln, Leu, and Met; ff15ipq is more consistent with NDRD 
distributions in which such conformations are rare, due to the broader sampling of such uncommon 
backbone conformations in the ff15ipq fitting set. An exception is Ser, which retains this region 
and exhibits overall broader sampling, in contrast to the NDRD distribution, in which 
conformations are restricted largely to the canonical wells. For the neutral residues whose Cβ 
atoms are bound to three heavy atoms (Ile, Thr, and Val), the NDRD dataset shows increased 
conformational preferences in the β region and in the region adjacent to the α well, centered at Φ 
≈ -120°, Ψ ≈ -60°. These preferences are captured by both ff14ipq and ff15ipq, but the lower region 
is erroneously disfavored by both ff14SB and CHARMM36. While ff15ipq is improved compared 
to ff14ipq by disfavoring the Lα well of Thr, the near-absence of sampling of this well in the 
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NDRD distribution suggests that it may still be too favorable, relative to experiment. Differences 
between ff15ipq and ff14ipq for the bulky aromatic residues are less pronounced; the 
conformational preferences of these residues may be more dependent on sterics as modeled by the 
Lennard Jones parameters, which have not been changed in ff15ipq from those of ff14ipq. The 
greatest differences between ff15ipq and ff14ipq are observed for the negatively charged residues 
Asp and Glu, which have been granted their own Φ, Ψ, Φ᾽, and Φ᾽ torsions in ff15ipq. These 
residues largely restrict sampling to the of PPII, γ᾽, and α wells, lacking clearly-defined β wells 
and any wells on the right side of the Ramachandran plot. The differences for the positively 
charged residues Arg and Lys are much smaller, likely because these residues were already 
assigned unique Φ᾽ and Ψ᾽ torsions in ff14ipq. 
To complement the above qualitative comparisons, we obtained quantitative measures of 
the accuracy of ff15ipq’s backbone conformational preferences by calculating J-coupling 
constants for the Ala5 peptide and comparing these values to experiment. This peptide was the 
focus of a study by Best et al.145 in which multiple force fields were compared in terms of their 
ability to reproduce experimental J-coupling constants using the Karplus equation and three 
different sets of Karplus coefficients: the original coefficients as used by Graf et al.146–149 and two 
sets of DFT-based coefficients (DFT-1 and DFT-2) by Case et al.150 In this study, a suggested 
criterion for a high-quality force field is that the χ2 value between calculated and experimental J-
coupling constants should be 2.25 for all three sets of Karplus coefficients. Three useful points 
of reference are the recently developed ff14SB, CHARMM36, and ff03w force fields, which were 
empirically corrected to improve reproduction of experimental Ala5 J-coupling constants.
81,85,87 
The ff14SB force field yielded χ2 values of 0.9 and 1.2 with the original and DFT-2 coefficients, 
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respectively, but a higher χ2 of 2.7 with the DFT-1 coefficients; CHARMM36 and ff03w were 
tested only with the DFT-2 coefficients, yielding χ2 of 1.16 and 0.9, respectively. 
As shown in Table 3.2, ff15ipq yields χ2 of 0.53 with the original coefficients, χ2 of 1.08 
with the DFT-2 coefficients, and a χ2 of 0.67 with an additional set of Karplus coefficients from 
Lindorff-Larsen et al.151 However, like ff14SB, we obtained a higher χ2 value of 2.91 with the 
DFT-1 coefficients; in our case, the higher χ2 value is driven primarily by a single outlier that 
deviates greatly from experiment, 3JHNCβ. Based on results from preliminary versions of ff15ipq, 
it appears that lower χ2 values with the original Karplus coefficients may come at the expense of 
higher χ2 values with the DFT-1 coefficients. Notably, ff15ipq – which employs a general 
parametrization to reproduce QM potential energies – performs at least as well as ff14SB, 
CHARMM36, and ff03w, which have been parametrized specifically to reproduce Ala5 J-coupling 
constants.81,87 All four force fields yield results much improved relative to force fields developed 
only a few years ago.145 
 
Table 3.2. Ala5 J-coupling constants 
  Simulation 
Experiment J-coupling Residue Original DFT-1 DFT-2 KLL 
1JN,Cα 2 11.38 11.38 11.38 11.38 11.36 
1JN,Cα 3 11.06 11.06 11.06 11.06 11.26 
2JN,Cα 2 8.64 8.64 8.64 8.64 9.20 
2JN,Cα 3 8.50 8.50 8.50 8.50 8.55 
3JC,C 2 0.67 0.48 0.57 0.67 0.19 
3JHα,C 2 1.57 1.31 1.47 1.38 1.85 
3JHα,C 3 1.83 1.60 1.77 1.67 1.86 
3JHN,C 2 1.26 1.27 0.88 1.46 1.10 
3JHN,C 3 1.19 1.20 0.88 1.37 1.15 
3JHN,Cβ 2 2.10 4.06 3.24 2.17 2.30 
3JHN,Cβ 3 1.99 3.79 3.02 2.04 2.24 
3JHN,Hα 2 5.35 4.78 5.50 4.92 5.59 
3JHN,Hα 3 5.73 5.29 5.92 5.36 5.74 
3JHN,Cα 2 0.63 0.63 0.63 0.63 0.67 
3JHN,Cα 3 0.62 0.62 0.62 0.62 0.68 
χ2
l
 
 0.53±0.02 2.91±0.06 1.08±0.03 0.67±0.02  
                                               
l Uncertainties on χ2 values represent one standard error of the mean calculated using a block averaging method.64 
Uncertainties on individual J-coupling constants are omitted for clarity. 
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Note that the calculated J-couplings depend on the ratios of various backbone 
conformations, between which transitions may be relatively rare. In our studies of Ala5, we found 
that 1.5 μs of aggregate simulation time, which we had previously used in our validation of 
ff14ipq,91 did not yield sufficiently precise calculations of the J-couplings. Although the J-
couplings may appear to be converged based on their relatively small statistical variances 
(evaluated using block averaging), these variances may be misleading. For example, we observed 
what appeared to be small, but statistically significant differences in the J-couplings between 
simulations run with and without hydrogen mass repartitioning after 1.5 μs of simulation, but these 
differences ultimately disappeared after 6 μs. The extensive sampling needed to obtain converged 
J-couplings illustrates the challenge of mapping the conformations of just a few residues using 
brute-force MD simulation. 
3.4.4 α-helices: K19 and (AAQAA)3 peptides 
To assess the propensity of ff15ipq to form α-helices, we studied the temperature-
dependent behavior of two model α-helical peptides: K19 and (ΑΑQAA)3.120,121 Both peptides are 
variants of the motif (Ala-Ala-Xaa-Ala-Ala)n, in which Xaa is Lys in K19 and Gln in (AAQAA)3; 
their sequences are listed in Table 3.1. For each peptide, we carried out six 4-μs simulations at 
different temperatures and monitored the formation of various types of secondary structure. As 
shown in Figure 3.4, both peptides undergo multiple folding and unfolding events, though our 
simulations are not sufficiently long to obtain converged estimates of the probability of adopting 
α-helical conformations. Qualitatively, K19 adopts α-helical conformations for a greater 
proportion of the simulation than (AAQAA)3, which is consistent with the experimental 
observation that K19 and (AAQAA)3 are ~40% and ~20% α-helical, respectively, at 300 K.120,121 
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Both peptides transiently form β-sheet contacts, which do not appear to be stable for more than 
100 ns, indicating that ff15ipq correctly identifies the favored secondary structures of these 
peptides. 
 
 
Figure 3.4. Secondary structure of model α-helical peptides K19 (A) and (AAQAA)3 (B) at various simulated 
temperatures over the course of 4-μs simulations. 
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While the two peptides differ in length, the observed difference in α-helical stability is 
likely due to parameters of Gln and Lys residues at the central positions of the peptides. In our 
umbrella sampling simulations of tetrapeptides, which are too small to form an α-helix (Figure 
3.16), we observed a broader, deeper α well for Lys than for Gln, suggesting that the observed 
difference in α-helical stability between the two peptides has already been “built-in” to ff15ipq at 
the residue level. In addition, the two residues have different backbone charges: Gln shares its N, 
H, C, and O charges with the other neutral residues, and Lys shares its charges with the positively 
charged residues. While the backbone H charges for neutral and positively-charged residues are 
similar, the backbone O of the positively charged residues is ~0.05 e more negative than that of 
the neutral residues, which may result in more stable hydrogen bonding. 
3.4.5 β-sheets: GB1 hairpin, chignolin, and Cln025 peptides 
In order to assess the stability of β-sheet structures in ff15ipq, we simulated three model β-hairpin 
systems: the GB1 hairpin, the designed peptide chignolin, and its hyper-stable variant Cln025.122–
124 We simulated the GB1 hairpin at six temperatures ranging from 275 K to 325 K, Cln025 at ten 
temperatures ranging from 280 K to 370 K, and chignolin only at 298 K. Figure 3.5 shows the 
secondary structures observed during 4-μs simulations of these systems. As with our simulations 
of the α-helical peptides, our β-hairpin simulations are not sufficiently long to precisely quantify 
secondary structure stability, though qualitative trends may be identified. As shown in Figure 3.5A, 
the GB1 hairpin is metastable over the tested temperature range of 275-325 K, and in two of our 
simulations unfolds and refolds. Our simulations at 285 K are in qualitative agreement with 
experiment, which have indicated that the GB1 hairpin is ~85% folded at 275 K, ~50% folded at 
295 K, and ~20% folded at 325 K.152 However, an anomaly is observed in our 275 K simulation, 
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in which the GB1 hairpin unfolds after ~200 ns and does not refold. This unfolding event may 
simply be an artifact of our limited sampling that would disappear were the simulations run to 
convergence. Alternatively, it may reflect limitations of the SPC/Eb water model at temperatures 
distant from those at which it was parametrized; while the temperature-dependent behavior of 
SPC/Eb has not been characterized, to our knowledge, three-point water models including the 
parent SPC/E water model are known to poorly reproduce the temperature dependence of 
properties such as density.90,153,154 
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Figure 3.5. Secondary structures of model β-hairpin peptides GB1 hairpin (A), chignolin (B) and Cln025 (C) at 
various simulated temperatures over the course of 4-μs simulations. 
 
In contrast, our simulations of chignolin and Cln025 suggest that these β-hairpin systems 
may be more stable than observed experimentally. As shown in Figure 3.5B, chignolin maintains 
its β-hairpin configuration throughout our 4-μs simulation at 298 K, including two hydrogen bonds 
in an anti-parallel sheet configuration, while experimentally the peptide is only ~60% folded at 
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this temperature.123 Chignolin’s hyper-stable variant Cln025 has an experimental melting 
temperature of 343 K.124 As shown in Figure 3.5C, in our simulations at temperatures ranging from 
280 to 370 K we observe unfolding and refolding events at several temperatures, though the overall 
folded population is larger than measured experimentally. In particular, Cln025 is >80% folded in 
our simulation at 370 K, while, experimentally, the peptide is only ~25% folded at this 
temperature.124 
As with α-helices, we expect ff15ipq to yield residue-specific propensities in β-sheet 
stability, though the large difference in sequence between the two tested types of model β-hairpins 
make comparing them difficult. The aforementioned lack of a clear β well in Asp may destabilize 
the GB1 hairpin, which contains two adjacent Asp residues, one of which forms part of the anti-
parallel β-sheet and the other, the turn. The observed stabilities of chignolin and Cln025 preclude 
the notion that ff15ipq is biased against β-sheet structure in general. Further studies including 
additional hairpin sequences and parallel β-sheet structures will be necessary to quantify and 
mitigate residue-specific biases for future IPolQ force fields. 
3.4.6 The Trp-cage miniprotein and globular proteins BPTI, villin, GB3, ubiquitin, 
binase, and lysozyme 
In order to assess the stability of proteins with ff15ipq, we simulated the Trp-cage miniprotein and 
a series of six globular proteins: BPTI, villin, GB3, ubiquitin, binase, and lysozyme. Extensive 
experimental data is available for all of these model systems, providing excellent opportunities for 
validation of our simulations. We carried out 24 μs of aggregate equilibrium simulations of Trp-
cage at temperatures ranging from 275 to 325 K and simulations 2-10 μs in duration of the six 
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globular proteins at temperatures between 298 and 303 K. Details of our simulations are listed in 
Table 3.1. 
The designed miniprotein Trp-cage is central to a long-running computational success story 
for AMBER force fields. Folding simulations of this miniprotein using the AMBER ff99SB force 
field have successfully recovered the folded structure, yielded multiple folding and unfolding 
events, and provided a melting temperature (Tm) of 318 K, which is in reasonable agreement with 
the experimental Tm of ~315 K.
26,125,155 As shown in Figure 3.6, Trp-cage remained stable in our 
simulations between 275 K and 295 K, with an average backbone RMSD from the experimental 
NMR structure of < 1 Å, and unfolded between 305 and 325 K. While our simulations are not 
extensive enough to obtain precise estimates of the Tm, these results suggest that the Tm is 
somewhere between 295 K and 305 K, which is slightly lower than experiment. Each unfolding 
event is marked by an initial shift of the backbone Φ/Ψ of Pro 12 from the α well to the PPII well, 
followed by the loss of the N-terminal α-helical component of the polypeptide. Notably, in our 
simulation that was run at 325 K, the protein refolded for ~500 ns, indicating that the folded state 
is a stable free energy minimum. Thus, despite the extensive reoptimization of the parameter set, 
the important success of the AMBER force fields in modeling the stability of Trp-cage has been 
maintained. 
 
Figure 3.6. Stability of the Trp-cage miniprotein over the temperature range of 275-325 K over the course of 4-μs 
simulations, as monitored by the backbone RMSD, relative to the experimental NMR structure. 
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Note that the Pro-rich sequence of Trp-cage allows the opportunity to validate the unique 
pre-Pro Ψ and Ψ’ terms of ff15ipq, because it contains Gly, Arg, and Pro residues that precede 
Pro. Whenever Trp-cage was folded in our simulations, Gly 11 remained stably in its PPII’ well, 
while Arg 16 sampled broadly across the β and PPII regions without a clear barrier between them. 
These results are in good agreement with the experimental NMR ensemble, within which the Φ 
and Ψ backbone torsions of Arg 16 are distributed in a line across these two regions,125 and with 
the pre-Pro distributions observed for these residues in the NDRD dataset.143 Also consistent with 
both the NMR ensemble and NDRD dataset are the observed distributions of Pro 17 and Pro 18, 
which strictly maintained their positions in the PPII well even as the protein unfolded. 
As shown in Figure 3.7, the overall structures of all six globular proteins – BPTI, villin, 
GB3, ubiquitin, binase, and lysozyme – remained stable over their entire simulations. The BPTI 
protein stayed closest to its crystal structure, yielding an average backbone RMSD of 0.7 Å, which 
may be a result of its three disulphide bonds among a total of 58 residues. All α-helical and β-sheet 
regions of this protein were retained for the entire simulation. The only notable deviation from the 
crystal structure of BPTI was observed for Ala 16 and Arg 17, which form the end of the loop 
preceding the first β-sheet. These two residues, which occupy the α and ξ wells, respectively, in 
the crystal structure, made temporary excursions of several hundred nanoseconds to alternative 
conformations before returning to the crystal conformation (Figure 3.17 and Figure 3.18). The 
villin headpiece subdomain also remained close to its crystal structure, yielding an average 
backbone RMSD of 1.1 Å. In order to test our parameters for the noncanonical amino acid 
norleucine (Nle), which was included alongside the canonical residues during development of 
ff15ipq, we have simulated the fast-folding double-Nle mutant of villin.131 The Nle residues, both 
of which are located in the third α-helix, strictly sampled the α-helical well, suggesting that our 
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parameters for Nle are appropriate. The only significant deviation from the crystal structure of this 
mutant of villin is a ~0.5 μs excursion made by residues 10-12, which form the end of helix 1 and 
the loop linking helices 1 and 2, to an alternative conformation different from that observed in the 
crystal structure (Figure 3.19 and Figure 3.20). 
 
Figure 3.7. Stability of folded proteins over the course of 10-μs simulations as monitored by the backbone RMSD 
relative to the experimental structures. For binase, the mean RMSD relative to the ensemble of 20 NMR structures is 
shown along with the range between the minimum and maximum values (light blue shaded region). 
 
Our simulation of GB3 yielded an average backbone RMSD of 1.0 Å from the NMR 
structure. Three of the residues exhibit significant deviations from the crystal structure: Leu 12, 
Asp 40, and Thr 55 (Figure 3.21 and Figure 3.22). The conformation of Leu 12, which is located 
in the turn linking the first and second β-strand, falls precisely between the β and PPII wells in the 
NMR structure, while both wells were nearly equally sampled in our simulation. As a result of this 
increased conformational flexibility at Leu 12, adjacent residues also occasionally sampled 
conformations outside their NMR structure. The presence of a free energy barrier between the β 
and PPII wells is a necessity for maintaining stable conformations within these wells; it is likely 
that the forces contributing to the stabilization of Leu 12’s unusual conformation in the NMR 
structure are simply not captured by the functional form of ff15ipq. Consistent with this 
hypothesis, nearly identical deviations were observed for the ff14SB force field which shares this 
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functional form.81 The conformation of Asp 40, which is located in the loop between the α-helix 
and third β-strand, occupies the ξ well in the crystal structure while other conformations, 
predominantly β, were sampled in our simulations. Indeed, based on this result and others 
presented below, the negatively charged residues of ff15ipq completely lack an ξ well. As with 
Leu 12, the increased conformational flexibility of Asp 40 led to broader sampling by adjacent 
residues. It is worth noting that GB3 contains two negatively charged residues, Glu 15 and Asp 
22, which remained stable in β-sheets, indicating that the limited sampling of this region observed 
in our umbrella sampling simulations may be overcome within the context of a folded protein. 
Finally, a notable deviation from the NMR structure occurs for Thr 55 during the last microsecond 
of our simulation when the antiparallel β-sheet hydrogen bonds between this residue and Val 42 
are broken, though the remainder of the β-sheet remains in place. While this deviation may be a 
transient event, it could also be a consequence of the conformational deviations of the nearby Asp 
40. 
Similar to GB3, ubiquitin in our simulations exhibited a low overall average backbone 
RMSD of 1.2 Å from the crystal structure, but significant deviations in certain regions. In 
particular, transient deviations from the crystal structure were observed for residues 8-11, which 
form the turn connecting the first and second β-strands (Figure 3.23 and Figure 3.24). While these 
residues sampled conformations that were different from the crystal structure, their turn 
conformation was retained throughout 80% of the simulation, and experimental NMR relaxation 
data suggests that is region is truly flexible.156 A more significant deviation was observed for Asp 
52 and Gly 53, which are located in a loop region; in the crystal structure, these residues both 
occupy the α well while in our simulation, Asp 52 and Gly 53 shift to the PPII and γ wells, 
respectively. Unlike the deviations observed in GB3, this shift does not lead to broader sampling 
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by adjacent residues or appear to otherwise destabilize the protein, suggesting that the observed 
alternative conformation may simply be erroneously modeled by ff15ipq to be lower in energy 
than the conformation found in the crystal structure. Finally, after ~8.5 μs of simulation, Glu 34, 
which is the last helical residue in the central α-helix, shifts to the PPII and β regions, leading to 
shifts in residues 33-36. Combined with the observations made for Asp 52, this shift suggests that 
for negatively charged residues, ff15ipq may overstabilize PPII conformations relative to α. 
Among the simulated globular proteins, the greatest deviations from the initial structure 
were observed for binase, with an average backbone RMSD of 3.4 Å from the NMR ensemble of 
20 models.126 The same average RMSD was also obtained with respect to the crystal structure of 
wild-type binase, which differs in the amino acid sequence at six positions (PDB code: 1GOU).157 
These larger differences are primarily caused by variability in loop regions as noted for the 
experimental structures,126,157 and the core structure of binase remained relatively close to the 
experimental structures with an average backbone RMSD of 1.9 Å. The first loop, which comprises 
residues 34-39, adopted multiple conformations in our simulation, which is consistent with the 
NMR ensemble (Figure 3.25 and Figure 3.26). Moreover, this loop adopts the conformation 
observed in the crystal structure for 75% of the simulation. The second loop comprises residues 
56-62, which also sampled broadly in our simulations, consistent with diverse conformations in 
the NMR ensemble and poorly defined electron density in the crystal structure.157 Notably, in both 
our simulation and the NMR ensemble, flexibility in this region extends to Gly 67. This difference 
may relate to the difference in sequence between the NMR and crystal structure proteins, in which 
Ser 66 is replaced by Gly and Gly 67 by Ser. The third loop, comprised of residues 76-83, is also 
broadly sampled in our simulation, and is the source of greatest difference relative to the 
experimental structures. The final loop is comprised of residues 99-104 and in our simulation we 
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observe several residues sampling two different conformations, consistent with the observation of 
two states in crystal structures determined under different conditions.157 
The largest protein system, lysosome, was simulated for 2 μs, over which it exhibited an 
average backbone RMSD of 1.2 Å with respect to the crystal structure. As shown in Figure 3.27 
and Figure 3.28, the largest deviations were found in the loop comprised of residues 100-104. 
Residues 101 through 104 adopted an alternative conformation, with the flanking residue Val 99 
no longer part of the preceding α helix and Gly 104 part of the following helix. Similar to our 
observations for ubiquitin, this difference appears to be related to the shift of a negatively charged 
residue, Asp 101, from the α well to the PPII well. 
Four of the the six globular proteins – BPTI, GB3, ubiquitin, and lysozyme – have also 
been used for validation of previously developed force fields, including ff14ipq, ff14SB, and 
CHARMM36.81,87,91 Similar to these force fields, ff15ipq yielded low average backbone RMSD 
values for these proteins, relative to their initial structures (i.e., 1.2 Å). A key point to be 
considered while comparing our results to those of previous force fields is that advancements in 
GPU computing over the last several years79 have enabled us to validate ff15ipq using simulations 
up to 10 μs, which is up to 10x as long as those used for the other force fields. In particular, ff14SB 
was validated using sets of four 1-μs simulations,81 while CHARMM36 was validated using 200-
ns simulations.87 Many of the key deviations we observe do not occur for several microseconds; 
for example, we observe changes in the C-terminus of GB3 after 9 μs, and in the loops of ubiquitin 
after 8.5 μs. These deviations are informative and will guide development of successors to ff15ipq, 
illustrating the utility of long-time scale simulations for force field development. 
A particularly appealing feature of the SPC/Eb water model with which we have developed 
ff15ipq is its ability to more accurately reproduce the rotational diffusion of solvated proteins 
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relative to water models such as TIP3P and TIP4P-Ew.96 In order to measure how accurately the 
combination of ff15ipq and SPC/Eb are able to reproduce rotational diffusion, we branched off sets 
of ten 200-ns simulations in the microcanonical ensemble (NVE) from our 10-μs simulations in 
the canonical ensemble (NVT) for GB3, ubiquitin, and binase, thereby avoiding perturbation of 
the dynamics by the use of a thermostat. As shown in Table 3.3, ubiquitin, GB3, and binase, 
diffused ~14%, ~15%, and ~22% more slowly than measured experimentally by NMR, 
respectively. Note that the experimental values were corrected for differences in temperature, 
isotopic labeling, and solvent D2O content, potentially introducing error into the comparison of 
simulated and experimental values.29 Interestingly, while the errors we obtained were consistent 
with our test simulations with the AMBER ff99SB-ILDN force field and SPC/Eb (Figure 3.13), 
we found CHARMM22* and SPC/Eb to yield lower errors of 7%, 6%, and 16%, illustrating the 
coupling of solute and solvent parameters on the motions of proteins through solution. Since the 
SPC/Eb water model had been empirically optimized for proteins with the AMBER ff99SB force 
field, this is no fault of ff15ipq (or CHARMM22*, for that matter), but suggests that improved 
performance might be obtained by optimizing the protein and solvent models in tandem. Finally, 
it is worth noting that our use of the Langevin thermostat in the NVT simulations results in ~42%-
52% longer rotational diffusion times, relative to those of the NVE simulations, demonstrating, for 
the first time (to our knowledge), that the use of a thermostat can significantly perturb dynamical 
properties for proteins and not just for small molecules and polymer chains.158 
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Table 3.3. Rotational diffusion of globular proteins simulated with ff15ipq. 
System Experimental τc 
(ns)
m
 
Simulated τc, 
One 10-μs NVT simulation 
(ns)
n
 
Simulated τc, 
Ten 200-ns NVE simulations 
(ns)
o
 
GB3 3.03 4.94±0.02 3.47±0.05 
Ubiquitin 4.07 6.67±0.04 4.62±0.08 
Binase 5.95 11.06±0.07 7.26±0.18 
 
A major advantage of performing simulations with accurate rotational diffusion is that one 
can directly calculate NMR relaxation parameters 15N R1and R2, and 
15N-1H heteronuclear NOE, 
which report on the dynamics of individual residues, and compare these values with experiment. 
Therefore, we calculated relaxation parameters for GB3 and ubiquitin, for which experimental data 
are available at five and four magnetic field strengths, respectively (Figure 3.8 and Figure 3.9). 
Overall, our calculated R2 values are in excellent agreement with experiment, with average mean 
absolute percent errors (MAPE) of 8% for GB3 and 9% for ubiquitin. Our R1 values are also in 
good agreement, with average MAPE of 10% and 12%, with a consistent offset observed across 
all residues. However, our heteronuclear NOE values are somewhat poorer agreement, with 
average MAPE of 22% and 30% for the two systems. 
                                               
m Experimental rotational diffusion measured using NMR relaxation128,156,218 and corrected for differences in 
temperature and D2O content between simulation and experiment.29 
n Uncertainties represent one standard error of the mean calculated from 50 consecutive 200-ns blocks from a single 
10-μs simulation. 
o Uncertainties represent one standard error of the mean calculated from 10 independent 200-ns simulations. 
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Figure 3.8. Comparison of NMR relaxation and order parameters for the GB3 protein from simulation and experiment. 
All parameters from simulation were calculated by applying the iRED method140 to a set of ten 200-μs simulations 
with the ff15ipq force field, considering the autocorrelation function of each backbone N-H vector to 17 ns, which is 
five times the overall rotational correlation time (τc) of the protein.159 Experimental R1, R2, and heteronuclear NOE 
data were available at five magnetic field strengths (400, 500, 600, 700, and 800 MHz), and experimental order 
parameters (S2) were based on the combined data set from all five magnetic field stengths.160 At a magnetic field 
strength of 600 MHz (A, B, C), ff15ipq yields good agreement in R2, reasonable agreement in R1 with a consistent 
offset, and somewhat poorer agreement in heteronuclear NOE; similar agreement is achieved at other magnetic field 
strengths. Error bars represent 95% confidence intervals; standard errors were obtained by calculating the standard 
deviation across the ten simulations. Comparison of simulated and experimental S2 values (D) shows acceptable 
agreement, with deviations in many of the same regions as those observed for the NMR relaxation parameters. The 
mean absolute percent error (MAPE) in simulated R1, R2, and heteronuclear NOE (E) was calculated by averaging the 
proportional errors in each parameter across the five magnetic field strengths, while the error in S2 was calculated 
relative to the single experimental dataset. Residues with above-average MAPE in R1 and R2, including Leu 12, Asp 
40, and Gly 41, are discussed in the main text. 
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Figure 3.9. Comparison of NMR relaxation and order parameters for the ubiquitin protein from simulation and 
experiment. All parameters from simulation were calculated by applying the iRED method140 to a set of ten 200-ns 
simulations with the ff15ipq force field, considering the autocorrelation function of each backbone N-H vector to 23 
ns, which is five times the overall rotational correlation time (τc) of the protein.159 Experimental R1, R2, and 
heteronuclear NOE data were available from Lee et al. at four magnetic field strengths (400, 500, 600, and 750 MHz), 
and from Tjandra et al. at 600 MHz, and experimental order parameters (S2) were available from both groups.156,161 
At a magnetic field strength of 600 MHz (A, B, C), ff15ipq obtains good agreement in R2, reasonable agreement in 
R1 with a consistent offset, and somewhat poorer agreement in heteronuclear NOE; similar agreement is achieved at 
other magnetic field strengths. Error bars represent 95% confidence intervals; standard errors were obtained by 
calculating the standard deviation across the ten simulations. Comparison of simulated and experimental order 
parameters (D) shows acceptable agreement, with deviations in many of the same regions as observed for the NMR 
relaxation parameters. The mean absolute percent error (MAPE) in simulated R1, R2, and heteronuclear NOE (E) was 
calculated by averaging the proportional errors in each parameter across the four magnetic field strengths, while the 
error in S2 was calculated relative to the two experimental datasets. Residues with above-average MAPE in R1 and R2, 
including Lys 11, Asn 25, and Asp 52, are discussed in the main text. 
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Residues for which our calculated R1 and R2 differ by >20% from the experimental values 
may be due to limitations of our force field. Notably, we find that several such residues are those 
for which we also observed deviation in sampled backbone conformations relative to the 
experimental structures. For GB3, Leu 12 and Asp 40 yielded above average errors in R1 (25%), 
while Gly 41 had a larger error in both R1 and R2 (47% and 33%). Similarly for ubiquitin, Lys 11, 
and Asp 52 yielded above average errors in R1 (20%). Also in ubiquitin, Asn 25 yielded an error 
of 22% in R2; however, this residue is found experimentally to undergo chemical exchange,
156 
fluctuating at time scales beyond those captured by our simulations. Among residues with errors 
below 20%, one particular trend is apparent: Ile 7, Thr 16, Thr 49, and Thr 51 of GB3 and Thr 12 
and Ile 36 of ubiquitin all yielded errors in R2 of ≥15%, despite having tightly restricted Φ/Ψ 
sampling consistent with their experimental structures. This trend suggests that ff15ipq may have 
some discrepancy with the three branched residues that is not apparent when examining only 
backbone Φ/Ψ preferences, and will be the subject of further study. 
3.4.7 Disordered peptides: p53 peptide, S-peptide 
In order to test the suitability of ff15ipq for simulating disordered proteins, we focused on 
two model peptides: the N-terminal, 13-residue peptide fragment of the tumor suppressor p53, and 
the 22-residue S-peptide fragment of RNase A. Both of these disordered peptides (p53 peptide and 
S-peptide) only adopt α-helical conformations when bound to their structured partner proteins 
(MDM2 and S-protein, respectively).162,163 For each of these peptides, we carried out two 10-μs 
simulations: one of the isolated peptide and the other of the native peptide-protein complex. 
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Figure 3.10. Stability of p53 and S-peptide alone and in complex with binding partners MDM2 and S-protein over 
the course of 10-μs simulations as measured by backbone RMSD relative to the crystal structures (A, B) and the 
percent of native contacts formed (C, D). 
 
As shown in Figure 3.10, both peptides in their isolated states adopted conformations 
distant from their partner-bound conformations, sampling a diverse set of conformations with 
average backbone RMSDs of 5 Å from their corresponding bound conformations in the crystal 
structures of the peptide-protein complexes and maintaining only ~25% of their native intra-
peptide contacts. Furthermore, the p53 peptide only transiently adopted α-helical conformations 
that resembled its partner-bound conformations (backbone RMSD < 3 Å) with these conformations 
unfolding within ~200 ns (Figure 3.29). In contrast, the S-peptide did not even transiently sample 
α-helical conformations resembling its bound state; instead, the peptide formed β-hairpins which 
persisted for periods as long as 4 μs (Figure 3.32). 
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In our simulation of the p53/MDM2 complex, the peptide remained stably bound to its 
partner protein for the entire 10 μs of simulation, with an average backbone RMSD of 1 Å from 
its bound conformation in the crystal structure (Figure 3.10). Curiously, while most of the 
intramolecular native contacts of the p53 peptide and MDM2 were retained (~95% and ~85%, 
respectively), only ~60% of the intermolecular p53/MDM2 native contacts persisted. Examination 
of the structure showed that many of these contacts lay just below the threshold distance of 5.5 Å 
between their heavy atoms in the crystal structure. Thus, these contacts were no longer “formed” 
when slightly different conformations were adopted in our simulations. Throughout our 
simulation, the p53 peptide retained the α-helical structure of residues 19-25 (Figure 3.29). In 
contrast, our simulation of the S-peptide/S-protein complex sampled conformations more distant 
from its crystal structure with average backbone RMSDs of 3 Å for both S-peptide and S-protein. 
Although the S-peptide partially lost its α-helical structure near the N-terminus from ~1.5 μs to ~5 
μs in our simulation (Figure 3.10 and Figure 3.32), the structure reformed and persisted for the 
remainder of the simulation during which both the S-peptide and S-protein retained most of their 
intramolecular native contacts (~90% and ~80%, respectively). Similar to the p53/MDM2 
complex, the S-peptide/S-protein complex retained ~60% of its peptide-protein contacts 
throughout our simulation. 
Our simulations of these flexible, disordered peptides provide an additional opportunity to 
validate the backbone conformational preferences of ff15ipq. From our four simulations, we have 
calculated the backbone Φ/Ψ sampling of the p53 peptide (Figure 3.11) and S-peptide (Figure 
3.33). For comparison, we have provided the distributions for the peptide sequences obtained from 
the NDRD dataset, which accounts for the influence of adjacent residues on each distribution.143 
In our simulation of the p53/MDM2 complex, residues 18-27 of p53 occupied exclusively the 
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wells observed in the crystal structure, aligning with the observed low RMSD and high percentage 
of native contacts. Our simulation of the isolated p53 peptide exhibits similarities with the NDRD 
distribution for most residues, but several inconsistencies are informative: in particular, the neutral 
residues exhibit reasonable overall agreement and the bulky aromatic residues Phe 19 and Trp 23 
closely resemble the NDRD distributions, while Leu 22 and Leu 25 sampled the β-region more 
extensively than suggested by the NDRD. The negatively charged residues Glu 17 and Glu 28 
sampled consistently with the NDRD, while Asp 21 missed sampling in the ξ region. The sole 
positively charged residue, Lys 24, sampled the β-well more extensively than suggested by the 
NDRD. 
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Figure 3.11. Backbone conformational sampling of the disordered p53 peptide observed in 10-μs simulations in 
complex with the MDM2 protein (A) and alone (B). For comparison are shown distributions for the p53 sequence 
obtained from the Neighbor-Dependent Ramachandran Distribution (NDRD) dataset,143 derived from conformations 
observed in the loops of solved structures (C).  
 
In our simulation of the S-peptide/S-protein complex, the crystal conformations were 
retained for most of the simulation (Figure 3.33). As described above, several residues near the N-
terminus left the α-helical well, and the adjacent Thr 3, which is not helical in the crystal structure, 
eventually joined the helix as it reforms. The clearest difference from the crystal structure is found 
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for Asp 14; This residue occupies the ξ well in the crystal structure, which is not present for Asp 
in ff15ipq, causing it to adopt a PPII conformation. Within the S-protein, residue Gln 60 is notable 
for its uncommon ‘plateau’ conformation (Φ ≈ -100°, Ψ ≈ -130°),133,164 which was retained 
throughout our simulation (Figure 3.35). In our simulation of the isolated, unbound S-peptide, the 
formation of long-lived β-hairpin structures prevented us from obtaining converged 
conformational preferences for comparison with the NDRD distributions, despite the long duration 
of the simulations (10 μs). 
Taken together, the above results indicate that ff15ipq can reliably predict disorder as well 
as order for peptides that fold upon binding their partner proteins. These encouraging results are 
worth pointing out since ff15ipq was not specifically parametrized for disordered 
peptides/proteins, as is the case for contemporary force fields such as ff03w and its subsequent 
variants.85,165 As shown in Figure 3.1, both ff03 (whose atomic charges and radii are shared by 
ff03w) and ff15ipq are able to reliably model propensities of salt bridge formation, which can be 
critical for such systems that are rich in polar and/or charged residues. Thus, ff15ipq is a reasonable 
alternative to ff03w for the simulation of disordered peptides/proteins. 
3.5 DISCUSSION 
Since the establishment of the “one atom, one site” model of all-atom fixed-charge force fields 
over 20 years ago, several major lineages of protein force fields and countless branches have been 
developed through cycles of validation and refinement. In this work, we present the ff15ipq force 
field, the latest in the AMBER IPolQ lineage, and validate its accuracy by >200 μs of aggregate 
MD simulation. The distinguishing features of ff15ipq are (i) a charge set that accounts directly 
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for water induced polarization, (ii) the incorporation of two related charge sets for creating new 
force fields based purely on ab initio calculations, (iii) the scope of the parameter optimization, 
including backbone angles alongside torsions, and (iv) the degree of automation and transferability 
of the methods to other regions of chemical space. Our simulations suggest that ff15ipq yields 
reasonable salt bridge propensities, maintains secondary structures and globular protein folds on 
the μs time scale, predicts order as well as disorder in protein structures, and yields strong 
agreement with NMR J-couplings and relaxation rates. However, even with this extensive amount 
of validation, several unconverged results remain and will be explored further using enhanced 
sampling techniques such as replica exchange166,167 or recent variants168,169 of the weighted 
ensemble path sampling strategy.170 Here, we will discuss the origins of ff15ipq and its current 
trajectory. 
A major motivation for creating ff15ipq was to address concerns about the overstabilization 
of salt bridge interactions by ff14ipq, a limitation shared by other contemporary force fields.56 We 
addressed these concerns by abandoning the mixed Lennard-Jones radii of ff14ipq and instead 
increasing the radii of polar hydrogen atoms bonded to nitrogens in both the protein backbone and 
side-chains to yield more accurate salt bridge propensities. The atomic charges of the force field 
were then rederived by applying the automated machinery which had created ff14ipq, exchanging 
the TIP4P-Ew water model for SPC/Eb. Finally, all torsion and selected backbone angle parameters 
were refit to a QM dataset over four times as large as that used for ff14ipq. In doing so, we found 
that angle optimization was essential for recovering reliable results with our more extensive 
dataset. 
While the angle optimization feature and other particulars of the torsion fitting are subjects 
of ongoing development in our force field engine mdgx, our results with ff15ipq indicate that the 
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workflow illustrated in Figure 3.12 is a viable approach to creating new force fields. Each step 
entails additional layers of details in order to address practical considerations such as infinite 
electrostatics or the forms of molecular mechanics basis functions and the shape of the target 
energy surface. We have addressed each of these issues in Sections 3.2 and 3.3 as well as in prior 
publications,33,91 but the synthesis of all these details reflects the physical arguments behind the 
IPolQ charge derivation. 
 
Figure 3.12. IPolQ force field development workflow. Starting from an existing model, selected global changes are 
optionally first applied to obtain an initial model for optimization. The IPolQ charge deviation protocol is then used 
to fit a pair of atomic charge sets for the vacuum (Qvac) and solution (Qsolv) phases. The vacuum-phase charges are 
used to fit parameters for bonded terms to vacuum-phase QM targets, and these parameters are subsequently paired 
with the solution-phase charges to yield a complete force field for solution-phase simulations. The force field is then 
validated through extensive MD simulation, informing future development. 
 
This approach should be viewed in context with the contemporary Force Balance approach, 
which also performs sweeping optimization of hundreds of parameters simultaneously.90 Unlike 
our MM-minimized conformations, Force Balance typically considers conformations QM-
minimized at the same level of theory at which the target QM energies are calculated, though this 
is not a strict requirement. Going beyond the capabilities of mdgx, Force Balance includes 
numerous non-linear optimization methods and offers the capability to incorporate results from 
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sources beyond QM single-point energies, including in vitro experiments, directly into the 
parameter optimization. In the future, such diverse targets might be paired with the IPolQ method, 
for example by using the vacuum charge set (Qvac) for comparison with vacuum-phase QM data, 
but to use the polarized charge set (Qsolv) in simulations for comparison to experimental results in 
solution. 
It is rather remarkable that a viable protein force field can be produced in months, almost 
entirely from QM data. Also noteworthy is the fact that features such as angle optimization and 
generational refinement, which had incremental but definite effects on the accuracy of data fitting, 
could be so influential in the final result. One way of considering the remaining error in our MM 
model is to partition it between two sources: bonded and nonbonded interactions. The 
improvements in ff15ipq that were obtained relative to ff14ipq, whose nonbonded parameters are 
of similar accuracy, resulted from optimization of angles and the branching of bonded parameters. 
While the inclusion of anharmonicity in bond and angle stretching or a spline-based treatment of 
torsion cross terms (CMAP) may reduce errors further,67,82 greater improvements might be 
accomplished in the non-bonded interactions. 
For this reason, the next planned advance of the AMBER IPolQ force field lineage is to 
improve the accuracy of electrostatic interactions by making liberal use of virtual charge sites. The 
"one atom, one site" paradigm used for ff15ipq which was established several decades ago appears 
sufficiently accurate for most purposes, economical by construction, and thoroughly optimized in 
existing MD engines. Models with significant numbers of virtual charge sites are presently in the 
process of becoming established. These models offer improved accuracy for various chemistries 
with clear physical motivations, accompanied by a more modest increase in computational cost 
than afforded by polarizable functional forms.171,172 Future AMBER IPolQ development at the one 
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site per atom level will continue to explore the applicability of our methodology to the chemical 
space of other biologically important molecules, including nucleic acids, carbohydrates, and small 
molecules. Further ahead along the path lie multi-site IPolQ models which will push the mimicry 
of QM potential energy surfaces – within the confines of a non-polarizable model – to new levels. 
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3.7 SUPPORTING INFORMATION 
3.7.1 Supporting methods 
3.7.1.1 Simulations of salt bridge formation using the CHARMM Drude-2013 polarizable 
force field 
Systems were initially prepared with the CHARMM36 force field using psfgen, 87,173 equilibrated 
using NAMD 2.10.0,109 and uploaded to the CHARMM-GUI server to obtain Drude-2013 
topologies.174,175 The Drude-2013 systems were then subjected to another round of energy 
minimization and equilibration prior to production simulation. The equilibration process for these 
systems involved three stages of unrestrained simulation in which a 1-ps simulation was first 
performed at constant pressure using a 0.1-fs time step, followed by a 20-ps simulation at constant 
pressure using a 0.5-fs time step, and finally a 1-ns simulation at constant pressure using a 1-fs 
time step. Production simulations were then carried out for 100 ns at constant pressure using a 1-
fs time step. Throughout equilibration and production temperature was maintained at 298 K using 
a dual Langevin thermostat (frictional constant of 1 ps-1) and 1 K for Drude particles (frictional 
constant of 20-ps-1),110 while pressure was maintained at 1 atm using a Langevin piston barostat 
(piston period and decay time of 200 fs and 100 fs, respectively).176 Van der Waals interactions 
were smoothly switched off between 8 and 10 Å, while short-range electrostatic interactions were 
truncated at 10 Å and long-range electrostatic interactions were calculated using the particle mesh 
Ewald method.61 To enable a 1-fs time step, a hard-wall barrier was applied to restrict the 
maximum distance between Drude particles and their hosts to 0.2 Å,107 and bonds to hydrogen 
were constrained to their equilibrium lengths using the M-SHAKE algorithm.60 
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3.7.1.2 Simulations of salt bridge formation using the AMOEBA polarizable force field 
Systems were built using TINKER and converted to AMBER format using the AMBERTools 15 
software package.93,177 Each system was subjected to energy minimization followed by a 20-ps 
simulation at constant temperature and a 1-ns simulation at constant pressure. Production 
simulations were then carried out for 50 ns at constant pressure. Throughout equilibration and 
production temperature was maintained at 298 K using a Langevin thermostat (frictional constant 
of 1 ps−1), while pressure was maintained at 1 atm using a Berendsen barostat (time constant of 1-
ps).178 Van der Waals interactions were truncated at 12 Å, while short-range electrostatic 
interactions were truncated at 7 Å and long-range electrostatic interactions were calculated using 
the PME method.61 Dynamics were integrated using a 1-fs time step. 
3.7.1.3 Derivation of amino acid side-chain analogue parameters with AMOEBA 
Parameters that are consistent with the AMOEBA polarizable force field were derived for 
imidazolium, guanidinium, and acetate using the software Poltype.111 The structures of these side-
chain analogues were optimized at the HF/6-31G* level of theory, followed by density calculation 
at the MP2/6-311G** level of theory using the Gaussian 09 software package.179 Multipoles were 
fit using Stone’s distributed multipole analysis as implemented in the GDMA program,180,181 and 
refined via fitting of the electrostatic potential using a convergence criterion of 0.1 kcal/(mol 
electron2). Van der Waals radii and well-depths were assigned based on both the element and 
valence orbitals of each atom, while atomic polarizabilities were assigned based solely on the 
element. Parameters for bonded interactions were selected based on the analogues’ chemical 
connectivity from a database of small-molecule parameters.111 
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3.7.1.4 Simulations of GB3, ubiquitin, and binase with AMBER ff99SB-ILDN and 
CHARMM22* 
Systems for the simulations reported in Figure 3.13 were prepared and equilibrated using the 
Desmond 3.0.1.0 software package.57 Each system was subjected to energy minimization followed 
by a 20-ps equilibration at constant temperature, and a 1-ns equilibration at constant pressure. 
Temperature was maintained at 298 K and pressure at 1 atm using the Martyna-Tobias-Klein 
thermostat and barostat (time constants of 1 ps and 2 ps, respectively).59 To enable a 2-fs time step, 
bonds to hydrogen were constrained to their equilibrium values using the M-SHAKE algorithm.60 
A short-range nonbonded cutoff of 10 Å was used, and long-range electrostatics were calculated 
using the particle mesh Ewald (PME) method.61 
Production simulations were carried out for 1 μs at constant pressure using a 64-node Anton 
special-purpose supercomputer and the Multigrator integrator.25,182 Temperature was maintained 
at 298 K using the Nosé-Hoover thermostat and pressure at 1 atm using the Martyna-Tobias-Klein 
barostat (time constants of 1 ps). To enable a 2.5-fs time step, bonds to hydrogen were constrained 
to their equilibrium values using the M-SHAKE algorithm.60 Van der Waals and short-range 
electrostatic interactions were truncated at 10 Å; long-range electrostatic interactions were 
calculated using the Gaussian split Ewald method,63 and were updated every third time step. 
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3.7.2 Supporting figures 
 
Figure 3.13. Comparison of simulated vs. experimental rotational correlation times c of GB3, ubiquitin, and binase. 
Simulated c values were obtained using two different force fields (AMBER ff99SB-ILDN and CHARMM22*)28,32 
and four different water models (SPC/Eb, TIP3P, TIP4P-D, and TIP4P-Ew).27,70,96,102 Experimental c values were 
measured using NMR relaxation and corrected for differences in temperature and D2O content between simulation 
and experiment.29,156,160,183 Error bars represent 95% confidence intervals; standard errors were obtained by dividing 
each 1-μs simulation into five 200-ns blocks and calculating the standard deviation. 
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Figure 3.14. Probability of binding (Pbound) between acetate and one or more molecules of three cationic side-chain 
analogues using the ff14ipq and ff15ipq charge sets paired with different Lennard Jones radii. The ff13α radii tested 
with ff14ipq included an increase in the σ of the carboxylate oxygen (type ‘O’) and a decrease in the ammonium 
nitrogen (type ‘N’) relative to ff94;33 the final version used ‘mixed radii’ in which the ff13α σ were applied only to 
interactions with water.91 The ff14ipq force field was simulated with the TIP4P-Ew water model,27 while ff15ipq was 
simulated with SPC/Eb.96 The Pbound values corresponding to the experimentally-determined KA values of guanidinium 
acetate and butylammonium acetate are depicted as horizontal gray bars;51,69 no experimental value is available for 
the imidazolium acetate system. Error bars represent 95% confidence intervals calculated using a block averaging 
method.64 
 
Figure 3.15. Distributions of errors in molecular mechanical energies UMM relative to their quantum mechanical 
targets UQM for amino acid dipeptides representing alternative protonation states (Ash, Cym, Glh, Hid, Hip, Lyn), the 
disulphide form of cysteine (Cyx), and the noncanonical amino acid norleucine (Nle). 25th, 50th, and 75th percentiles 
are represented by horizontal lines, and root mean square errors are represented by white circles. Each dataset is 
colored by its corresponding backbone torsion class. 
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Figure 3.16. Comparison of residue-specific conformational preferences of the central residue of Ace-Ala-Xaa-Ala-
Nme tetrapeptides observed in umbrella sampling simulations with distributions of Ala-Xaa-Ala obtained from the 
Neighbor-Dependent Ramachandran Distribution (NDRD) dataset.143 Simulations were performed using four 
different force fields (AMBER ff15ipq, ff14ipq, ff14SB, and CHARMM36),81,87,91 which were each paired with either 
the water model with which they were derived or that with which they are most-commonly used. For each system, 
both the absolute free energy as well as the difference in free energy relative to Ala-Ala-Ala is shown. Regions in 
which the free energies of both Ala-Xaa-Ala and Ala-Ala-Ala are greater than 5 kcal/mol are omitted for clarity. 
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Figure 3.16 (continued). 
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Figure 3.16 (continued). 
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Figure 3.16 (continued). 
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Figure 3.16 (continued). 
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Figure 3.16 (continued). 
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Figure 3.16 (continued). 
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Figure 3.16 (continued). 
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Figure 3.16 (continued). 
 
 
Figure 3.17. Secondary structure (A) and per-residue backbone RMSD relative to the crystal structure (PDB code 
5PTI)127 (B) of BPTI observed over the course of a 10-μs simulation. 
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Figure 3.18. Backbone conformational sampling of BPTI observed in a 10-μs simulation. The Φ/Ψ angles observed 
in the crystal structure (PDB code 5PTI)127 are shown as gray points. Overall retention of the crystal conformation of 
most residues is good; regions of deviation mentioned in the main text are highlighted in blue. 
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Figure 3.19. Secondary structure (A) and per-residue backbone RMSD relative to the crystal structure (PDB code 
2F4K)131 (B) of the double-norleucine mutant of the villin headpiece subdomain observed over the course of a 10-μs 
simulation. 
 
 
Figure 3.20. Backbone conformational sampling of the double-norleucine mutant of the villin headpiece subdomain 
observed in a 10-μs simulation. The Φ/Ψ angles observed in the crystal structure (PDB code 2F4K)131 are shown as 
gray points. Overall retention of the crystal conformation of most residues is good; regions of deviation mentioned in 
the main text are highlighted in blue. 
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Figure 3.21. Secondary structure (A) and per-residue backbone RMSD relative to the NMR structure (PDB code 
1P7E)128 (B) of GB3 observed over the course of a 10-μs simulation. 
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Figure 3.22. Backbone conformational sampling of GB3 observed in a 10-μs simulation. The Φ/Ψ angles observed in 
the NMR structure (PDB code 1P7E)128 are shown as gray points. Overall retention of the NMR conformation of most 
residues is good; regions of deviation mentioned in the main text are highlighted in blue. 
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Figure 3.23. Secondary structure (A) and per-residue backbone RMSD relative to the crystal structure (PDB code 
1UBQ)130 (B) of ubiquitin observed over the course of a 10-μs simulation. 
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Figure 3.24. Backbone conformational sampling of ubiquitin observed in a 10-μs simulation. The Φ/Ψ angles 
observed in the crystal structure (PDB code 1UBQ)130 are shown as gray points. Overall retention of the crystal 
conformation of most residues is good; regions of deviation mentioned in the main text are highlighted in blue. 
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Figure 3.25. Secondary structure (A) and average per-residue backbone RMSD relative to the twenty structures of 
the NMR ensemble (PDB code 1BUJ)126 (B) of binase observed over the course of a 10-μs simulation. 
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Figure 3.26. Backbone conformational sampling of binase observed in a 10-μs simulation. The Φ/Ψ angles observed 
in the twenty structures of the NMR ensemble (PDB code 1BUJ)126 are shown as gray points, while those observed in 
the crystal structure (PDB code 1GOU)157 are shown as white points. Overall retention of the crystal conformation of 
most residues is good; regions of deviation mentioned in the main text are highlighted in blue. 
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Figure 3.27. Secondary structure (A) and per-residue backbone RMSD relative to the crystal structure (PDB code 
4LZT)129 (B) of lysozyme observed over the course of a 2-μs simulation. 
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Figure 3.28. Backbone conformational sampling of lysozyme observed in a 10-μs simulation. The Φ/Ψ angles 
observed in the crystal structure (PDB code 4LZT)129 are shown as gray points. Overall retention of the crystal 
conformation of most residues is good; regions of deviation mentioned in the main text are highlighted in blue. 
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Figure 3.29. Secondary structure (A, C) and per-residue backbone RMSD relative to the crystal structure (PDB code 
1YCR)132 (B, D) of p53 observed over the course of 10-μs simulations alone (A, B) and in complex with MDM2 (C, 
D). Horizontal gridlines indicate the portion of p53 that forms an α-helix in the experimental structure of the 
p53/MDM2 complex. 
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Figure 3.30. Secondary structure (A) and per-residue backbone RMSD relative to the crystal structure (PDB code 
1YCR)132 (B) of MDM2 observed over the course of a 10-μs simulation in complex with p53. 
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Figure 3.31. Backbone conformational sampling of MDM2 observed in a 10-μs simulation in complex with p53. The 
Φ/Ψ angles observed in the crystal structure (PDB code: 1YCR)132 are shown as gray points. 
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Figure 3.32. Secondary structure (A) and per-residue backbone RMSD relative to the crystal structure (PDB code 
1RNU)133 (B) of S-peptide observed over the course of a 10-μs simulation alone. Horizontal gridlines indicate the 
portion of S-peptide that forms an α-helix in the experimental structure of the S-peptide/S-protein complex. 
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Figure 3.32 (Continued). Secondary structure (C) and per-residue backbone RMSD relative to the crystal structure 
(PDB code 1RNU)133 (D) of S-peptide observed over the course of a 10-μs simulation in complex with S-protein. 
Horizontal gridlines indicate the portion of S-peptide that forms an α-helix in the experimental structure of the S-
peptide/S-protein complex. 
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Figure 3.33 Backbone conformational sampling of S-Peptide observed in 10-μs simulations in complex with S-protein 
(A) and alone (B). The Φ/Ψ angles of residues present and resolved in the crystal structure of the S-peptide/S-protein 
complex (PDB code 1RNU)133 are shown as gray points. For comparison are shown distributions for the S-peptide 
sequence obtained from the Neighbor-Dependent Ramachandran Distribution (NDRD) dataset, derived from 
conformations observed in the loops of solved structures (C).143 
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Figure 3.34. Secondary structure (A) and per-residue backbone RMSD relative to the crystal structure (PDB code 
1RNU)133 (B) of S-protein observed over the course of a 10-μs simulations in complex with S-peptide. 
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Figure 3.35. Backbone conformational sampling of S-protein observed in a 10-μs simulation in complex with S-
peptide. The Φ/Ψ angles observed in the crystal structure (PDB code: 1RNU)133 are shown as gray points. Overall 
retention of the crystal conformation of most residues is good; Gln 60, which retains its uncommon ‘plateau’ 
conformation throughout the simulation, is highlighted in blue. 
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3.7.3 Supporting tables 
Table 3.4. Backbone torsion classes and terms applied to heavy atoms for 28 nonterminal residue forms. 
Residue Φ/Ψ Class Φ'/Ψ' Subclass φ ψ φ' ψ' 
Ala Neutral Alanine C-N-CX-C N-CX-C-N C-N-CX-CT CT-CX-C-N 
Ash Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Asn Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Cys Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Cyx Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Glh Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Gln Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Leu Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Lyn Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Met Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Nle Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Ser Neutral Two-branched C-N-CX-C N-CX-C-N C-N-CX-2C 2C-CX-C-N 
Ile Neutral Three-branched C-N-CX-C N-CX-C-N C-N-CX-3C C-N-CX-3C 
Thr Neutral Three-branched C-N-CX-C N-CX-C-N C-N-CX-3C C-N-CX-3C 
Val Neutral Three-branched C-N-CX-C N-CX-C-N C-N-CX-3C C-N-CX-3C 
Hid Neutral Aromatic C-N-CX-C N-CX-C-N C-N-CX-TA TA-CX-C-N 
Hie Neutral Aromatic C-N-CX-C N-CX-C-N C-N-CX-TA TA-CX-C-N 
Phe Neutral Aromatic C-N-CX-C N-CX-C-N C-N-CX-TA TA-CX-C-N 
Tyr Neutral Aromatic C-N-CX-C N-CX-C-N C-N-CX-TA TA-CX-C-N 
Trp Neutral Aromatic C-N-CX-C N-CX-C-N C-N-CX-TA TA-CX-C-N 
Asp Negatively-Charged C-N-TM-C N-TM-C-N C-N-TM-2C 2C-TM-C-N 
Cym Negatively-Charged C-N-TM-C N-TM-C-N C-N-TM-2C 2C-TM-C-N 
Glu Negatively-Charged C-N-TM-C N-TM-C-N C-N-TM-2C 2C-TM-C-N 
Arg Positively-Charged C-N-TP-C N-TP-C-N C-N-TP-C8 C8-TP-C-N 
Hip Positively-Charged C-N-TP-C N-TP-C-N C-N-TP-C8 C8-TP-C-N 
Lys Positively-Charged C-N-TP-C N-TP-C-N C-N-TP-C8 C8-TP-C-N 
Gly Glycine C-N-TG-C N-TG-C-N   
Pro Proline C-TN-TJ-C TN-TJ-C-N C-TN-TJ-CT CT-TJ-C-N 
3.8 SUBSEQUENT DEVELOPMENTS 
Having developed an improved force field that yielded more accurate stability of salt bridge 
interactions, and validated the force field’s accuracy on globular proteins and disordered peptides, 
I began simulating the more complex MoCVNH3 protein with AMBER ff15ipq and the SPC/Eb 
water model with which it was developed. I also planned to test the CHARMM22* force field, 
which includes a similar correction to its salt bridge interactions, but needed to select an 
appropriate water model with which to pair it. It had recently been found that fixed-charge water 
models generally overstabilize protein-protein relative to protein-solvent interactions, and this 
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overstabilization had been addressed in the recently-developed TIP4P-D water model.102 Since the 
CHARMM22*/TIP4P-D pair had been tested extensively during TIP4P-D’s development, I 
elected to use this combination for my second set of simulations of MoCVNH3, as described in 
the following chapter. 
   121 
4.0  BIOPHYSICAL CHARACTERIZATION OF THE MOCVNH3 PROTEIN 
This chapter is based on a research article submitted for publication as: Debiec, K. T.; Whitley, M. 
J.; Koharudin, L. M. I.; Chong, L. T.; and Gronenborn, A. M. Merging Structure and Dynamics 
from Biophysical Experiments and Atomistic Simulations of a Model Two-Domain Protein. 
4.1 INTRODUCTION 
Multi-domain proteins in which the connected domains each fold and function independently are 
prevalent in nature.1,2 Such proteins, through spatial and temporal coordination of their varied 
functional units, are capable of executing specific and tailored activities in catalysis, signaling, 
regulation of gene expression, and other cellular processes.3 The individual domains are connected 
by inter-domain linkers whose length and composition enable them to adopt orientations that have 
evolved for specific biological activities and functions.4,5 In many cases, the linkers are highly 
flexible, allowing the domains to adopt numerous inter-domain orientations, from which the 
selection of functional competent conformations may occur.6 While most multi-domain proteins 
are linked linearly in sequence, roughly one tenth possess domain insertions where a ‘guest’ 
domain is implanted into a loop of a ‘host’ domain, such that the two domains are connected by a 
pair of inter-domain linkers.7 
Characterization of the relative domain orientations within multi-domain proteins has been 
challenging by traditional structural biology techniques, such as X-ray crystallography, due to the 
inherent flexibility of inter-domain linkers, lack of density for certain segments of the polypeptide 
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chain, and influence of crystal packing on the positioning of domains. On the other hand, multi-
domain proteins represent intriguing targets for integrative structural biology approaches, which 
combine results from experiments and computer simulations5,8 by either (i) computationally 
generating a large ensemble of potential structural models and subsequently filtering the models 
based on agreement with the experimental data, or (ii) explicitly biasing the generation of structural 
models in accord with the experimental data. Such approaches have been particularly useful for 
studying flexibly linked multi-domain proteins and protein complexes,9–15 often integrating data 
from NMR, SAXS, X-ray crystallography, and other experimental techniques into a single 
structural model. Critically, the validity of any approaches aimed at bridging the gaps between 
experimentally accessible and computationally generated data depends on the accuracy of the 
biomolecular force fields used in the computations, which dictate sampling of the conformational 
space for the entire system. 
Traditionally, force fields have been parameterized to reproduce the properties of small 
molecules, with parameters derived from experiment and quantum mechanical calculations, and 
their accuracy for biomolecules are validated using simulations of well-characterized benchmark 
systems. Such systems have included small globular proteins (e.g. ubiquitin, GB3, and 
lysozyme),81,87,92,184 although more recently, simulations of significantly more flexible, disordered 
peptides and proteins (e.g. the MDM2-binding p53 peptide and α-synuclein) have been carried 
out.102,184,185 The latter have revealed that most force fields, when paired with their intended 
explicit water models, suffer from an imbalance between protein-protein and protein-water 
interactions, yielding conformations of nonglobular proteins that are much more compact than 
experimentally observed, as well as overstabilizing the folded states of globular proteins.102 Since 
the conformational space accessible to nonglobular systems is very large, exhaustive sampling is 
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beyond the capabilities of current simulation methods, and experimentally well-characterized 
systems are necessary to serve as a link between globular and nonglobular proteins. In particular, 
simultaneous validation of both the interior protein structure and the balance between protein-
protein and protein-water interactions is needed. Flexibly linked, multi-domain proteins present an 
ideal opportunity to fulfill this requirement, since the inter-domain conformational space of such 
proteins is large, yet sufficiently restricted to be addressed with current simulation methods. Such 
affordable, yet complex model systems are becoming increasingly valuable as computational 
methods shift towards more intricate and expensive algorithms, such as implemented in the 
AMOEBA and CHARMM Drude polarizable force fields.107,108 
An ideal test system among flexibly linked multi-domain proteins is the relatively small, 
two-domain protein MoCVNH3 that has been structurally characterized by our group using both 
NMR spectroscopy and X-ray crystallography.16,17 MoCVNH3 is a domain-insertion protein in 
which a ‘guest’ LysM domain is inserted into a surface loop of a ‘host’ Cyanovirin-N Homology 
(CVNH) domain, positioning the LysM domain between the two pseudo-symmetric halves of two-
lobed CVNH domain.18 This protein is found in Magnaporte oryzae, an ascomycete fungus that 
causes rice blast disease, the most devastating infection of cultivated rice, which destroys crops in 
unprecedented amounts worldwide.19 Functionally, both CVNH and LysM are carbohydrate-
binding domains: CVNH binds to mannose sugars, while LysM interacts with GlcNAc-containing 
carbohydrates such as peptidoglycan and chitin.20,21 The binding of carbohydrates by each domain 
in MoCVNH3 is independent of the other, with no communication between the domains.22 While 
the wild-type protein could not be crystallized, complete removal of the inter-domain linkers 
yielded a construct that crystallized and maintained the ability to bind both carbohydrate ligands. 
A comparison of the resulting crystal structure with the NMR structure of wild-type MoCVNH3 
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revealed that the absence of the linkers has no effect on the structures of the individual domains.17 
However, although the domain structures of wild-type MoCVNH3 were solved to high resolution 
by NMR, no fixed relative domain orientations were compatible with the solution data, due to the 
lack of inter-domain restraints.22 
Here, we investigated the influence of inter-domain linker length on the overall structure 
and dynamics of MoCVNH3, as well as the conformational space of inter-domain orientations in 
solution, using an integrated approach that combines biophysical experiments and molecular 
dynamics (MD) simulations. In particular, we performed SAXS, NMR relaxation, and 
paramagnetic relaxation enhancement (PRE) experiments along with microsecond (μs)-scale MD 
simulations in explicit solvent. In carrying out the simulations, we compared the accuracy of two 
biomolecular force field/water model combinations in modeling the structure and dynamics of this 
tethered two-domain protein, and establish that each combination is accurate for certain properties 
and inaccurate for others. Overall, we demonstrate that an integrated approach, incorporating 
different experimental and computational methods, permits characterization of both the inter-
domain orientations and dynamic of multi-domain proteins, using the MoCVNH3 protein as an 
example. 
4.2 MATERIALS AND METHODS 
4.2.1 Protein expression and purification 
Proteins were expressed and purified as described previously for wild-type MoCVNH3.22 In brief, 
pET-15b(+) vectors containing the different coding sequences for the individual protein constructs 
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were used to transform E. coli Rosetta2 (DE3) cells (Novagen). All constructs encoded N-terminal 
polyhistidine tags, followed by a TEV protease cleavage site. After cleavage, the native protein N-
terminus was obtained, removing a four-residue addition that was present in the earlier protein 
constructs. Mutant coding sequences were created using the QuikChange XL II site-directed 
mutagenesis kit (Stratagene). Cells were initially grown at 37 °C, induced with 1 mM isopropyl β-
D-1-thiogalactopyranoside at an OD600 of ~0.8, and further grown for 18 hr at 16 °C for protein 
expression. Cells were harvested by centrifugation, resuspended in lysis buffer (25 mM Tris-HCl 
(pH 8.0), 150 mM NaCl, 5 mM DTT, and 3 mM NaN3) and ruptured by passage through a 
microfluidizer (MicroFluidics M-110Y, Hyland Scientific). Cell debris was removed by 
ultracentrifugation (19,000 RPM), and the supernatant was loaded onto an Ni2+-derivatized 
HisTrap column (GE Healthcare), pre-equilibrated with loading buffer (25 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 1 mM DTT, and 3 mM NaN3). Proteins were eluted using a linear (25–500 mM) 
imidazole gradient in the same buffer and protein-containing fractions were subjected to TEV 
digestion in 25 mM Tris-HCl buffer, pH 8.0, 25 mM NaCl, 5 mM DTT, and 3 mM NaN3 for 
removal of the N-terminal polyhistidine tag. Further purification of the cleaved proteins involved 
gel filtration on a Superdex75 column (GE Healthcare) in 25 mM sodium acetate buffer, pH 5.0, 
25 mM NaCl, 5 mM DTT, and 3 mM NaN3, and cation exchange on an HiTrap SP column (GE 
Healthcare), pre-equilibrated with loading buffer (25 mM sodium acetate (pH 5.0), 25 mM NaCl, 
5 mM DTT, 3 mM NaN3), and elution by a linear (0-250 mM) NaCl gradient in the same buffer. 
Protein-containing fractions were collected, buffer exchanged into 25 mM sodium acetate, pH 5.0, 
25 mM NaCl, 5 mM DTT, 3 mM NaN3, and concentrated using Centriprep devices (Millipore). 
For 15N isotopic labeling, the bacterial cell culture was grown in modified minimal medium, 
containing 15NH4Cl as the sole nitrogen source, while for 
13C isotopic labeling 13C-glucose was 
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provided as the sole carbon source. The purity and identity of all proteins were confirmed by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS–PAGE) and mass spectrometry. 
4.2.2 Site-selective spin-labeling 
The purified single-cysteine variant of Mo-WT, Mo-SAVC (C15S, C25A, C82V), was split into 
two equal portions for parallel spin-labeling at the C-terminal C167 with (1-oxyl-2,2,5,5-
tetramethyl-Δ3-pyrroline-3-methyl)methanethiosulfonate (MTSL) and the diamagnetic analog of 
MTSL: (1-acetyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl)methanethiosulfonate (dMTSL, 
Toronto Research Chemicals Inc.), in which the oxygen on the nitroxide of MTSL is replaced with 
an acetyl group. Both reagents were added from 0.2 mM stocks in 10-fold molar excess to a 65 
μM protein solution in 25 mM NaPhosphate buffer, pH 7.0, 25 mM NaCl, 3 mM NaN3, and the 
reaction mixture was incubated at 4 °C for 16 h in the dark. Excess free tags were removed by 
serial dialysis against 25 mM NaAc buffer, pH 5.0, 25 mM NaCl, 3 mM NaN3. The extent of spin-
labeling (>95%) was confirmed by mass spectrometry. 
4.2.3 Molecular dynamics simulations 
Heavy atom coordinates of the Mo-WT and Mo-0v constructs were extracted from the solution 
NMR structure of Mo-WT (PDB code 2L9Y)22 and X-ray crystal structure of Mo-0v (PDB code 
58CO),17 respectively. Coordinates of the reduced linker-length constructs Mo-2G and Mo-0G 
were generated using the MODELLER 9.9 software package186 based on the coordinates of the 
CVNH and LysM domains from the Mo-WT NMR structure. Each system was solvated in a 105 
x 105 x 105 Å cubic box, which generated a minimum solute-wall distance of 22 Å for the largest 
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two-domain construct (Mo-WT). Amino acid side chains were assigned protonation states 
consistent with the experimental pH of 5.0; i.e. arginine, lysine, and histidine residues were 
protonated while aspartate and glutamate were deprotonated. The net positive charges on the 
protein were neutralized through the addition of Cl- ions; additional Na+ and Cl- ions were added 
to be consistent with the experimental salt concentration of 25 mM. Identical system 
configurations were used for simulations run using the AMBER software package93 and Anton25. 
Simulations run using AMBER were carried out using the GPU implementation of the 
pmemd module.93,97,134 Prior to running production simulations, each system was subjected to 
energy minimization, followed by a three-stage equilibration. In the first stage, a 20-ps simulation 
of the energy minimized system was carried out at constant temperature, while restraining the 
solute heavy atoms to their initial positions using a harmonic potential with a force constant of 1 
kcal/(mol Å2). In the second stage, a 1-ns simulation was carried out at constant pressure with the 
same harmonic restraints on positions. Finally, an additional 1-ns unrestrained simulation was 
carried out at constant temperature and pressure. The temperature was maintained at 25 °C using 
a Langevin thermostat (frictional constant of 0.1 ps−1) while the pressure was maintained at 1 atm 
using a Monte Carlo barostat (200 fs between attempts to change the system volume).58 Van der 
Waals and short-range electrostatic interactions were truncated at 10 Å; long-range electrostatic 
interactions were calculated using the particle mesh Ewald method.61 To enable a 4-fs time step, 
hydrogens were constrained to their equilibrium values using the SHAKE and SETTLE 
algorithms, and hydrogen mass repartitioning was used.135–137 The masses of solute hydrogen 
atoms were increased by a factor of three, and that of their attached heavy atoms decreased by the 
corresponding amount, such that the total mass remained constant; the masses of water molecules 
were not repartitioned. Coordinates were saved every 100 ps for analysis. 
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Simulations run on the Anton special-purpose supercomputer were equilibrated using the 
Desmond 3.0.1.0 software package.25,57 Each system was subjected to energy minimization 
followed by a 20-ps equilibration at constant temperature, and a 1-ns equilibration at constant 
pressure. The temperature was maintained at 25 °C and the pressure at 1 atm, using the Martyna-
Tobias-Klein thermostat and barostat (time constants of 1 ps and 2 ps, respectively).59 To enable a 
2.5-fs time step, hydrogen were constrained to their equilibrium values using the M-SHAKE 
algorithm.60 A short-range non-bonded cutoff of 10 Å was used, and long-range electrostatics were 
calculated using the particle mesh Ewald method.61 Production simulations were carried out at 
constant pressure using a 512-node Anton special-purpose supercomputer and the Multigrator 
integrator.25,182 The temperature was maintained at 25 °C using the Nosé-Hoover thermostat and 
the pressure at 1 atm using the Martyna-Tobias-Klein barostat (time constants of 1 ps).59,62 To 
enable a 2.5-fs time step, bonds to hydrogen were constrained to their equilibrium values using the 
M-SHAKE algorithm.60 Van der Waals and short-range electrostatic interactions were truncated 
at 10 Å; long-range electrostatic interactions were calculated using the Gaussian split Ewald 
method,63 and were updated every third time step. Coordinates were saved every 105 ps for 
analysis. 
Analyses of MD simulations were carried out primarily using the AmberTools cpptraj 
program.138 Secondary structure was assigned using the DSSP method,139 rotational correlation 
times (τc) were calculated using the method of Wong et al.,29 and NMR relaxation rates were 
calculated using the iRED method.140 Small-angle X-ray scattering curves were calculated using 
the saxs_md and CRYSOL programs,187,188 and standard errors were estimated using a block 
averaging method.64 
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4.2.4 Small-angle X-ray scattering 
Small-angle X-ray scattering data were collected for the Mo-WT, Mo-2G, Mo-0G, and Mo-0v 
constructs at 25 °C. Samples were prepared in 25 mM NaAc buffer (pH 5.0), 25 mM NaCl, 5 mM 
DTT, and 3 mM NaN3. For the Mo-WT, Mo-2G, and Mo-0G constructs, data were collected using 
protein concentrations of 5.0, 2.5, and 1.25 mg/mL. No concentration-dependent effects were 
observed, and the 5.0 mg/mL data are presented here. For the less soluble Mo-0v construct, data 
was collected at 0.55 mg/mL. All experimental SAXS data were collected at beamline 12-ID-B of 
the Advanced Photon Source at Argonne National Laboratory (Lemont, IL, USA) using X-rays of 
energy 14 keV (λ ≈ 0.8856 Å). For each measurement, 30 individual exposures of 1 second each 
were collected, compared to check for radiation damage, and averaged to yield the final scattering 
curves. Buffer scattering measurements were performed in an equivalent fashion using protein-
free buffer aliquots from the final purification step and subtracted from the protein scattering data. 
All data were processed and analyzed using tools from the ATSAS software package including 
PRIMUS and CRYSOL.188–190 
4.2.5 NMR spectroscopy 
All spectra were recorded at 25 °C on Bruker 600 MHz, 700 MHz and 800 MHz AVANCE 
spectrometers, equipped with 5 mm, triple resonance, three-axis gradient probes, or z-axis gradient 
cryoprobes. For three-dimensional NMR experiments, the sample contained 300 μM 13C/15N-
labeled protein in 25 mM NaAc buffer, pH 5.0, 25 mM NaCl, 5 mM DTT, 3 mM NaN3, and 5% 
D2O. For chemical shift assignments, a series of heteronuclear, multidimensional experiments, 
routinely used in our laboratory, were recorded.191 Complete 1H, 15N, and 13C backbone resonance 
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assignments were obtained from 3D HNCACB and HN(CO)CACB spectra, using the program 
CCPNMR.192 Weighted chemical shift differences were calculated using the expression: 
Δδ=√((ΔδH)2+(0.15•ΔδN)2). 
15N R1 and R2 relaxation and 
15N-{1H} heteronuclear NOE data were collected on a sample 
of 100 μM 15N-labeled Mo-WT protein in 25 mM NaAc buffer, pH 5.0, 25 mM NaCl, 5 mM DTT, 
3 mM NaN3, and 5% D2O, using 
1H-15N HSQC-based pulse sequences at 600 MHz.193 The R1 and 
R2 experiments employed delays of 0, 100, 150, 200, 300, 500, and 800 ms, and 0, 8, 16, 32, 48, 
64, and 80 ms, respectively. Spectra were processed using NMRPipe. R1 and R2 relaxation rates 
were calculated using single exponential fits, and 15N-{1H} heteronuclear NOE values were 
calculated using a ratio of experiments recorded with and without 1H saturation.194 Rotational 
correlation times (τc) were calculated using the program relax.195,196 Overlapped resonances and 
those exhibiting heteronuclear NOE values below 0.7 were omitted from the calculation. 95% 
confidence intervals of τc values were estimated by selecting 1000 subsamples, each with a 
randomly selected 75% set of rates, calculating τc for each. 
PRE data were recorded using the single-cysteine variant of Mo-WT, Mo-SAVC (C15S, 
C25A, C82V). Spectra were recorded at 25 °C using 55 μM 15N-labeled protein in 25 mM NaAc 
buffer, pH 5.0, 25 mM NaCl, 3 mM NaN3, and 5% D2O at 800 MHz. Delays of 0.5, 1.0, 2.0, 4.0, 
and 8.0 ms were employed. 15N R2 relaxation rates were calculated using single exponential fits, 
and 1HN-Γ2 were extracted from the difference between the paramagnetically- and 
diamagnetically-tagged samples. Results were visualized using the program Visual Molecular 
Dynamics.173 
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4.2.6 Structure calculation of Mo-WT 
Structure calculation of Mo-WT was carried out using XPLOR-NIH version 2.44,197 subject to 
restraints from the experimental SAXS and PRE data. Starting models for the calculations were 
generated by building the MTSL tag onto C167 for each of the 25 solution NMR conformers 
deposited in the PDB,22 followed by a round of simulated annealing. During the initial structure 
generation only XPLOR’s molecular geometry terms were applied, and the positions of all atoms 
in the CVNH and LysM domains were kept fixed while those of the inter-domain linkers (residues 
55-61 and 111-117) were unrestrained. The annealing process involved simulating at 10,025 °C 
for 10 ns before ramping down to 25 °C in 100 °C intervals using a 0.2-ps simulation at each 
temperature, followed by a 1000-step energy minimization. From each of the 25 original NMR 
conformers, 25 inter-domain orientations were thereby generated, yielding a total of 625 starting 
models from which calculations were seeded. 
Rotational correlation times used in the back-calculation of 1HN-Γ2 rates from molecular 
coordinates were fixed at the values calculated for the CVNH and LysM domains from the 
experimental 15N R1 and R2 and 
15N-{1H} heteronuclear NOE data. SAXS restraints were applied 
by back-calculating scattering intensity from the molecular coordinates.198 PRE 1HN-Γ2 restraints 
were derived according to the Solomon–Bloembergen equation and weighted based on the 
experimental error.199 These restraints were grouped into intra-domain restraints within the CVNH 
domain and inter-domain restraints with the LysM domain.  
During the production calculations, the CVNH and LysM domain backbone coordinates 
were fixed, while side chain atoms and all residues in the inter-domain linkers were unrestrained. 
In each production run, an ensemble of 24 structures was subjected to simulated annealing, with 
the average back-calculated PRE 1HN-Γ2 rates and SAXS intensity restrained to their experimental 
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values.198,199 Since residues very close to the MTSL label lack visible amide resonances, 1HN-Γ2 
rates could not be measured for all residues in the CVNH domain. To derive acceptable 
conformations of the solvent exposed MTSL tag, which is surrounded by relatively few restraints, 
simulated annealing was performed in two stages. In the first stage, XPLOR’s molecular geometry 
terms were applied alongside 67 PRE 1HN-Γ2 restraints between the MTSL label and backbone 
amide hydrogens of the CVNH domain. The system was equilibrated at 3000 °C for 100 ps to 
allow different inter-domain orientations to emerge, compared to those present in the initial 
structures. Subsequent simulated annealing of the equilibrated system involved cooling down from 
3000 °C to 25 °C in 25 °C intervals, with 0.2 ps of simulation at each temperature, followed by a 
1000-step energy minimization, after which the coordinates of C167 and the attached MTSL tag 
were fixed. During the second stage of simulated annealing, XPLOR’s molecular geometry terms 
were applied alongside 39 PRE 1HN-Γ2 restraints between the MTSL tag and residues on the LysM 
domain, as well as a SAXS intensity restraint on the overall system. The system was re-equilibrated 
at 3000 °C for 100 ps, followed by simulated annealing and energy minimization as described 
above. Overall, 625 ensembles of 24 structures each were calculated, yielding a total of 15,000 
structures. In order to quantify the influence of the inter-domain PRE and SAXS restraints on the 
resulting structural ensemble, three control calculations were carried out, omitting (i) inter-domain 
PRE restraints, (ii) SAXS restraints, or (iii) both inter-domain PRE and SAXS restraints from the 
second stage of simulated annealing. 
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4.3 RESULTS AND DISCUSSION 
The structure and dynamics of flexibly linked multi-domain proteins are particularly challenging 
to characterize by experimental methods such as X-ray crystallography. Instead, they are well-
suited as targets for integrated methods that combine experimental data with computer simulations. 
Here, we apply such methodology to the two-domain protein MoCVNH3, whose domain-insertion 
topology sets it apart from linearly connected multi-domain proteins. Our prior structural work by 
solution NMR and X-ray crystallography17,22 demonstrated that the two domains have no fixed 
inter-domain orientation and did not provide details about the nature or distribution of sampled 
orientations. Here, we used a combination of SAXS, NMR, and MD simulation to characterize the 
inter-domain orientations of MoCVNH3 as well as the influence of the inter-domain linker lengths 
on the overall structure and dynamics of the protein. Our results provide extensive data for 
evaluating the accuracy of simulation models, utilizing this unique system for validating the 
structure and dynamics of the individual domains in tandem with the overall inter-domain 
dynamics. 
 
4.3.1 Accessible inter-domain orientations 
In our previous work, we investigated the wild-type MoCVNH3 construct, called Mo-WT 
throughout this manuscript, and several reduced linker-length constructs. Here, we study two of 
these constructs, Mo-0G and Mo-0v, as well as a new construct, Mo-2G, in detail. In the Mo-0G 
and Mo-2G constructs, each inter-domain linker is shortened to zero and two glycine residues, 
respectively (Figure 4.1B). In the Mo-0v construct, three additional residues adjacent to the second 
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linker are replaced by a single glycine. Mo-0v was successfully crystallized, which proved 
impossible for the Mo-WT and Mo-0G constructs, despite considerable effort.17 To eliminate 
potential confounding factors on the global structure of this two-domain system, we also deleted 
the four- or six-residue N-terminal cloning artifacts that were present in the proteins studied 
previously,17,22 preserving the native amino acid sequence. Consistent with our prior work, a 
comparison of the 1H-15N HSQC NMR spectra of our new, native, Mo-2G, Mo-0G, and Mo-0v 
constructs with native Mo-WT revealed only very small chemical shift changes for residues distant 
from the linkers, demonstrating that the structures of the individual domains are retained in all 
constructs (Figure 4.1). 
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Figure 4.1. MoCVNH3 wild-type (Mo-WT) and reduced linker-length constructs Mo-2G, Mo-0G and Mo-0v. (A) 
1H-15N HSQC NMR spectra of Mo-WT. Resonances corresponding to residues in the CVNH domain are shown in 
red, in the LysM domain in blue, and in the inter-domain linkers in green. Side chain resonances are shown in grey. 
(B) Amino acid sequences of the MoCVNH3 constructs, highlighting the inter-domain linker regions. Amino acids in 
the CVNH domain are shown in red, in the LysM domain in blue, and in the inter-domain linkers in green. (C) 
Chemical shift differences between Mo-WT and Mo-2G, Mo-0G, and Mo-0v constructs. (D) Structures of MoCVNH3 
constructs. The Mo-WT structure was previously solved by NMR,22 and Mo-0v by X-ray crystallography,17 while 
Mo-2G and Mo-0G are represented by homology models. Selected residues highlighted in the text are labeled in the 
Mo-WT structure. 
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To characterize the influence of the lengths of the inter-domain linkers on the global 
structure and dynamics of MoCVNH3, we carried out MD simulations of the WT and each of the 
three reduced linker-length variants (Mo-2G, Mo-0G, and Mo-0v), using two current force 
field/water model combinations: (i) the AMBER ff15ipq force field (from this point onwards, we 
will refer to this force field as “ff15ipq”) with the SPC/Eb water model,96,184 and (ii) the 
CHARMM22* force field with the TIP4P-D water model.32,102 Both the ff15ipq and 
CHARMM22* force fields were parameterized to address the issue of overstabilizing salt bridges 
– a limitation of many other contemporary force fields.56 The ff15ipq force field is a complete 
reparametrization, which includes new implicitly polarized atomic charges, new angle parameters, 
new atomic radii for polar hydrogens, and a greatly expanded set of torsion terms. This force field 
was developed for use with the SPC/Eb water model, which more accurately reproduces the 
experimental rotational diffusion of globular proteins, compared to earlier water models.96 The 
CHARMM22* force field is a modification of CHARMM22 that includes adjustments to the 
atomic charges of arginine, aspartate, and glutamate side chains and updates to the backbone 
torsion parameters. This force field was paired with the TIP4P-D water model, which reduces the 
oversampling of compact conformations of nonglobular proteins by earlier water models. In total, 
eight MD simulations were each run for 5 to 10 μs, with an aggregate simulation time of >60 μs 
(Table 4.1). These simulations provide an excellent opportunity to validate the accuracy with 
which the two force field/water model combinations reproduce (i) the rotational diffusion of a two-
domain protein, expanding on efforts involving single-domain proteins29,96,184 and (ii) the 
compactness of a flexibly linked, globular two-domain protein, expanding on efforts involving 
nonglobular proteins.102 
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Table 4.1. MD simulations of MoCVNH3 constructs 
Construct Force Field Water Model Duration 
Mo-WT AMBER ff15ipq SPC/Eb 10.0 μs 
 CHARMM22* TIP4P-D 7.3 μs 
Mo-2G AMBER ff15ipq SPC/Eb 10.0 μs 
 CHARMM22* TIP4P-D 5.5 μs 
Mo-0G AMBER ff15ipq SPC/Eb 10.0 μs 
 CHARMM22* TIP4P-D 5.5 μs 
Mo-0v AMBER ff15ipq SPC/Eb 10.0 μs 
 CHARMM22* TIP4P-D 5.0 μs 
 
While our earlier solution NMR results lacked detailed information about the inter-domain 
orientations of the proteins, MD simulations afford the opportunity to efficiently generate large 
ensembles of orientations. As shown in Figure 4.2, our simulations reveal that ff15ipq/SPC/Eb and 
CHARMM22*/TIP4P-D yield very different ensembles of inter-domain orientations: while the 
ff15ipq/SPC/Eb simulations remained in a single inter-domain orientation, the 
CHARMM22*/TIP4P-D simulations of Mo-WT and Mo-2G sampled a range of inter-domain 
orientations with more extended conformations. Smaller differences between the two force 
field/water model combinations are observed for the Mo-0G construct. In contrast, both 
simulations of Mo-0v yielded nearly identical, more restricted sets of accessible inter-domain 
orientations. 
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Figure 4.2. Probability distributions of inter-domain orientations sampled in MD simulations for four MoCVNH3 
constructs. The CVNH domain is shown in red, the LysM domain in blue, and the inter-domain linkers in green. 
Trajectories were best fit to the CVNH domain coordinates and the simulation cell was divided into 1-Å3 bins; solid 
contours represent bins occupied by a heavy atom for at least 1% of the simulation, while transparent contours 
represent bins occupied for at least 0.1% of the simulation. 
CHARMM22*, TIP4P-DAMBER ff15ipq, SPC/Eb
Mo-WT
Mo-2G
Mo-0G
Mo-0v
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4.3.2 Structural characterization of the CVNH and LysM domains 
To assess the ability of the two force field/water model combinations to maintain the integrity of 
the individual CVNH and LysM domain structures, we monitored the backbone root mean 
standard deviations (RMSD) from the initial structures over the course of the simulations. All 
simulations yielded average RMSD values <3.0 Å for both domains. However, inspection of the 
distributions of RMSD values (Figure 4.3) reveal that significantly larger variations in the RMSD 
occur over the course of each simulation. In particular, in all of the simulations that were run, and 
most pronounced for the simulations run with CHARMM22*/TIP4P-D, the RMSD distribution 
for the CVNH domain is bimodal, sampling two minima with small and large deviations from the 
starting structure, respectively. In general, the RMSD values increased as the simulations 
progressed (Figure 4.11), e.g., for Mo-WT and Mo-0G, the RMSD of the CVNH domain remained 
<3 Å up until 4 μs, after which the deviations increased to ~4 Å. These results underscore the 
importance of reaching the multi-μs time scale when simulating complex systems such as the 
MoCVNH3 protein. Although the ff15ipq/SPC/Eb simulations also show a bimodal distribution 
for the backbone RMSD of the CVNH domain, the RMSD values were consistently <3.0 Å, with 
the trajectories for Mo-WT, Mo-2G, and Mo-0v settling at lower RMSD values, with few 
excursions to higher RMSD values. 
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Figure 4.3. Fluctuations in the CVNH and LysM domain coordinates in MoCVNH3 constructs over the course of MD 
simulations using the AMBER ff15ipq force field/SPC/Eb water model (magenta), and the CHARMM22* force 
field/TIP4P-D water model (purple), as represented by the distribution of backbone RMSD relative to their initial 
structures. Average backbone RMSD values are indicated by circles. 
 
For the LysM domain, lower and more tightly distributed RMSD values were observed for 
the Mo-WT, Mo-2G, and Mo-0G for both field/water model combinations, while RMSD values 
were more variable for Mo-0v. The overall higher RMSDs observed for the CHARMM22*/TIP4P-
D simulations are consistent with observations made during the development of the TIP4P-D water 
model, which suggested that the implemented increase in the protein-water interaction strength 
may destabilize the folded states of proteins.102 Compared to SPC/Eb and most other fixed-charge 
water models, TIP4P-D increases the relative strength of protein-water interactions vs. protein-
protein interactions to reduce the oversampling of compact states of nonglobular proteins that has 
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resulted from the use of other water models. Our simulations of MoCVNH3 with 
CHARMM22*/TIP4P-D suggest that this water model may also have the unintentional effect of 
reducing the sampling of compact (i.e., folded) states of folded proteins, resulting in both a more 
expanded overall system (Figure 4.2) and less closely packed internal domain structures. 
Some curious simulation artifacts were observed for the CVNH domain at the residue level 
(see Figure 4.12 through Figure 4.28, and Figure 4.1 for the position of highlighted residues within 
the domain structures). In all eight of our simulations, the N-terminal residues G1 through N6 of 
the CVNH domain sampled diverse conformations, while from F7 onwards, distributions around 
a single conformation consistent with the experimental structures dominated along the chain. 
However, in some of the simulations, a few deviations from the experimental structures were 
observed as far into the sequence as S10. Also, for the first half of the CVNH domain, the loop 
spanning residues L16 through A19 sampled multiple conformations in all simulations, while N45 
and D46 mostly retained the experimentally determined conformations in simulations run with 
ff15ipq/SPC/Eb but not with CHARMM22*/TIP4P-D. Within the second half of the CVNH 
domain, the loop comprising S143 and G144 did not maintain the native conformation in any of 
our simulations. The greatest differences in CVNH domain coordinates were observed in the 
simulation of Mo-WT with CHARMM22*/TIP4P-D in which a conformational change occurs in 
the β-strand that connects the end of the second inter-domain linker to the second half of the CVNH 
domain, although the antiparallel β-sheet (residues 125 to 151) that makes up most of the second 
half of CVNH stayed intact (Figure 4.13 and Figure 4.22). 
In all eight simulations, the overall structure of the LysM domain was retained more 
faithfully than that of the CVNH domain. Interestingly, the experimental conformations of loop 
residues F80 and D81 in the LysM domain were better retained in simulations with 
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CHARMM22*/TIP4P-D than those with ff15ipq/SPC/Eb. This better retention is most likely due 
to D81’s native left-handed α-helical conformation, which is disfavored by ff15ipq.184 
Interestingly, in seven of the eight simulations, I99 primarily sampled a rare conformation centered 
at Φ ≈ 60°, Ψ ≈ 150° while this residue exhibits a PPII conformation in the experimental structures 
of Mo-WT and Mo-0v. The occurrence of the rare conformation, which is essentially the inverse 
of the rare “plateau” conformation, may simply be a consequence of the limited functional form 
of the ff15ipq and CHARMM22* force fields. 
To provide insight into why it was possible to crystallize Mo-0v, but not Mo-0G,17 we 
compared the inter-domain linker regions of Mo-0G and Mo-0v. In Mo-0G, the first linker between 
the CVNH and LysM domains, comprising consecutive residues V53, S54, T62, and A63, 
exhibited diverse conformations in the AMBER ff15ipq/SPC/Eb simulation, while in the 
CHARMM22*/TIP4P-D simulation, these residues occupied a single conformation. However, in 
the second inter-domain junction, involving residues P108, T109, K110, G118, and N119, both 
force fields resulted in diverse conformations for Mo-0G. In contrast, for Mo-0v, in which P108, 
T109, and K110 have been replaced by a single G117, simulations with both force fields stably 
retained the conformations that were seen in the crystal structure for the inter-domain junctions. 
This result suggests that the changes that were introduced into the second linker of Mo-0v resulted 
in a conformationally more restricted system and may therefore be responsible for its successful 
crystallization. 
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4.3.3 Compactness of the two-domain systems 
To quantify the influence of the inter-domain linker-lengths on the overall structure of the two-
domain MoCVNH3 system, small-angle X-ray scattering (SAXS) curves were measured for Mo-
WT and the three reduced linker-length constructs (Figure 4.4). During sample preparation of the 
Mo-0v protein we noted that this protein was less soluble than the other three constructs, requiring 
data collection at a lower concentration (0.55 mg/mL compared to 5.0 mg/mL), therefore resulting 
in noisier data. The lower solubility of Mo-0v may relate to its reduced net charge, as this construct 
contains one fewer lysine than the larger constructs (Figure 4.1). Earlier work on Mo-0v with the 
construct, which included a four-residue N-terminal cloning artifact, including a histidine 
(positively charged at the experimental pH), did not exhibit reduced solubility difference,17 
illustrating that small amino acid changes can greatly influence a protein’s behavior. In the present 
study, we removed the non-native N-terminal amino acids from our protein constructs to eliminate 
their potential contributions to inter-domain interactions. While the removal of these amino acids 
had the unfortunate consequence of lowering the solubility of Mo-0v, the data obtained with all 
the proteins are of sufficient quality for a valid comparison as described below. 
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Figure 4.4. Small-angle X-ray scattering intensity of MoCVNH3 constructs measured by experiment (cyan) and back- 
calculated from MD simulations (magenta, purple). The left panel depicts simulated curves back-calculated using 
AmberTools’ saxs_md program,187 which includes explicit water molecules for calculating the scattering, and the right 
panel shows simulated curves back-calculated with ATSAS’ CRYSOL program,188 which represents solvent 
implicitly. The scale of the y-axis is arbitrary; shaded regions represent 95% confidence intervals for the experimental 
and simulated values; the larger uncertainty in the experimental scattering for the Mo-0v construct arises from the 
need to collect the data at lower concentration due to the protein's lower solubility. 
 
The experimental SAXS data offer the opportunity to validate our MD simulations’ 
modeling of the overall structural of the two-domain system. To this end, we back-calculated 
SAXS curves from the simulation coordinates, using two different methods: (i) AmberTools’ 
saxs_md program,187 which explicitly includes the coordinates of surrounding water molecules in 
the calculation, and (ii) ATSAS’ CRYSOL program,188 which implicitly accounts for the scattering 
   145 
of surrounding water molecules. As shown in Figure 4.4, for q values below 0.2 Å-1, the two 
methods yield results that are broadly similar to one another and to experiment. Beyond 0.2 Å-1, 
the saxs_md program consistently yields higher scattering intensity than observed experimentally, 
while CRYSOL yields lower scattering intensity. Since we were interested in capturing differences 
between the four constructs, we calculated the differences in the corresponding scattering 
intensities (Figure 4.29). The small, systematic difference between the two calculation methods is 
of little consequence, since for q >0.2 Å-1 the curves for the MoCVNH3 constructs are 
indistinguishable. For q <0.2 Å-1, the two methods of back-calculation yield similar results, 
suggesting that, for the region of q measured here, the computationally more expensive explicit-
solvent saxs_md calculation does not provide a tangible benefit over the less demanding CRYSOL 
calculation. Qualitatively, the CHARMM22*/TIP4P-D simulations reproduce the experimental 
trends more accurately than ff15ipq/SPC/Eb. Overall, the above results suggest that the global 
structure of the MoCVNH3 two-domain system is more accurately represented by using 
CHARMM22*/TIP4P-D than ff15ipq/SPC/Eb. 
A key structural parameter that can be calculated from the measured SAXS curves is the 
radius of gyration (Rg), which reflects the compactness of the protein. Since all the MoCVNH3 
constructs are similar in overall mass, Rg provides a means by which the effect of the different 
linker lengths on the population of extended vs. collapsed conformations in the two-domain system 
can be assessed. As shown in Figure 4.5, the Rg for Mo-WT, Mo-2G, and Mo-0G, calculated from 
the experimental SAXS curves, exhibit a clear and intuitively expected decrease of Rg, with 
reduced inter-domain linker length. While the data for Mo-0v are too noisy to confidently 
differentiate its Rg from that of Mo-0G and Mo-2G, the Rg of Mo-0v is statistically distinguishable 
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from that of Mo-WT, and the center of the confidence interval lies just below that of Mo-0G, 
consistent with its slightly shorter second inter-domain linker. 
 
Figure 4.5. Radius of gyration (Rg) of MoCVNH3 constructs calculated from experimental SAXS intensity (cyan) 
and from conformations sampled in MD simulations (magenta, purple). Cyan shaded regions represent 95% 
confidence intervals on the experimental values. Average Rg values are indicated by circles. 
 
Rg can be calculated straightforwardly from the MD simulation coordinates, providing 
further validation of the accuracy of the constructs’ global simulated ensembles. The distributions 
of Rg, sampled over the course of each simulation (Figure 4.5), are consistent with the observations 
about the back-calculated SAXS curves: the CHARMM22*/TIP4P-D simulations more accurately 
reproduce the experimental Rg value, compared to the ff15ipq/SPC/Eb simulations. Both the 
ff15ipq/SPC/Eb and CHARMM22*/TIP4P-D trajectories yielded Rg values of ~18 Å for Mo-0v 
and Mo-0G, in excellent agreement with experiment. The simulations of Mo-2G and Mo-WT, run 
   147 
with ff15ipq/SPC/Eb, yielded Rg values similar to those of Mo-0G and Mo-0v, while those run 
with CHARMM22*/TIP4P-D resulted in larger Rg values, in much better agreement with 
experiment. However, the Rg value of Mo-WT obtained with CHARMM22*/TIP4P-D is still ~1 
Å below the experimental value and fluctuated significantly over the course of the simulation 
(Figure 4.30). The observed broad distribution suggests that longer simulations than performed 
here (7.3 μs) may be necessary to achieve convergence for Mo-WT. Both experiment and 
simulation yielded Rg values of ~18 Å for Mo-0G and Mo-0v; our simulations of Mo-WT sampled 
conformations this compact when the domains were in contact, as well as conformations with Rg 
of up to 23 Å when the domains were not in contact. The experimental data for Mo-WT shows an 
Rg value of 20.4 Å, which is 12% larger than those of Mo-0G and Mo-0v as a result of more 
frequent sampling of extended conformations. 
4.3.4 Dynamical properties of wild-type MoCVNH3 (Mo-WT) 
The global structural information obtained from SAXS can be complemented with single-residue 
and single-domain dynamics information, accessible by NMR relaxation approaches. In particular, 
the ratio between the 15N transverse (R2) and longitudinal (R1) relaxation of the backbone amide 
resonances provides a measure of the system’s rotational diffusion in solution, the isotropic 
rotational correlation time, τc. NMR relaxation data were collected for the Mo-WT construct, and 
the two domains exhibited characteristic R2/R1 ratios of ~9 and ~5 for the CVNH and LysM 
domains, respectively (Figure 4.6), corresponding to τc values of 8.7 and 6.7 ns. This difference in 
correlation time confirms that both domains tumble essentially independently in solution. 
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Figure 4.6. Rotational diffusion of CVNH and LysM domains of Mo-WT calculated from experimental NMR 
relaxation (cyan) and MD simulation (red, purple). Top, distribution of R2/R1 relaxation ratios for residues in the 
CVNH (left) and LysM domain (right). Bottom, distribution of calculated rotational correlation times (τc) for the 
CVNH (left) and LysM domains (right). Cyan shaded regions represent 95% confidence intervals of the experimental 
values. Average values are indicated by circles. 
 
To validate the accuracy of the two MD simulations for Mo-WT, 15N R1 and R2 relaxation 
rates were back-calculated from the motions of the backbone amide N-H vectors over the course 
of the simulations. We previously noted that the ff15ipq/SPC/Eb force field/water model 
combination yielded accurate rotational diffusion times for single-domain globular proteins, while 
the CHARMM22*/TIP4P-D combination yielded less accurate results.184 In contrast to the well-
defined distributions of the experimental R2/R1 ratios, the R2/R1 ratios back-calculated from the 
simulations exhibited much greater variability for individual residues within each domain (Figure 
4.31). Inspection of the rotational correlation times extracted from the simulation of Mo-WT with 
ff15ipq/SPC/Eb resulted in similar τc values of 9-10 ns for both domains. This implies that in the 
ff15ipq/SPC/Eb simulations the dynamics of the two domains are too tightly coupled and is 
consistent with our observation that the ff15ipq/SPC/Eb conformational ensemble is too compact 
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(Figure 4.5), adopting only a single inter-domain orientation (Figure 4.1). The 
CHARMM22*/TIP4P-D simulation yielded τc values of ~11 ns and 7 ns, capturing the difference 
in rotational diffusion between the domains. However, the τc value of the CVNH domain is 
somewhat higher than the experimentally measured one, consistent with our prior results for 
single-domain proteins using this force field/water model combination.184 
Tracking τc over the course of the simulation reveals that for the first microsecond of the 
ff15ipq/SPC/Eb simulation the τc of the LysM domain was relatively accurate, but became worse 
at ~700 ns when the two domains collapsed onto each other and remained in a single inter-domain 
orientation for the remainder of the simulation (Figure 4.32). It therefore appears that the 
ff15ipq/SPC/Eb combination provided accurate rotational diffusion for the conformations that 
were sampled, but that the distribution of sampled conformations was inaccurate. 
4.3.5 Preferred inter-domain orientations of Mo-WT 
To determine the distribution of inter-domain orientations within the Mo-WT protein, 
paramagnetic relaxation enhancement (PRE) measurements were carried out with a single-cysteine 
variant of Mo-WT. PREs represent the increased relaxation of nearby nuclear spins around a 
paramagnetic moiety, resulting in broadening of the associated resonances. The large magnetic 
moment of the unpaired electron causes a large effect, and PREs can be observed over distances 
up to 35 Å. The PRE effect scales as 1/r6, with r the distance between the unpaired electron in the 
paramagnetic center and the affected nucleus. Further, in systems that exchange rapidly between 
different conformations, the measured PREs are the population-weighted averages of the PREs for 
all sampled conformations, allowing even transient, low-population contacts to be captured.200 
Finally, PREs can be back-calculated from known structures, permitting integration into structure 
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calculations and validation of candidate models,199 rendering the PRE approach the ideal 
methodology for the characterization of distributions. 
To probe whether contacts between the two domains of Mo-WT can be captured by PREs, 
we attached the paramagnetic MTSL tag to a cysteine residue in the CVNH domain and measured 
PREs on residues in the LysM domain. Since Mo-WT contains four cysteines, none of which are 
involved in disulphide bonds in the native structure,22 it was necessary to remove all but one 
cysteine for single site spin-labeling. This was achieved by introducing C15S and C25A mutations 
into the CVNH domain and the C82V mutation into the LysM domain, leaving C167 at the C-
terminus exclusively available for attachment of the paramagnetic tag (Figure 4.9 and Figure 4.33). 
To verify that attachment of the MTSL tag did not affect the structure of the protein, we recorded 
the 1H-15N HSQC spectrum of Mo-SAVC tagged with the diamagnetic analog of MTSL at C167 
(Figure 4.7A). Compared to the spectrum of untagged Mo-SAVC, only very small chemical shift 
changes were noted for amino acids close to the C167 attachment site, but not elsewhere (Figure 
4.7B, D). Interestingly, several of the affected resonances exhibited doubling, suggesting that 
attachment of the tag results in two slightly different conformations its vicinity. In the 
paramagnetically-tagged species, however, the equivalent resonances were broadened beyond 
detection and were therefore not included in the analysis. 
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Figure 4.7. PRE data for Mo-WT. (A) Superposition of the 1H-15N HSQC NMR spectra of untagged Mo-SAVC 
(green) and Mo-SAVC with paramagnetic (teal) or diamagnetic (gold) tags attached to C167. (B) Chemical shift 
differences between Mo-WT and Mo-SAVC, and between tagged and untagged Mo-SAVC. The positions of the 
changed cysteines C15S, C25A, and C82S are marked with asterisks, and C167 to which the tags are attached is 
marked with a caret. (C) Ratio of peak intensities for the paramagnetically- and diamagnetically-tagged proteins, 
measured experimentally (cyan) and calculated from MD simulations (red, purple). Cyan shaded region represents 
95% confidence interval of the experimental ratios. Since the MTSL tag was not present in the MD simulations, 
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simulated intensities were calculated based on the distances between each backbone amide hydrogen and Sγ of C167. 
(D) Chemical shift differences between Mo-WT and diamagnetically-tagged Mo-SAVC, mapped onto the structure 
of MoCVNH3, using a white to green gradient to represent the degree of difference. Residues for which chemical shift 
differences are not available are shown in blue. The substituted amino acids C15, C25, and C82, as well as C167 with 
the tag are shown in licorice representation. (E) Experimental and back-calculated (F) AMBER ff15ipq/SPC/Eb and 
(G) CHARMM22*/TIP4P-D ratios of peak intensities mapped onto the experimental NMR structure, using a red to 
white gradient to represent the intensity ratio. Residues for which intensity ratios are not available are shown in blue. 
C167 with the tag is shown in licorice representation. 
 
PREs were quantified by comparing resonance intensities in the spectra of 
paramagnetically- and diamagnetically-tagged samples (Figure 4.7C). For the CVNH domain, the 
experimentally determined intensity ratios exhibited a clear dependence on the distance between 
each residue and the MTSL tag (Figure 4.7E). For residues in the LysM domain, the amide 
resonances of T64, T66, D83, and F84 show strikingly lower intensity ratios than resonances of 
other residues in this domain. Given that T64 and T66 lie on one side of the LysM domain and 
D83 and F84 lie on the other side of the domain, it is impossible for all four of these residues to 
be simultaneously close to the MTSL tag. Thus, the Mo-WT protein must be exchanging between 
two different orientations with different sides of the LysM domain transiently approaching the 
MTSL tag. 
To determine whether our MD simulations of Mo-WT captured these two different 
orientations, PRE intensity ratios were back-calculated from the sampled conformations. Since the 
MTSL tag was not included in the simulation model, the Sγ atom of C167 was used as a proxy. 
Within the CVNH domain, agreement between the simulated and experimental intensity ratios was 
observed only for residues far away from C167 (Figure 4.7C, F, G). This indicates that the 
approximation of the paramagnetic group's location in our simulations is insufficiently accurate 
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for residues close to the site, where small inaccuracies in distance and orientation have large effects 
on the back-calculated PREs. However, the imprecision of the paramagnetic tag’s location has a 
smaller effect on ratios calculated for residues in the LysM domain, which are on average further 
away from C167. For the first contact site on the LysM domain, containing T64 and T66, neither 
simulation reproduces the experimental ratios, and none of these two amino acids gets close to 
C167. However, for the second contact site, including D83 and F84, the simulation with 
CHARMM22*/TIP4P-D results in smaller intensity ratios for these and several nearby residues 
centered around D81. Although it is possible that the simulated conformations in which D81 
approaches C167 are representative of the experimental conformations that are responsible for the 
low intensity ratios of D83 and F84, the large standard errors of the back-calculated inter-domain 
PREs suggest that even longer simulations may be required to obtain reliable distributions of inter-
domain orientations. 
To quantitatively link the two contact sites on the LysM domain to the global structure of 
Mo-WT, we measured 1HN-Γ2 PRE rates, representing the R2 relaxation induced by the 
paramagnetic tag, and incorporated them alongside our SAXS data as restraints in the calculation 
of a structural ensemble using XPLOR-NIH.197,201 The calculation was seeded from the prior NMR 
structure,18 in which the individual domain structures of CVNH and LysM were retained. A total 
of 15,000 structures were calculated, and the results yielded good agreement with the experimental 
restraints. The Q-factors for the PRE 1HN-Γ2 rates are 0.41 for CVNH domain residues and 0.52 
for LysM domain residues, while the back-calculated SAXS curves resulted in a Χ2 value of 0.04. 
The average Rg of the calculated structural ensemble is 20.0 Å, which is within the 95% confidence 
interval of the value calculated from the experimental SAXS data using Guinier analysis (20.4 Å). 
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Figure 4.8. Structural ensemble of Mo-WT based on experimental SAXS and PRE data. (A) Probability distributions 
of inter-domain orientations in the calculated structural ensemble. The CVNH domain is shown in red, the LysM 
domain in blue, the inter-domain linkers in green, and MTSL paramagnetic tag in yellow. Structures were best fit to 
the CVNH domain coordinates, and the simulation cell was divided into 1-Å3 bins; solid contours represent bins 
occupied by a heavy atom for at least 1% of the ensemble, while transparent contours represent bins occupied for at 
least 0.1% of the ensemble. (B) A representative structure illustrating the approach between the MTSL tag and T64 
and T66. (C) A representative structure illustrating the approach between the MTSL tag and D83 and F94. (D) 
Distributions of inter-atomic separation between the backbone amide hydrogen of each residue and the nitroxide 
radical of MTSL. (E) Γ2 relaxation measured experimentally (cyan) and back-calculated from the structural ensemble 
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(blue). Cyan shaded region represents 95% confidence interval of the experimental ratios. For clarity, residues whose 
Γ2 exceeded 100 are shown as 100. (F) Contribution of mutually exclusive subsets of conformations to back-calculated 
Γ2. For both the first (T64 and T66) and second contact sites (D83 and F84), nearly all contribution to the back-
calculated Γ2 comes from a subset of structures comprising ~5 % of the total ensemble. 
 
Within the calculated, experimental data-derived ensemble, the probability distribution of 
inter-domain orientations shows that a wide range of orientations is sampled by the system (Figure 
4.8A). Comparison of this experiment-driven ensemble with the two ensembles derived from MD 
simulations alone (Figure 4.2) revealed that CHARMM22*/TIP4P-D reproduced the sampled 
inter-domain orientations in the experiment-driven ensemble more accurately than 
ff15ipq/SPC/Eb. This demonstrates that the rebalancing of protein/protein and protein/water 
nonbonded dispersion interactions in the TIP4P-D water model has benefits for systems beyond 
disordered peptides and proteins, such as the one investigated here. 
 
Table 4.2. Structure calculation of Mo-WT 
Restraints Applied 
CVNH Domain PRE LysM Domain PRE SAXS 
Q-Factor R2 Q-Factor R2 Χ2 
Inter-Domain PRE and SAXS 0.41 0.94 0.56 0.67 0.04 
Inter-Domain PRE only 0.41 0.94 0.52 0.70 0.95 
SAXS only 0.41 0.94 0.67 0.53 0.04 
None 0.41 0.94 0.76 0.47 0.13 
 
The distributions of sampled inter-atomic distances between each backbone amide 
hydrogen and the nitroxide group of MTSL (Figure 4.8D) reveal that in most structures, amino 
acids in the LysM domain are relatively far away from MTSL. However, for distances <25 Å, it is 
possible to discern subsets of structures for which parts of the LysM domain are closer to the 
MTSL tag. Indeed, the back-calculated PRE 1HN-Γ2 rates (Figure 4.8E) reveal that the two contact 
sites on the LysM domain, identified above from the paramagnetic/diamagnetic intensity ratios 
(Figure 4.7C, E), are captured in the ensemble. The high Γ2 of residues D83 and F84 are accurately 
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reproduced, and residues T64 and T66 also yield high Γ2. This finding is particularly gratifying, 
since no restraints on the Γ2 of T64 and T66 were applied during the calculation. Although their 
low intensity ratio indicated that their Γ2 rate had to be high, the peak intensities were too low to 
confidently measure a Γ2 rate, which could be converted into a restraint. However, the Γ2 restraints 
of surrounding residues clearly were sufficient to capture this contact site in the calculated 
ensemble. The subset of structures in which the backbone amide hydrogens of both T64 and T66 
are within 13 Å of MTSL’s nitroxide group comprises 4.0% of all structures and is responsible for 
over 80% of the ensemble’s calculated Γ2 for these two residues (Figure 4.8B, F). The analogous 
subset for D83 and D84 (Figure 4.8C, F) comprises 6.6% of structures, which are responsible for 
over 90% of the calculated Γ2 of these residues. The two subsets are mutually exclusive, and each 
one does not contribute to the Γ2 values of the other set’s contact site. This result vividly 
demonstrates and supports previous findings about the significant influence of low-population 
states on measured PRE Γ2 rates.200 
In order to dissect the influence of the individual inter-domain PRE and SAXS restraint 
terms on the ensemble’s distribution of inter-domain orientations, we calculated three control 
ensembles, in which the inter-domain orientations were restrained by (i) only inter-domain PRE 
restraints, (ii) only the SAXS restraint, or (iii) neither. The Q-factors and Χ2 values for all three 
ensembles are summarized in Table 4.2 (the distributions are depicted in Figure 4.34). 
Unexpectedly, the ensemble that included neither the inter-domain PRE nor SAXS restraints 
yielded a surprisingly low SAXS Χ2 value of 0.13, suggesting that a repulsion term which ensures 
that the domains cannot overlap spatially and geometric terms that account for the linker lengths 
reproduce the conformational space accessible to the domains relatively well. However, this 
unrestrained ensemble does not satisfactorily reproduce the LysM domain Γ2 values, resulting in 
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a Q-factor of 0.76. It also does not capture the two contact sites on the LysM domain. This 
illustrates that, although no fixed inter-domain orientation is present for the two domains, 
measurable differences in population between the accessible orientations for the ensembles can be 
discerned. 
4.4 CONCLUSIONS 
In this work, we have characterized the global structure and dynamics of the flexibly linked 
domain-insertion protein MoCVNH3, using experimental NMR and SAXS studies in combination 
with μs time scale MD simulations. To evaluate the influence of inter-domain linker length on the 
properties of the system, we studied a series of reduced linker-length constructs, in which the two 
domains ultimately become locked into a single inter-domain orientation. For four tested linker 
lengths, the global structural properties of the systems were measured by SAXS, and results were 
compared to MD simulations, testing the ff15ipq/SPC/Eb and CHARMM22*/TIP4P-D force 
field/water model combinations. We found that while ff15ipq/SPC/Eb more accurately retained the 
experimental structures of the individual domains, only CHARMM22*/TIP4P-D reproduced the 
observed increase in the radii of gyration (Rg) for increasing linker length. The inter-domain 
orientations of the wild-type protein were evaluated by PRE measurements, which identified two 
mutually exclusive contact sites between the CVNH and LysM domains. Finally, we used our 
SAXS and PRE data in combination to calculate an overall structural ensemble. Our results show 
that while no fixed inter-domain orientation exists for the two domains of MoCVNH3, measurable 
differences in population for the accessible orientations can be discerned. 
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The above findings are valuable in the context of integrative structural biology, where 
through combinations of various experimental data and computer models one aspires to derive a 
more comprehensive view of structure and dynamics than is accessible from either experiment or 
computation alone. Naturally, all computational models are subject to the accuracy of the selected 
molecular mechanical force fields, which, although quite robust, still possess considerable room 
for improvement. Recent advancements in model development, such as implemented in the 
Implicitly Polarized Q (IPolQ) and ForceBalance approaches, reduce the necessary time 
consuming efforts in each round of improvement.92,184 Coupled to advances in computer hardware 
and algorithms, which increasingly enable longer simulations of larger systems,25,78,79,202,203 ever 
more complex systems will become accessible to simulation. We suggest that the joint 
simulation/experimental study of MoCVNH3 reported here provides a valuable benchmark 
towards this end, in particular for the characterization of structural and dynamical properties of 
multi-domain proteins. 
Overall, the characterization of the structure and dynamics of the two-domain MoCVNH3 
protein is, to our knowledge, the most in-depth biophysical characterization of a domain-insertion 
protein system and illustrates the value of integrating a synergistic combination of NMR, SAXS, 
and long time scale atomistic simulations for characterizing structural ensembles of flexibly linked 
multi-domain systems. 
4.5 ACKOWLEDGEMENTS 
This work was supported by National Institutes of Health grants RO1GM115805 (to L.T.C.) and 
RO1GM080642 (to A.M.G.). K.T.D. was supported by a National Institutes of Health training 
   159 
grant GM088119 and a University of Pittsburgh Andrew Mellow Fellowship. Anton computer 
time was provided by the National Resource for Biomedical Supercomputing (NRBSC), the 
Pittsburgh Supercomputing Center (PSC), and the BTRC for Multiscale Modeling of Biological 
Systems (MMBioS) through Grant P41GM103712-S1 from the National Institutes of Health. The 
Anton computer at NRBSC/PSC was generously made available by D. E. Shaw Research. Local 
computational resources, including GPU nodes, were provided by a National Science Foundation 
MRI Award CNS-1229064 and the University of Pittsburgh’s Center for Research Computing. 
The SAXS data were collected through the SAXS Core Facility of the Center for Cancer Research, 
National Cancer Institute. Time on the shared scattering beamline 12-ID-B was allocated under 
the PUP-24152 agreement between the National Cancer Institute and Argonne National 
Laboratory (Lemont, IL, USA). The Advanced Photon Source, a US Department of Energy Office 
of Science User Facility, is operated by Argonne National Laboratory under Contract No. DE-
AC02-06CH11357. We thank Mike Delk for NMR technical support, Drs. Rieko Ishima and 
Zhaoyong Xi for help setting up NMR relaxation experiments, and David Case and Charles 
Schwieters for enlightening discussions.  
 
   160 
4.6 SUPPORTING INFORMATION 
4.6.1 Supporting figures 
 
Figure 4.9. Amino acid sequences of MoCVNH3 constructs. Residues in the CVNH domain are shown in red, in the 
LysM in blue, respectively, and in the inter-domain linkers in green. In the Mo-SAVC sequence, the C15S, C25A, 
and C82V amino acid changes as well as C167, to which the paramagnetic or diamagnetic tags were attached, are 
shown in bold type. 
Mo-WT   GNYAGNFSGS SRDICLDGAR LRAECRRGDG GYSTSVIDLN RYLSNDNGHF
Mo-2G   GNYAGNFSGS SRDICLDGAR LRAECRRGDG GYSTSVIDLN RYLSNDNGHF
Mo-0G   GNYAGNFSGS SRDICLDGAR LRAECRRGDG GYSTSVIDLN RYLSNDNGHF
Mo-0v   GNYAGNFSGS SRDICLDGAR LRAECRRGDG GYSTSVIDLN RYLSNDNGHF
Mo-SAVC GNYAGNFSGS SRDISLDGAR LRAEARRGDG GYSTSVIDLN RYLSNDNGHF
        1                                                   50
Mo-WT   RWVSGGGGGG GTATVTVQQG DTLRDIGRRF DCDFHEIARR NNIQNEDLIY
Mo-2G   RWVSG----- GTATVTVQQG DTLRDIGRRF DCDFHEIARR NNIQNEDLIY
Mo-0G   RWVS------ -TATVTVQQG DTLRDIGRRF DCDFHEIARR NNIQNEDLIY
Mo-0v   RWVS------ -TATVTVQQG DTLRDIGRRF DCDFHEIARR NNIQNEDLIY
Mo-SAVC RWVSGGGGGG GTATVTVQQG DTLRDIGRRF DVDFHEIARR NNIQNEDLIY
        51                                                 100
Mo-WT   PGQVLQVPTK GGSGGGAGNF WDSARDVRLV DGGKVLEAEL RYSGGWNRSR
Mo-2G   PGQVLQVPTK G-----GGNF WDSARDVRLV DGGKVLEAEL RYSGGWNRSR
Mo-0G   PGQVLQVPTK -------GNF WDSARDVRLV DGGKVLEAEL RYSGGWNRSR
Mo-0v   PGQVLQV--- ------GGNF WDSARDVRLV DGGKVLEAEL RYSGGWNRSR
Mo-SAVC PGQVLQVPTK GGSGGGAGNF WDSARDVRLV DGGKVLEAEL RYSGGWNRSR
        101                                                150
Mo-WT   IYLDEHIGNR NGELIHC
Mo-2G   IYLDEHIGNR NGELIHC
Mo-0G   IYLDEHIGNR NGELIHC
Mo-0v   IYLDEHIGNR NGELIHC
Mo-SAVC IYLDEHIGNR NGELIHC
        151            167
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Figure 4.10. Superposition of the 1H-15N HSQC NMR spectra of Mo-2G (olive), Mo-0G (peach), Mo-0v (brown) and 
Mo-WT (black). 
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Figure 4.11. Backbone RMSD of CVNH and LysM domain atoms of MoCVNH3 constructs over the course of 
simulations with ff15ipq/SPC/Eb (magenta) and CHARMM22*/TIP4P-D (purple). The probability distributions of 
sampled values are shown in the right panels, with the average values indicated by circles. 
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Figure 4.12. Secondary structure (A) and per-residue backbone RMSD for CVNH and LysM domain residues relative 
to the NMR structure (PDB code 2L9Y) (B) of Mo-WT over the course of a 10-μs simulation with ff15ipq/SPC/Eb. 
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Figure 4.13. Secondary structure (A) and per-residue backbone RMSD for CVNH and LysM domain residues relative 
to the NMR structure (PDB code 2L9Y) (B) of Mo-WT over the course of a 7.3-μs simulation with 
CHARMM22*/TIP4P-D. 
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Figure 4.14. Secondary structure (A) and per-residue backbone RMSD for CVNH and LysM domain residues relative 
to the initial model (B) of Mo-2G over the course of a 10-μs simulation with f15ipq/SPC/Eb. 
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Figure 4.15. Secondary structure (A) and per-residue backbone RMSD for CVNH and LysM domain residues relative 
to the initial model (B) of Mo-2G over the course of a 5.5-μs simulation with CHARMM22*/TIP4P-D. 
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Figure 4.16. Secondary structure (A) and per-residue backbone RMSD for CVNH and LysM domain residues relative 
to the initial model (B) of Mo-0G over the course of a 10-μs simulation with f15ipq/SPC/Eb. 
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Figure 4.17. Secondary structure (A) and per-residue backbone RMSD for CVNH and LysM domain residues relative 
to the initial model (B) of Mo-0G over the course of a 5.5-μs simulation with CHARMM22*/TIP4P-D. 
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Figure 4.18. Secondary structure (A) and per-residue backbone RMSD for CVNH and LysM domain residues relative 
to the crystal structure (PDB code 5C8O) (B) of Mo-0v over the course of a 10-μs simulation with f15ipq/SPC/Eb. 
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Figure 4.19. Secondary structure (A) and per-residue backbone RMSD for CVNH and LysM domain residues relative 
to the crystal structure (PDB code 5C8O) (B) of Mo-0v over the course of a 5-μs simulation with 
CHARMM22*/TIP4P-D. 
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Figure 4.20. Distribution of per-residue backbone RMSD values of Mo-WT, Mo-2G, Mo-0G, and Mo0v relative to 
the initial structures over the course of simulations with ff15ipq/SPC/Eb (magenta) and CHARMM22*/TIP4P-D 
(purple). Lines represent the average RMSD values over the simulations, and shaded regions comprise the range 
between the 5th and 95th percentiles of sampled values. 
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Figure 4.21. Backbone Φ/Ψ sampling for individual residues of Mo-WT over the course of a 10-μs simulation with 
ff15ipq/SPC/Eb. The corresponding Φ/Ψ angles in the NMR ensemble (PDB code 2L9Y) are shown in gray. 
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Figure 4.21 (Continued). 
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Figure 4.22. Backbone Φ/Ψ sampling for individual residues of Mo-WT over the course of a 7.3-μs simulation with 
CHARMM22*/TIP4P-D. The corresponding Φ/Ψ angles in the NMR ensemble (PDB code 2L9Y) are shown in gray. 
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Figure 4.22 (Continued). 
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Figure 4.23. Backbone Φ/Ψ sampling for individual residues of Mo-2G over the course of a 10-μs simulation with 
ff15ipq/SPC/Eb. The corresponding Φ/Ψ angles in the initial model are shown in gray. 
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Figure 4.23 (Continued). 
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Figure 4.24. Backbone Φ/Ψ sampling for individual residues of Mo-2G over the course of a 5.5-μs simulation with 
CHARMM22*/TIP4P-D. The corresponding Φ/Ψ angles in the initial model are shown in gray. 
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Figure 4.24 (Continued). 
   180 
 
Figure 4.25. Backbone Φ/Ψ sampling for individual residues of Mo-0G over the course of a 10-μs simulation with 
ff15ipq/SPC/Eb. The corresponding Φ/Ψ angles in the initial model are shown in gray. 
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Figure 4.25 (Continued). 
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Figure 4.26. Backbone Φ/Ψ sampling for individual residues of Mo-0G over the course of a 5.5-μs simulation with 
CHARMM22*/TIP4P-D. The corresponding Φ/Ψ angles in the initial model are shown in gray. 
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Figure 4.26 (Continued). 
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Figure 4.27. Backbone Φ/Ψ sampling for individual residues of Mo-0v over the course of a 10-μs simulation with 
ff15ipq/SPC/Eb. The corresponding Φ/Ψ angles in the crystal structure (PDB code 5C8O) are shown in gray. 
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Figure 4.27 (Continued). 
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Figure 4.28. Backbone Φ/Ψ sampling for individual residues of Mo-0v over the course of a 5-μs simulation with 
CHARMM22*/TIP4P-D. The corresponding Φ/Ψ angles in the crystal structure (PDB code 5C8O) are shown in gray. 
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Figure 4.28 (Continued). 
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Figure 4.29. Difference in experimentally measured (cyan), and back-calculated (magenta, purple) small-angle X-ray 
scattering intensity between the different MoCVNH3 constructs. Y-axis units are arbitrary; shaded regions represent 
95% confidence intervals of the experimental and simulated values. 
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Figure 4.30. Radius of gyration (Rg) of MoCVNH3 constructs over the course of simulations with ff15ipq/SPC/Eb 
(magenta) and CHARMM22*/TIP4P-D (purple). The probability distributions of sampled values are shown in the 
right panels, with the average values marked by circles. Experimental radii of gyration calculated from the SAXS data 
are shown in cyan, and the shaded regions represent 95% confidence intervals on the experimental values. 
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Figure 4.31. Experimental (cyan) and simulated 15N R1, R2, and R2/R1 ratio and 1H-15N heteronuclear NMR relaxation 
data for Mo-WT from simulations with ff15ipq/SPC/Eb (magenta) and CHARMM22*/TIP4P-D (purple), calculated 
using a rolling 500-ns window. Shaded regions of the experimental values and the vertical bars of the simulated values 
represent 95% confidence intervals. 
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Figure 4.32. Rotational correlation time (τc) of the CVNH and LysM domains of Mo-WT over the course of 
simulations with ff15ipq/SPC/Eb (magenta) and CHARMM22*/TIP4P-D (purple), calculated using a rolling 500-ns 
window. The probability distribution of sampled values are shown in the right panels, with average values marked by 
circles. Experimental τc values calculated from the NMR relaxation data are shown in cyan, and the shaded regions 
represent 95% confidence intervals on the experimental values. 
 
 
Figure 4.33. Superposition of 1H-15N HSQC spectra of Mo-WT (black) and the single-cysteine mutant Mo-SAVC 
(green). 
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Figure 4.34. Probability distributions of inter-domain orientations in ensembles calculated using different restraint 
sets. The CVNH and LysM domains are shown in red and blue, respectively, the inter-domain linker in green, and 
MTSL paramagnetic tag in yellow. Structures were best fit to the CVNH domain coordinates, and the simulation cell 
was divided into 1-Å3 bins. Solid contours represent bins occupied by a heavy atom in at least 1% of the ensemble, 
while transparent contours represent bins occupied in at least 0.1% of the ensemble. 
Inter-Domain PRE and SAXS Inter-Domain PRE Only
SAXS Only Unrestrained
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5.0  CONCLUSIONS AND FUTURE DIRECTIONS 
As discussed in Chapter 1, multi-domain proteins are challenging to characterize with traditional 
experimental structural biology techniques, but are amenable to study using integrative methods 
that combine the results of experiments with computer simulations. However, these methods are 
subject to the accuracy of the force fields used for the simulations, and well-characterized 
benchmark systems against which to validate models are therefore needed. The flexibly linked 
two-domain protein MoCVNH3 is an excellent system for such validation. Prior to the work 
described here, our group had solved the structure of MoCVNH3 using solution NMR, finding that 
while the two domains have well-defined structures, there is no fixed inter-domain orientation 
between them. This prevented crystallization, although a variant with shortened inter-domain 
linkers was successfully crystallized and its structure solved.  The conformational sampling of 
flexible systems such as MoCVNH3 in computer simulations depends on the balance of protein-
protein and protein-solvent interactions in the force fields used. MoCVNH3 can be used to 
simultaneously validate force fields’ accuracy in (i) maintaining the structures of folded proteins 
and (ii) balancing protein-protein and protein-solvent interactions. After running  an MD 
simulation of MoCVNH3 using the recently-developed AMBER ff99SB-ILDN force field and 
TIP4P-Ew water model, I found that the two domains stuck together in a single inter-domain 
orientation, in contrast to expectations based on our solution NMR data. Examination of the 
contacts between the two domains revealed a series of salt bridges, leading me to suspect that the 
force field was overstabilizing these interactions. 
I therefore investigated the strength of salt bridge interactions in biomolecular force fields, 
as described in Chapter 2. Using minimal model systems, consisting of side-chain analogues of 
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three oppositely charged amino acid pairs, I compared an assortment of current biomolecular force 
fields and water models both to each other and to experiment. I found considerable variation 
between the force fields, and that salt bridge interactions were overstabilized by all of them. I 
confirmed that our results extend to the complete amino acids by also simulating blocked arginine 
and aspartate dipeptides. With this system, I found that the AMBER ff13α force field offered 
apparent improvement. Importantly, this force field was developed using a new approach to fitting 
nonbonded parameters, the Implicitly Polarized Charge (IPolQ) method, that offered a promising 
path towards more accurate force fields without resorting to more expensive function forms 
(Figure 5.1). 
 
Figure 5.1. Phylogeny of selected AMBER force fields mentioned in this text. At each step changes were made to a 
subset of parameters including charges (Q), van der Waals parameters (σ), backbone torsions (Φ/Ψ), side-chain 
torsions (Χ), angles (θ), and bonds (L). Force field names are colored based on their charge set; the three IPolQ charge 
sets (green) were derived using the same philosophy but have minor differences. For force fields whose name does 
not reflect their approximate year of release, the year of publication is listed below their name. 
 
As AMBER ff13α was extended to a complete force field, ff14ipq, changes were made that 
we discovered had led to drastic overstabilization of salt bridge interactions. I collaborated with 
ff14ipq’s designers to develop an improved version, AMBER ff15ipq, that yields accurate salt 
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bridge interactions relative to other fixed-charge force fields, as described in Chapter 3. However, 
I found that ff15ipq still underperforms relative to more expensive force fields that include explicit 
polarization. Alongside ff15ipq’s updated nonbonded parameters, we improved the bonded 
parameters by quadrupling the number of quantum mechanical target conformations and 
decoupling the parameters of different amino acids. Through extensive simulations of peptides and 
proteins we found that ff15ipq yields extremely encouraging reproduction of NMR observables. 
In particular, ff15ipq reproduces the J-coupling constants of the Ala5 peptide more accurately than 
contemporary force fields that have been fit specifically to this empirical result, providing a major 
validation of the IPolQ method of parameterization. In addition, when paired with the SPC/Eb 
water model with which the force field was developed, ff15ipq yields  accurate 15N R1 and R2 
relaxation parameters. These parameters report on the kinetics of each residue, and when paired 
with the thermodynamics provided by the conformational sampling provide a composite view of 
the per-residue accuracy of the force field. We demonstrated that ff15ipq accurately retains the 
folded structures of globular proteins over multiple microseconds, and captures the folding of 
disordered peptides upon interaction with their binding partners. 
After developing an updated force field that addressed the suspected artifacts observed in 
my initial simulation, I simulated MoCVNH3 and a series of mutants containing reduced length 
inter-domain linkers using AMBER ff15ipq/SPC/Eb and another force field/water model 
combination, CHARMM22*/TIP4P-D. Alongside these simulations we collected additional 
experimental data, such as SAXS for validating the overall structure of the two-domain system. I 
found that despite the adjustments made to the salt bridges, my ff15ipq/SPC/Eb simulation 
remained stuck in a single inter-domain orientation for most of the simulation. However, my 
CHARMM22*/TIP4P-D simulation did not, due to adjustments to the balance of protein-protein 
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and protein-water interactions made in the TIP4P-D water model. Thus, while our adjustments to 
the strength of salt bridge interactions may be valid and necessary, the adjustments were not 
sufficient to completely fix the underlying deficiency as changes to the water model were also 
necessary. My ff15ipq/SPC/Eb simulations did, however, retain the internal structure of the CVNH 
and LysM domains more reliably than our CHARMM22*/TIP4P-D simulations, reinforcing the 
promise of the IPolQ parameterization method. 
I established with this work that MoCVNH3 was a valuable model system, and collected 
further experimental data in order to determine the overall structure of the two-domain system. In 
particular, I collected PRE data to experimentally characterize the distribution of inter-domain 
orientations, attaching a paramagnetic tag to the CVNH domain and measuring the effect on 
resonances in the LysM domain. Our PRE data revealed a pair of mutually exclusive contact sites 
on opposite sides of the LysM domain; both sites cannot approach the paramagnetic tag on the 
CVNH domain simultaneously, demonstrating that the inter-domain orientations must exchange 
rapidly. Using our experimental SAXS and PRE data for MoCVNH3, we calculated a structural 
ensemble of inter-domain orientations. We found that while the two domains of MoCVNH3 indeed 
have no fixed inter-domain orientation, it is still possible to resolve differences in population 
among the possible inter-domain orientations. 
The results of the work carried out during my thesis research have already led to tangible 
improvements in biomolecular force fields. In our comparison of salt bridge interactions between 
different force fields, we found that the CHARMM27 force field was one of the more strongly 
overstabilizing. The latest iteration in this force field lineage, CHARMM36m,204 has been revised 
in light of our results to have weaker salt bridge interactions. Similar adjustments have been made 
to variants of the AMBER ff99SB-ILDN force field, with which we first observed the issue.94,95 
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However, the post hoc corrections made to these force fields, the bulk of whose nonbonded 
parameters have not changed since the 1990s, leave AMBER ff15ipq as the only force field to 
have all its nonbonded and bonded parameters fit consistent with its correction to the strength of 
salt bridges. 
 
Figure 5.2. Comparison of QM target, AMBER ff15iq model, and empirical energy surfaces for Ala, Met, Lys, Asp, 
and Ash (aspartic acid). Top, target QM potential energy surfaces (PES) for the Ace-Ala3-Nme tetrapeptide and the 
Ace-Xaa-Nme depeptides of Met, Lys, Asp, and Ash. Middle, AMBER ff15ipq free energy surface (FES) for the Ace-
Ala-Xaa-Ala-Nme tetrapeptides of each amino acid. Bottom, empirical FES of …-Ala-Xaa-Ala-… for each amino 
acid, derived from statistical analysis of the loop regions of high-resolution crystal structures.143 The Ala3 tetrapeptide 
QM potential energy surface (PES) contains features not present in the Met dipeptide PES (serving as a representative 
example of all neutral dipeptide PES), and these features are expected to be present based on the empirical FES. The 
QM PES of the charged dipeptides of Lys and Asp bear little resemblance to the empirical FES. 
 
The main direction for future development of the AMBER IPolQ lineage of force fields 
will be the addition of virtual sites. These will enable more accurate reproduction of the distribution 
of charge within molecules without altering the inexpensive functional form of the force field. 
However, analysis of our results carried out since the work described in Chapter 3 was completed 
has revealed several potential directions for improvement that do not require virtual sites. Detailed 
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analysis of the target QM potential energy surface (PES) shows that the PES for tetrapeptides 
contain many more of the expected features than do the PES for dipeptides, which comprised most 
of the fitting set (Figure 5.2). This is likely why ff15ipq’s improvements in Ala are so stark, as 
manifested in its excellent Ala5 J-couplings, while the improvements for other residues are more 
ambiguous. Applying the IPolQ method to a fitting set that included exclusively tetrapeptides 
could therefore yield considerable improvement. Also clear from examination of the QM target 
PES is that the PES of charged residues have few of the expected features based on the empirical 
conformations of these residues. This is likely why, in ff15ipq, negatively charged residues Asp 
and Glu exhibit much more restricted wells, while positively charged residues Arg and Lys exhibit 
little discrimination between conformations. These observations extend to our simulations of 
benchmark peptides and proteins: nearly all deviations from native structure involved charged 
residues. It appears that the QM PES of charged amino acids may simply be a poor target against 
which to fit force fields for the solution phase. A key future direction will therefore be to explore 
adjustments to the IPolQ protocol to enable the omission of QM calculations on charged systems 
from the fitting set. 
As force fields continue to improve, our results described in Chapter 4 for MoCVNH3 will 
provide a valuable reference data set against which to validate future force fields, including 
polarizable force fields. While polarizable force fields exceed nonpolarizable force fields for 
selected metrics such as salt bridge stability, polarizable force fields have other limitations that 
will need to be addressed before systems like MoCVNH3 will be useful enough to justify the cost 
of simulating them. For example, in tests of polarizable force fields, the loss of native structure of 
GB3 and ubiquitin observed within tens of nanoseconds108 exceeds that which occurs after multiple 
microseconds for nonpolarizable force fields. Once such issues are addressed in single-domain 
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protein systems, MoCVNH3 will become a valuable validation system for polarizable force fields. 
Overall, our work on MoCVNH3 has laid important groundwork for the characterization of the 
structure and dynamics other flexibly linked multi-domain proteins using integrative structural 
biology methods. 
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6.0  APPENDIX 
6.1 ADDITIONAL PUBLICATIONS 
In addition to the three first-author manuscripts reproduced above, over the course of this work 
smaller contributions were made to two additional publications. The abstracts of each are 
reproduced below. 
6.1.1 Characterization of the Mo-0v reduced linker-length variant of MoCVNH3 
Published as: Koharudin, L. M. I., Debiec, K. T.; Gronenborn, A. M. Structural insight into 
fungal cell wall recognition by a CVNH protein with a single LysM Domain. Structure, 2015, 
23, 2143-2154. 
 
MGG_03307 is a lectin isolated from Magnaporte oryzae, a fungus that causes devastating rice 
blast disease. Its function is associated with protecting M. oryzae from the host immune response 
in plants. To provide the structural basis of how MGG_03307 protects the fungus, crystal 
structures of its CVNH- LysM module were determined in the absence and presence of GlcNAc-
containing cell wall chitin constituents, which can act as pathogen-associated molecular patterns. 
Our structures revealed that glycan binding is accompanied by a notable conformational change in 
the LysM domain and that GlcNAc3 and GlcNAc4 are accommodated similarly. GlcNAc5 and 
GlcNAc6 interact with the LysM domain in multiple conformations, as evidenced by solution 
nuclear magnetic resonance studies. No dimerization of MoCVNH3 via its LysM domain was 
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observed upon binding to GlcNAc6, unlike in multiple LysM domain-containing proteins. 
Importantly, we define a specific consensus binding mode for the recognition of GlcNAc 
oligomers by single LysM domains.  
6.1.2 Validation of the IPolQ method of force field parameterization 
Submitted to Journal of Chemical Physics for publication as: Cerutti, D. S.; Debiec, K. T.; 
Case, D. A.; Chong L. T. Significance of the charge model in biomolecular force field design. 
 
The ff15ipq protein force field is a fixed-charge model built by automated tools based on the two 
charge sets of the Implicitly Polarized Charge method: one set for deriving bonded parameters and 
the other for running simulations. The duality is intended to treat water-induced electronic 
polarization with an understanding that fitting data for bonded parameters will come from quantum 
mechanical calculations in the gas phase. In this study, we compare ff15ipq to two alternatives 
produced with the same fitting software and a large subset of the same data, but following more 
conventional methods for tailoring bonded parameters (harmonic angle terms and torsion 
potentials) to the charge model. The first, f15ipq-Qsolv, derives bonded parameters in the context 
of the ff15ipq solution-phase charge set, and ff15ipq-Qvac, which takes ff15ipq’s bonded 
parameters and runs simulations with ff15ipq’s vacuum-phase charge set used to derive those 
parameters. The IPolQ charge model and associated protocol for deriving bonded parameters are 
shown to be an incremental improvement over protocols that do not account for the material phases 
of each source of their fitting data. Both force fields incorporating the polarized charge set depict 
stable globular proteins and have varying degrees of success modeling the metastability of short 
(5 to 19 residue) peptides. In this particular case, ff15ipq-Qsolv increases stability in a number of 
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α-helices, correctly obtaining 70% helical character in the K19 system at 275K and showing 
appropriately diminishing content up to 325K, but overestimating the helical fraction of AAQAA3 
by 50% or more, forming long-lived a-helices in simulations of a β-hairpin, and increasing the 
likelihood that the disordered p53 N-terminal peptide will also form a helix. In contrast, ff15ipq-
QVac incorrectly depicts globular protein unfolding in numerous systems tested, including Trp 
cage, villin, lysozyme, and GB3, and does not perform any better than ff15ipq or ff15ipq-Qsolv in 
tests on short peptides. We analyze the free energy surfaces of individual amino acid dipeptides 
and the electrostatic potential energy surfaces of each charge model to explain the differences. 
6.2 SOFTWARE DEVELOPED 
6.2.1 MolDynPlot 
MolDynPlot is a Python package for analyzing and plotting data from MD simulations and 
biophysical experiments. MolDynPlot reads in data from sources including AmberTools’ cpptraj 
program for MD simulations,138 the PRIMUS, CRYSOL, and FOXS programs for SAXS 
data,188,190,205 and the Nmrglue library for NMR data.206 Once read in from their original formats, 
data are organized into a consistent data structure provided by the pandas library,207 which may be 
written to and read from either text or the efficient HDF5 database format.208 MolDynPlot 
integrates data processing and analysis, supporting operations including the calculation of averages 
(with block-average standard errors)64 and probability distributions over the course of time series. 
MolDynPlot includes tools for plotting time series, probability distributions, SAXS curves, NMR 
spectra, and several other formats using the Matplotlib package,209 which is extended through the 
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addition of a framework for configuring plots using the YaML text format.210 Plot configuration 
is specified using a hierarchical structure that makes precise per-figure, per-plot, and per-dataset 
configuration possible without needing to write additional Python code. MolDynPlot additionally 
supports writing amino acid sequence-based datasets onto the β or occupancy column of PDB files, 
which may be subsequently used by the Visual Molecular Dynamics program to draw protein 
structures whose coloration corresponds to the data.173 MolDynPlot is freely available on GitHub 
under a 3-clause BSD license.211 
6.2.2 Ramaplot 
Ramaplot is a Python package for the generation of Ramachandran plots, used for visualizing 
probability, free energy, potential energy, or other quantities as a function of the backbone Φ/Ψ 
angles of an amino acid. Like MolDynPlot, Ramaplot is equipped to parse, analyze, and plot output 
from AmberTools’ cpptraj program, which includes complementary functions for analyzing MD 
simulations.138 Ramaplot is also equipped to work with data from the Weighted Histogram 
Analysis Method (WHAM),119 an enhanced sampling technique useful for rapidly quantifying the 
backbone Φ/Ψ conformational preferences of amino acids. For validating the results of MD 
simulations, Ramaplot supports experimental data from two datasets generated through statistical 
analysis of known protein structures. The Neighbor-Dependent Ramachandran Distribution 
(NDRD) dataset includes Φ/Ψ distributions for each amino acid derived from the loop regions of 
high-resolution structures, including consideration of the influence of adjacent residues.143 The 
Conformation-Dependent Library (CDL) dataset includes the average values of the backbone 
heavy atom bond lengths, angles, and ω torsion as a function of backbone Φ/Ψ.212,213 Ramaplot 
supports analysis functions including the subtraction of distributions and the calculation of the 
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populations of different states within Φ/Ψ space. Ramaplot is freely available on GitHub under a 
3-clause BSD license.214 
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